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Abstract 
 The molecular events after spinal cord injury that lead to the establishment of a 
permissive environment and epimorphic regeneration remain unclear. Two molecular 
pathway regulators that may converge to create a spinal cord regeneration-permissive 
environment in the urodele are retinoic acid (RA) and microRNAs (miRNAs). Recent 
evidence suggests that RARβ-mediated signaling is necessary for tail and caudal spinal 
cord regeneration in the adult newt. MicroRNAs are attractive candidates as mediators of 
retinoid signaling during regeneration, as their pleiotropic effects are vital in situations 
where global changes in gene expression are required. Thus, the overall aim of this thesis 
was to determine if miRNAs are involved in tail and caudal spinal cord regeneration in 
the adult newt, and if they act as regulators and/or effectors of retinoid signaling during 
this process. I have demonstrated here, for the first time, that multiple miRNAs are 
dysregulated in response to spinal cord injury in the adult newt, as well as in response to 
inhibition of retinoid signaling. Two of these miRNAs, miR-133a and miR-1, appear to 
target RARβ2 transcripts both in vivo and in vitro. Inhibition of RA signaling via RARβ 
with a selective antagonist, LE135, alters the pattern of expression of these miRNAs, 
which leads to an inhibition of tail regeneration. These data are indicative of a negative 
feed back loop, albeit potentially an indirect one. I also aimed to examine which miRNAs 
are affected by inhibiting RA synthesis during regeneration, and provided a long list of 
miRNAs that are dysregulated. These data provide the foundation for future studies on 
the putative roles of these miRNAs, as well as their function in retinoid signaling. 
Overall, these studies provide the first evidence for a role for miRNAs as mediators of 
retinoid signaling during caudal spinal cord regeneration in any system.  
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1.01 General Introduction 
Regeneration is a phenomenon that has fascinated scientists for centuries. It is 
defined as an organism’s ability to replace a lost structure, which can be achieved through 
several different processes including stem cell compensation, morphallaxis or epimorphic 
regeneration (Gilbert, 2000). Epimorphic regeneration involves the replacement of lost 
structures through blastema formation and proliferation of dedifferentiated cells, while 
morphallactic regeneration is simply the reorganization of the remaining tissue (Gilbert, 
2000). The ability to regenerate varies widely across the animal kingdom, for example 
planaria are capable of regenerating almost an entire organism from a fraction of the 
original adult (Ermakova et al., 2009; Romero and Bueno, 2001). However this degree of 
regenerative capacity is rare, most mammalian species have a very limited capacity to 
regenerate lost structures in response to injury, particularly after reaching adulthood.  
Urodele amphibians are unique in that they are the only tetrapod vertebrates capable 
of regenerating lost structures into adulthood, including limbs, heart tissue, lens, brain, 
tail and spinal cord (Chernoff et al., 2003; Lee-Liu et al., 2013). Understanding the 
mechanisms and signaling pathways that contribute to an organism’s regenerative 
capacity is a major area of research, and could eventually lead to innovative approaches 
for injury treatments. The mechanisms that allow for tail and spinal cord regeneration in 
the newt remain poorly understood. It has been documented that retinoid signaling is vital 
for this process, and is specifically regulated through its ligand-activated receptor, 
retinoic acid receptor β (RARβ) (Carter et al., 2011; Dmetrichuk et al., 2005). However 
the upstream regulators of this signaling pathway as well as its downstream target genes 
remain unclear.  
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MicroRNAs are attractive candidates as effectors of retinoid signaling. They are 
small, non-coding RNAs that post-transcriptionally regulate gene expression. 
MicroRNAs are pleiotropic, meaning that they can have multiple targets, which makes 
them useful in situations where rapid changes in gene expression are required. This 
research examined the expression, localization and function of several microRNAs as 
potential effectors of retinoid signaling during caudal tail regeneration in the adult newt. 
Of particular interest were the microRNAs miR-1 and miR-133a, which were found to 
target RARβ, and appear to maintain its low levels of expression in tail and spinal cord 
tissue prior to injury. In response to a spinal cord injury, their downregulation is required 
and maintained by the upregulation of RARβ for functional tail regeneration. These data 
represent the first to examine microRNAs involvement in retinoid signaling during spinal 
cord repair in any species. 
1.02 Spinal Cord Injury and the Regenerative Capacity of Mammals 
 Spinal cord injury (SCI) is a major health burden in humans since recovery from 
an injury to the central nervous system (CNS) is generally poor and can lead to 
permanent deficits such as paralysis. The World Health Organization estimates that more 
than 500,000 people suffer from an SCI each year (WHO, 2013). The majority of SCIs 
are the result of an accident and thus the type of injury is compression on the spinal cord, 
but the primary injury can also be the result of a stab lesion or blunt impact. This initial 
injury is characterized by immediate tissue damage, disruption of the meninges, 
hemorrhage, ischemia and wide spread cell death of glia and neurons (Anthony and 
Couch, 2014; Donnelly and Popovich, 2008; Harty et al., 2003; Zhou et al., 2014). While 
the primary trauma results in necrosis of tissue surrounding the site of injury, a 
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subsequent secondary response ensues, which leads to expansion of the injury site. This 
leads to further tissue death, as well as the establishment of both chemical and physical 
barriers that inhibit axonal regeneration (Zhou et al., 2014). This secondary injury 
response consists of inflammation, formation of the glial scar and the production of white 
matter inhibitors. 
Inflammation after SCI 
 An immediate consequence of a SCI, and the beginning of secondary trauma, is 
the ensuing inflammatory response, which although in some ways is beneficial, can 
persist for years after the initial injury. The inflammatory response is evoked by the 
release of inflammatory cytokines and chemokines such as tumor necrosis factor α (TNF-
α), interferon γ (IFN-γ) and interleukin β (IL-1β) from injured neurons and glia 
immediately after the injury (Donnelly and Popovich, 2008; Zhou et al., 2014). The first 
immune cells to migrate to the site of injury within the first few hours are neutrophils, 
which are circulating leukocytes that enter the lesion via chemotaxis. In the lesion, 
neutrophils release neurotoxic enzymes, free radicals and proteases that lead to further 
neuronal toxicity (Donnelly and Popovich, 2008; Zhou et al., 2014). Within the first 
week, lymphocytes infiltrate the site of injury, where reactive T cells mount a response 
against myelin and further exacerbate neuronal pathology (Donnelly and Popovich, 
2008). The activation of T cells can lead to a parallel activation of B cells and thus 
antibody production, which can result in systemic neurodegenerative pathologies but also 
the beneficial production of neurotrophins. From 7 days post injury onward, macrophages 
infiltrate the lesion, and like leukocytes, they can be both beneficial as well as damaging. 
Activated macrophages and resident microglia release inhibitory cytokines, free radicals, 
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proteases and neurotoxic enzymes, and are also adept at killing surrounding healthy glia 
and neurons, actually increasing axonal dieback (Cregg et al., 2014; Donnelly and 
Popovich, 2008; Zhou et al., 2014). While for the most part, these effects of activated 
macrophages are inhibitory towards functional healing, they are also involved in 
neuroprotection because they actively remove the debris of dead cells from the site of the 
lesion, and in some cases release neurotrophic factors as well as modulating 
excitotoxicity. Unfortunately, another role of macrophages in secondary trauma after SCI 
is to promote migration of resident astrocytes to the lesion, which ultimately leads to 
astrogliosis (Fig. 1.1) (Fitch et al., 1999). 
Formation of the Glial Scar 
 During astrogliosis, these resident astrocytes migrate not to the center of the 
lesion, but rather to the outer edges of the lesion, where secondary cell death occurs and 
they are activated and form the glial scar (Cregg et al., 2014; de Rivero Vaccari et al., 
2012; Sahni et al., 2010; Shearer et al., 2003; Silver and Miller, 2004). Around the 
periphery of the scar, these astrocytes proliferate and become hypertrophic, increasing in 
size as well as upregulating expression of glial fibrillary acidic protein (GFAP), nestin 
and vimentin. These hypertrophic astrocytes come together to form a mesh like layer with 
their long filamentous processes intertwined, forming the glial scar (Cregg et al., 2014; 
Silver and Miller, 2004). This layer of astrocytes acts not only as a physical barrier 
impeding axonal outgrowth, but also produces proteoglycans such as chrondroitin 
sulphate proteoglycans (CSPGs), which are potent inhibitors of axonal regeneration. 
Thus, even those injured axons that escape the initial trauma and are capable of regrowth 
encounter the glial scar and cannot overcome these barriers, and develop dystrophic end 
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bulbs which can persist for decades (Cregg et al., 2014). Furthermore, after dieback 
dystrophic axons become closely associated with NG2+ oligodendrocytes precursor cells, 
and actually form synaptic-like connections with these cells (Filous et al., 2014). This 
association prevents axonal regrowth and represents another obstacle that needs to be 
overcome for recovery from a SCI. When the scar is mature and fully formed, it has two 
very distinct components, the penumbra, which is the layer of hypertrophic astrocytes 
around the perimeter, and the inner lesion core that consists of oligodendrocyte precursor 
cells (OPCs), ependymal cells, phagocytic macrophages, meningeal cells and pericytes.   
 
Figure 1.1. The site of the initial injury to the spinal cord (red) is much smaller than the 
cavitation and cell death caused by the secondary injury (grey) due to inflammation and 
glial scarring after SCI (Taken from Zhou et al., 2014- no copyright permission required). 
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Myelin-Associated Inhibitors 
Inflammation and the formation of the glial scar together form an extremely 
inhibitory environment for axonal regrowth. Another contribution to this formation of an 
inhibitory environment comes from CNS myelin-associated inhibitors (MAIs), which are 
released with the breakdown of white matter during the SCI (Lang et al., 2014; Xie and 
Zheng, 2008). The three most common inhibitors are myelin-associated glycoprotein 
(MAG), neurite outgrowth inhibitor (Nogo) and oligodendrocyte-myelin glycoprotein 
(OMgp) (Lang et al., 2014). Their receptors can be found on the surface of neurons, with 
the most common shared receptor being the Nogo receptor (NgR). Ligand-bound-NgR 
inhibits neuronal growth through the activation of Rho kinase. This ultimately causes 
growth cone collapse through a negative modification of the actin cytoskeleton (Fujita 
and Yamashita, 2014; Xie and Zheng, 2008).  
Intrinsic Capacity for Axonal Regrowth 
Extrinsic inhibitors and glial scarring are not the sole reason for lack of axonal 
regrowth in the mammalian model; after development there is also a decrease in the 
number of growth promoting axonal guidance molecules such as neurotrophic factors 
(Giger et al., 2010). These factors include nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT-3, NT-4). With the 
exception of areas that maintain a level of neural plasticity, such as the PNS and certain 
areas of the brain, these growth promoting factors are not present in the adult mammalian 
CNS (Giger et al., 2010). A lack of regeneration may also reflect a decreased intrinsic 
capacity of the injured neuron to respond to permissive extracellular cues (Muramatsu et 
al., 2009). For example, gene expression that is required for cytoskeletal rearrangement 
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may not occur, which would lead to an inability for the axon to respond to extrinsic 
growth promoting cues (Muramatsu et al., 2009). Taken together, the cascade of events 
during the first weeks post SCI creates an extremely inhibitory environment for 
functional regrowth, and often results in an expansion of the original injury site due to 
cavitation with secondary cell death as well as scar formation. 
1.03  Spinal Cord Regeneration in Urodeles and Other Regeneration-Competent 
Species 
 Unlike mammals, adult urodele amphibians have the ability to regenerate several 
different tissues, including, but not limited to, lens, heart, limb and spinal cord (Chernoff 
et al., 2003, 2002; Iten and Bryant, 1976; Lee-Liu et al., 2013; Zukor et al., 2011). The 
regenerative capacity of these tetrapods makes them ideal models to study the cellular 
and molecular mechanisms that result in a permissive environment for spinal cord 
regeneration, as factors that are present in the newt may be altered in the mammalian 
system, or could be unique to the newt and thus completely absent in the mammalian 
model system. There are two methods of studying spinal cord regeneration that are 
frequently used in the urodele, spinal cord transection and caudal tail amputation (Fig. 
1.2) (Lee-Liu et al., 2013). The spinal cord in the adult newt surrounds a central canal, 
which is bordered by ependymoglial cells, gray matter which consists of dorsal and 
ventral horns, and white matter and thick layers of collagen produced by meningeal cells 
(Chernoff et al., 2003).  
The Transection Model 
Following a complete transection of the spinal cord, functional recovery, which is 
measured by the ability to swim, has been recorded as early as 4 weeks post injury in the 
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newt (Davis et al., 1990). Lesion of the spinal cord in the newt triggers an ependymal 
response, where reactive ependymal cells proliferate and migrate into the lesion. The 
ependymal cells reorganize into a characteristic mesenchyme, and form an ependymal 
bridge which seals the ends of the cord stump (Chernoff et al., 2003). Axons then 
regenerate across the lesion in close association with glial processes and meningeal cells, 
regenerating through ependymal processes, using the ependymal bridge as support to 
reach the other side of the lesion and reestablish functional connections (Zukor et al., 
2011).  
 
 
Figure 1.2. Different models used to study SCI, taken from Lee-Liu et al., (2013), 
copyright permission license #3646231145990. a) Caudal spinal cord regeneration 
following amputation of the tail of urodele amphibians as well as certain anuran tadpoles. 
b, c) Transection or resection of the spinal cord in urodele amphibians, which more 
closely resembles a crush injury, the most commonly used in the mammalian model 
system (d, e), as described above. 
 
The Caudal Tail Amputation Model 
The recovery from a complete transection of the spinal cord is simplistic 
compared to caudal tail regeneration, as the only area regenerating is the spinal cord and 
not surrounding tissue, and this model also bears a closer resemblance to SCI in 
mammals (Fig. 1.2) (Lee-Liu et al., 2013). However, the caudal tail amputation model is 
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more frequently used to study spinal cord injury in urodeles, in most cases due to the 
simplicity of the surgery compared to the transection models. This injury involves the 
complex regeneration and patterning of non-neural structures as well as the regrowth of 
the spinal cord (Chernoff et al., 2003; Diaz Quiroz and Echeverri, 2013; Lee-Liu et al., 
2013). The hallmark of this type of epimorphic regeneration is the establishment of a 
wound epilthelium within the first 24 hours post amputation (Fig. 1.3) (Iten and Bryant, 
1976), followed by the establishment of a highly proliferative mass of dedifferentiated 
cells which form the blastema (Tanaka and Weidinger, 2008). Contact between the spinal 
cord and wound epithelium is thought to induce the epimorphic regenerative response 
and blastema formation (Chernoff et al., 2003). The blastema also produces neurotrophic 
factors which stimulate neuronal regeneration in the tail (Bernard Bauduin et al., 2000). 
The blastema alone is capable of stimulating the regeneration of muscle and connective 
tissue, but is not sufficient to stimulate spinal cord regrowth, suggesting that non-
blastema factors are involved in this process.  
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Figure 1.3. Sagital sections of the adult newt tail, Notophthalmus viridescens, during 
regeneration, taken from Iten and Bryant, (1976), copyright permission license 
#3646240103239. A) 2 day regenerate displaying a thickened epidermis (E) and 
degenerating muscle (dM) X 67. B) 10 day regenerate showing the terminal vesicle (Tv), 
blastema (B) and transected vertebra (V) X 71. C) 21 day regenerate displaying the 
regenerating spinal cord (SC) X 57. 
 
The Ependymal Response 
Similar to the transection model, caudal tail and spinal cord regeneration is highly 
dependent on an ependymal response (Chernoff et al., 2003). The ependymal cells rostral 
to the site of amputation proliferate, migrate caudally, and form a caudal hollow terminal 
vesicle which is continuous with the central canal of the spinal cord (Chernoff et al., 
2003). Outgrowth occurs as a tubular extension within the regenerating tail, and these 
ependymal cells maintain this proliferative state along the length of the ependymal tube, 
while also maintaining their apical/basal polarity throughout regrowth (Chernoff et al., 
2003). New neurons and glia are produced from the ependymal tube, and newly formed 
ependymal cells also give rise to other neural tissue in the regenerating cord that would 
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normally be derived from the neural crest (Chernoff et al., 2003). The ependymal tube 
also acts as a scaffold for regenerating axons that regrow from the tail stump into the 
extending regenerate. Thus, reinnervation of the regenerating tail occurs from new 
neurons that are born through neurogenesis during tail regeneration, as well as from 
existing neurons (Chernoff et al., 2003). 
In both the spinal cord transection and caudal tail amputation injury models, there 
is an ependymal response, which is the critical step for spinal cord regeneration in both 
types of regeneration (Chernoff et al., 2003; Lee-Liu et al., 2013; Mchedlishvili et al., 
2012). The ependymal bridge in transection model SCIs and ependymal tube in the tail 
regenerate not only act as a scaffold for axonal regrowth, but also give rise to new 
neurons, glia and other CNS and PNS tissue via an epithelial to mesenchyme transition 
(Chernoff et al., 2003; Echeverri and Tanaka, 2002; Mchedlishvili et al., 2012). These 
ependymal cells are morphologically similar to radial glia during development, and have 
been demonstrated to have neural stem cell characteristics (Lee-Liu et al., 2013; 
Panayiotou and Malas, 2013). What is interesting is that similar cells are present in the 
mammalian spinal cord and are thought to represent a population of neural stem cells in 
the spinal cord in these organisms (Barnabé-Heider et al., 2010). Indeed, mammalian 
ependymal cells initiate an “ependymal response” after SCI, with an increase in 
proliferation. However, their fate is somewhat restricted in that they only give rise to cells 
of different glial lineages (Barnabé-Heider et al., 2010). 
Factors Inhibitory to Regeneration in Mammals are Present in the Newt After SCI  
Considering that the environment of the lesion post-SCI in mammals is not 
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urodeles would be completely different. Surprisingly, many of the factors that are 
inhibitory to regeneration in mammals such as CSPGs, MAIs and astrocytes are also 
present in the urodele (Hui et al., 2013; Zukor et al., 2011). Similar to mammals, there is 
an inflammatory response after spinal cord transection in the newt involving immune 
cells such as lymphocytes, monocytes and phagocytic macrophages (Zukor et al., 2011). 
In mammals, this inflammatory response is in some ways beneficial but ultimately causes 
more harm than good. Conversely, in the urodele the outcome of inflammation appears to 
be beneficial and not detrimental. Furthermore, ablation of macrophages in the axolotl 
limb during regeneration completely inhibited outgrowth (Godwin et al., 2013), 
suggesting that this inflammatory response is in fact a requirement for functional 
regrowth.  
The outcome of the glial response to SCI is very different in mammals and 
urodeles. There are astrocytes present in the newt SCI lesion, however they do not 
become hypertrophic and do not form a glial scar (Zukor et al., 2011). Like mammals, 
there are also CSPGs and inhibitory extra cellular matrix (ECM) proteins, but they are not 
produced by astrocytes in response to injury and are not detrimental to axonal 
regeneration (Zukor et al., 2011). Finally, there are also MAIs released from damaged 
oligodendrocytes in the urodele during SCI similar to those observed in the mammal (Hui 
et al., 2013). Despite the fact that the NgR receptor for these MAIs is broadly expressed 
in the urodele spinal cord, inhibition of axonal outgrowth is not apparent. If the same 
types of inhibitory factors are present in the urodele as the mammal, how are they able to 
recover from an SCI? What factors or mechanisms post SCI allow for the establishment 
of a permissive environment for spinal cord regeneration in the urodele that are absent in 
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the mammal? The identification of the complex factors and signaling cascades that 
contribute to this permissive environment represent the focus of most current research on 
spinal cord regeneration in urodeles. 
The cues that trigger the ependymal response and the establishment of a 
permissive environment in the urodele after injury remain elusive, however several 
factors have been implicated that may differ between the mammalian and urodele SCI 
models. Such factors include fibroblast growth factors (FGFs) and bone morphogenic 
proteins (BMPs) (Chernoff et al., 2003; Diaz Quiroz and Echeverri, 2013; Lee-Liu et al., 
2013). In mammals, FGF signaling is associated with glial scar formation after SCI 
(Chernoff et al., 2003), while BMPs have been linked to inhibition of oligodendrocyte 
precursor differentiation (Lee-Liu et al., 2013). Conversely, both of these signaling 
molecules are associated with the ependymal response in urodeles (Diaz Quiroz and 
Echeverri, 2013; Lee-Liu et al., 2013). How each of these signaling factors work together 
to direct an ependymal response in one system, but have a different outcome in another is 
a current area of research, as is many other factors that contribute to regeneration and 
stemness of the ependymal cells in urodeles. However, for the remainder of this review 
the focus will be on the role played by retinoic acid, a signaling molecule important 
during development, maintenance and regeneration of the CNS. 
1.04 Retinoic Acid Synthesis and Signaling after SCI 
Retinoic acid (RA) is a small lipophilic molecule that is a biologically active 
metabolite of vitamin A and is crucial during development of the CNS. Vitamin A is 
extracted from the diet as retinyl esters from animal products or carotenoids from plants 
(Maden, 2007). Retinoids are stored as retinyl esters primarily in the liver, and when 
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needed, they are hydrolyzed to retinol in the liver for transport to target cells with retinol-
binding protein 4 (RBP4), where retinol is taken up when RBP4 interacts with its 
membrane receptor STRA6 (Duester, 2008). Once in the cytoplasm, retinol is 
metabolized into all-trans RA (at-RA) in a two-step process. In the first step, RBP1 binds 
to retinol, which is then metabolized to retinaldehyde by retinol dehydrogenases (RDHs) 
(RDH1 and RDH10) and alcohol dehyrogenases (ADHs) (ADH1, ADH3 and ADH4) 
(Duester, 2008). The final step in RA synthesis occurs when retinaldehyde is oxidized to 
RA by several retinaldehyde dehydrogenases (RALDH1, 2 and 3). Newly synthesized 
RA can act either in a paracrine or autocrine manner. In its target cell, it enters the 
nucleus with the assistance of cellular retinoic acid binding protein (CRABP2). In the 
canonical pathway RA can bind to retinoic acid receptors (RARs) and retinoid X 
receptors (RXRs), which would trigger the formation of an RAR/RXR heterodimer 
(Maden, 2007). There are three RAR and RXR subtypes (RARβ, RARγ, RARα) (RXRγ, 
RXRβ, RXRα), each of which has different isoforms. Once bound to RA, the 
heterodimer associates with a transcription complex that binds to a retinoic acid response 
element (RARE), leading to the activation or repression of the expression of its target 
gene (Fig. 1.4) (Duester, 2008; Maden, 2007).  
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Figure 1.4. The canonical retinoic acid synthesis and signaling pathway. All-trans RA is 
synthesized through a two-step process, where it can then act on its own or a nearby cell. 
It enters the nucleus and binds to a RAR, which heterodimerizes with an RXR to activate 
or repress target gene expression, taken from Duester, (2008), copyright permissions not 
required. 
 
This cascade represents the classic RA synthesis and signaling pathway. Parallel 
sequencing and bioinformatics with multiple cell types have suggested that there are 
thousands of genomic RAR binding sites (Rochel and Moras, 2014), however not all RA-
regulated gene networks are associated with a RARE. There are several studies that 
suggest a non-canonical role for RA signaling, including interactions with intermediate 
transcription factors, receptor association with other regulatory proteins, or even non-
genomic receptor actions (Balmer, 2002; Farrar et al., 2009). Furthermore, even within 
the canonical RA signaling pathway, potential pleiotropic effects on target expression are 
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possible, as there are multiple combinations of RAR and RXR isoforms, which when 
hetero or homodimerized, could associate with multiple targets (Maden, 2007). 
Retinoid Signaling in the Mammalian and Avian CNS 
It has long been established that RA is involved in the patterning, development, 
maintenance and regeneration of the CNS (Blum and Begemann, 2013; Duester, 2008; 
Maden, 2007). During development, RA acts as a morphogenic factor, and is involved in 
the patterning of the anterior/posterior and dorsal/ventral axes of the neural tube and 
neural plate. In the neural tube pathway, RA is synthesized by newly formed somites, and 
specifies the fate of sensory and motor neurons, and is also responsible later on in 
development for the organization of the hindbrain and anterior segment of the spinal cord 
(Duester, 2008; Maden, 2007). RA can be found throughout the developing CNS, but is 
particularly abundant in the developing spinal cord, where it may also act as a 
chemotactic factor (Maden et al., 1998). Indeed, RA is capable of stimulating directed 
neurite outgrowth from both embryonic mouse dorsal root ganglia (DRG) (Corcoran et 
al., 2000), and embryonic chick DRGs in vitro (Maden et al., 1998). RA also elicits 
neurite outgrowth from adult rat DRGs, and this outgrowth is accompanied by an 
upregulation of both RARβ2 and RALDH2 (Corcoran and Maden, 1999). Futhermore, 
deletion of RARβ2 in mice significantly decreased the amount of neurite outgrowth of 
DRGs in vitro (So et al., 2006). These, and other data highlight the role of RARβ2 in 
modulating RA-stimulated neurite outgrowth in these cultures. For example, embryonic 
mouse DRGs express all three subtypes of RARs, but only DRGs that expressed RARβ2 
were able to respond to RA treatment (Corcoran et al., 2000).  
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While RA is able to induce directed neurite outgrowth in the adult PNS, the same 
abilities do not transcend to the adult CNS. Similar to the PNS, embryonic spinal cord 
explants from the mouse cultured with exogenous RA exhibit neurite outgrowth, however 
adult spinal cord explants were unresponsive (Corcoran et al., 2002). It was speculated 
that perhaps expression of RARβ2 was lost in the adult mammalian CNS, and that this 
lack of neurite outgrowth in response to RA treatment was due to an intrinsic inability to 
transduce the RA signal. Indeed, when adult mouse spinal cords were transduced with a 
lentiviral vector expressing RARβ2, they exhibited neurite outgrowth in response to RA 
similar to that seen in the embryonic explants (Corcoran et al., 2002). These data suggest 
RARβ2 is a crucial transducer of the RA signal and its downregulation in the adult 
mammalian CNS may contribute to a lack of regeneration after SCI.  
Increased RARβ Expression is Consistent with Regeneration In Vivo 
Increasing expression of RARβ2 has been shown to increase neurite outgrowth in 
non-permissive environments for both PNS and CNS neurons in vivo (Wong et al., 2006; 
P K Yip et al., 2006). Adult rat DRGs that were transduced with a lentivirus expressing 
RARβ2 exhibited neurite outgrowth in vitro and in vivo; specifically, they were able to 
regenerate past the inhibitory dorsal root entry zone to regain a level of both sensory and 
motor function (Wong et al., 2006). In a similar study, Yip et al., (2006) demonstrated 
that the same outcome was possible with neurons in the CNS. Corticospinal tract neurons 
transduced with the same lentiviral RARβ2 vector were capable of crossing a spinal cord 
lesion, achieving a modest degree of locomotor function. Each of these studies provides 
support for the postulate that not only is RARβ2 a crucial transducer of RA for neuronal 
regeneration, but that it is lost in the adult mammalian CNS. However, more recently, 
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Agudo et al., (2010) provided evidence that RARβ2 expression, while downregulated in 
the adult mammalian spinal cord, is in fact expressed in both the cerebellum and cerebral 
cortex. When adult rat cerebellar neurons were cultured with an agonist of RARβ, 
CD2019, they were capable of growth even in the presence of the myelin associated 
glycoprotein (MAG), a potent inhibitor of neurite outgrowth. Moreover, this RARβ2 
selective agonist was able to promote some functional recovery of the SCI in adult rats 
(Agudo et al., 2010).  
Another study examined the role of Lingo-1 as a potential target of RARβ2 in the 
mouse SCI model. Lingo-1 is associated with NgR, and its expression is associated with 
the production of a non-permissive environment for axonal growth in the adult 
mammalian CNS (Puttagunta and Di Giovanni, 2011). It was found that RARβ2-
mediated the downregulation of Lingo-1 post-SCI in these mice and resulted in a more 
favorable outcome with some functional recovery. These studies demonstrated that when 
RARβ2 is expressed in the adult mammal, it might contribute to the establishment of a 
permissive environment leading to axonal outgrowth and some recovery of function. 
Retinoic Acid Signaling and the Inflammatory Response to SCI 
 Previous studies have also demonstrated that RA has anti-inflammatory 
capabilities. Systemic administration of RA immediately after SCI in the rat reduced the 
production of pro-inflammatory cytokines such as IL-1β, IL-6 and TNFα, and thus the 
overall amount of secondary damage due to inflammation (van Neerven et al., 2010). As 
previously discussed, it has been demonstrated that inhibitory factors such as MAIs and 
inflammation occur in the urodele (Hui et al., 2013; Zukor et al., 2010). Urodeles are 
capable of recovery from SCI, so RAs involvement in inflammation contributes to the 
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idea that a difference between adult mammals and urodele amphibians with respect to 
regenerative capacity could be the ability to transduce the RA signal. 
Retinoid Signaling and Regeneration in Urodele Amphibians 
The role of RA has been examined during both limb and spinal cord regeneration 
in the urodele. During limb regeneration, inhibition of RA synthesis blocks regeneration 
and leads to patterning abnormalities (Maden, 1998). RA is synthesized during limb 
regeneration in the apical epithelium (Monaghan and Maden, 2012), with overlapping 
expression of RARδ1 (Hill et al., 1993), a potential transducer of the RA signal during 
limb regeneration. During spinal cord regeneration in the urodele, RA does in fact appear 
to exert a stimulatory effect on neurite outgrowth in this model system that leads to 
complete functional recovery and morphological reconstitution. Adult newt spinal cord 
explants cultured with limb blastemas exhibited enhanced neurite outgrowth compared to 
explants cultured alone (Bauduin et al., 2000).  Interestingly, limb blastemas pre-treated 
with citral (an RA synthesis inhibitor) had significantly reduced neurite outgrowth 
promoting activity (Prince and Carlone, 2003). These studies suggest that RA produced 
from limb blastemas is capable of promoting neurite outgrowth in vitro. In a study similar 
to those examining the effects of exogenous RA on embryonic mouse spinal cord 
explants, Hunter et al., (1991) demonstrated that RA treatment of adult axolotl spinal 
cord explants in vitro enhanced neurite outgrowth. Dmetrichuk et al., (2005) also 
demonstrated that RA is capable of acting as a chemotactic factor in the urodele as it is in 
the mammalian model. Beads soaked with RA and placed near spinal cord explants 
produced neurite outgrowth, and this outgrowth was directed towards the source of RA. 
Furthermore, this chemotactic effect of RA appeared to be mediated by RARβ, as 
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treatment with LE135, an RARβ-selective agonist completely abolished the trophic 
effects of exogenous RA treatment in vitro.  
The previous data are suggestive of a role for RARβ-mediated retinoid signaling 
in the urodele after SCI. In support of this notion, Carter et al., (2011) examined the 
expression pattern of RARβ2 in the adult newt, and found that unlike in the adult 
mammal, RARβ2 is expressed throughout the spinal cord and brain. In response to injury, 
RARβ2 is upregulated by 7 days post amputation (dpa), and expression is localized to the 
ependymal tube in the regenerating tail. Inhibition of RARβ2 with the selective 
antagonist, LE135 led to an inhibition of tail regeneration and a lack of ependymal tube 
formation (Carter et al., 2011). These data are very interesting, as the ependymal response 
and formation of the ependymal tube is essential for functional spinal cord regeneration 
in the urodele after tail amputation. Thus, the apparent role of RARβ2 post SCI is 
consistent with what has been described in mammals and highlights the importance of 
RARβ2 for functional regeneration. Expression of RARβ as well as other RA signaling 
genes does occur in the ependymal cells surrounding the third ventricle in adult rats 
(Helfer et al., 2012). It is possible that expression of RARβ in the ependymal cells 
surrounding the spinal cord provides them with the stem cell like qualities observed in the 
urodele but not mammalian CNS. However, the precise targets of RARβ2 signaling 
during the ependymal response remain to be elucidated. Uncovering the regulators of 
RARβ2 expression, as well as its downstream targets could provide a clearer picture of 
the mechanisms that allow for regeneration in the urodele after SCI. 
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1.05 MicroRNA Biogenesis and Function During Regeneration 
 Although the role of RARβ has been examined in detail in both the mammalian 
and urodele SCI models, very little research has examined the upstream factors or 
signaling pathways that activate RARβ2, or the downstream targets of RARβ2-mediated 
RA signaling during regeneration. MicroRNAs (miRNAs) are attractive candidates as 
effectors of retinoid signaling during recovery from SCI. miRNAs are an abundant class 
of small, endogenous non-coding RNAs that are approximately 22 nucleotides in length 
and can be found in most somatic cells (Ha and Kim, 2014; Kim et al., 2009; Kosik, 
2006; Thatcher and Patton, 2010). They are very highly conserved among distantly 
related species, and regulate gene expression post-transcriptionally. It is thought that 
more than 60% of protein coding genes are under the control of miRNAs (Ha and Kim, 
2014; Liu et al., 2009). miRNAs are involved in many biological processes including 
developmental timing, stem cell differentiation and signal transduction (Corbin et al., 
2009; Ha and Kim, 2014; Han et al., 2011; Hancock et al., 2014a). Their expression is 
very tightly regulated, so it is no surprise that miRNA dysregulation is often associated 
with cancer and other diseases (Ha and Kim, 2014). Many miRNAs are encoded within 
multiple loci, and have very similar sequences. However in order to be considered a part 
of a miRNA family, each miRNA must have the same “seed” sequence (nucleotides 2-8). 
Sister miRNAs can have very different localizations and thus functions, but for the most 
part are capable of acting redundantly on target mRNAs due to these identical seed 
regions (Ha and Kim, 2014). There are 34 families of miRNAs that are conserved from 
C. elegans to humans, and 196 families conserved among all mammals. Although 
nomenclature varies, miRNAs from different loci end with a number (miR-133a-1, miR-
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133a-2), while those from each precursor strand have a corresponding strand ID (5’= 
miR-133a-5p, 3’= miR-133a-3p) (Ha and Kim, 2014). 
 
 
Figure 1.5. MicroRNA biogenesis and function. MicroRNAs are transcribed in the 
nucleus then undergo two processing steps, one in the nucleus one in the cytoplasm, to 
form the mature miRNA which is incorporated into the RISC complex to target mRNA 
for translational repression. Taken from Fiore et al., (2008), copyright permission license 
# 3646451404901. 
 
Transcriptional Regulation and Processing 
Generally, miRNAs are encoded within the introns of both coding and non-coding 
transcripts, however there are examples where miRNAs are encoded by exonic regions as 
well (Ha and Kim, 2014). Many miRNA loci are often located within close proximity to 
each other within poly-cistronic transcription units, and these clusters are often co-
regulated, however epigenetic and post-transcriptional modifications can also influence 
miRNA expression. Transcription of miRNAs is mediated by RNA polymerase II and its 
associated factors, which generates a hairpin primary miRNA (pri-miRNA) transcript that 
is over a kilobase long (Fig. 1.5) (Ha and Kim, 2014; Kim et al., 2009; Kosik, 2006; 
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Thatcher and Patton, 2010). Processing of this pri-miRNA to its mature form occurs in 
several steps. The hairpin of the pri-miRNA contains the mature miRNA sequence, and 
has a long tail at the 3’ and 5’ ends, and enters a microprocessing unit containing the 
nuclear ribonuclease (RNase III) Drosha and its cofactor DGCR8. The stemloop is 
recognized by DGCR8, which triggers Drosha to asymmetrically cut the stemloop, 
liberating a stemloop with a 5’ phosphorylated end and a 3’ 2 nucleotide overhang, the 
double stranded pre-miRNA (Kim et al., 2009; Thatcher and Patton, 2010). The pre-
miRNA is then transported from the nucleus via the nuclear transport receptor Exportin 5, 
where it undergoes its second processing step. The cytoplasmic RNase III, Dicer, 
recognizes the 3’ overhang of the pre-miRNA. The PAZ domain of Dicer contains two 
pockets, one interacts with the phosphorylated end of the pre-miRNA, the other with the 
3’ overhang (Ha and Kim, 2014). Dicer then cleaves the pre-miRNA, which generates a 
mature miRNA duplex. This duplex is unwound when it associates with a member of the 
Argonaut protein family. Generally the less stable strand is kept while the other is 
discarded for degradation (Kim et al., 2009). Together with these Argonaut proteins, the 
mature miRNA is then incorporated into the RNA induced silencing complex (RISC). 
The mature miRNA recognizes and binds to the 3’ untranslated region (UTR) of its target 
mRNA, through Watson-Crick basepairing, with the key recognition occurring through 
the seed region (Saugstad, 2010; Valinezhad Orang et al., 2014). A perfect match of the 
miRNA to its target results in Argonaut-catalyzed cleavage, while central mis-matches 
result in translational repression, deadenylation and mRNA decay. Since it is only vital 
that the seed region of a miRNA binds to its target mRNA, it is not only possible that 
each miRNA could have many target mRNAs, but also that any given mRNA could be 
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regulated by multiple miRNAs, indicating that miRNAs could potentially regulate whole 
families of genes (Bhalala et al., 2013).  
MicroRNAs and SCI in Mammals 
The pleiotropic effects of miRNAs make them ideal candidates for situations 
where global changes in gene expression need to occur rapidly, such as after an SCI. 
Indeed, there have been several studies that have examined miRNA expression in 
response to SCI using microarray-based analyses (Liu et al., 2009; Nakanishi et al., 2010; 
Nieto-Diaz et al., 2014; Strickland et al., 2011; Yunta et al., 2012). These have revealed 
hundreds of miRNAs that are dysregulated in response to injury. Liu et al., (2009) 
identified a large number of miRNAs that were differentially expressed in the rat in 
response to SCI, and predicted that many of these miRNAs may have roles in 
inflammation, apoptosis and oxidative stress that contribute to secondary damage. In a 
similar study, Nakanishi et al., (2010) used a microarray to identify differentially 
expressed miRNAs after SCI in the mouse, and focused on the miRNAs, miR-124a and 
miR-223. They found that miR-124a is highly expressed in the uninjured spinal cord, but 
downregulated in response to injury (Yunta et al., 2012), while miR-223 expression 
increased in response to injury and was localized to the lesion site. miR-124a is thought 
to be a neural-specific miRNA, as it is highly expressed during neurogenesis, but in this 
case is likely downregulated in association with cell death in the nervous system. 
Conversely, miR-223 has been associated with inflammation, hence its upregulation in 
the lesion core. A microarray by Strickland et al., (2011) confirmed the downregulation 
of miR-124 as well as miR-1 in response to SCI, and also found an increase in miR-21, 
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which was localized in the same cells as SOX2, nestin and REST, suggestive of a stem 
cell niche.  
While each of these studies uncovered a plethora of miRNAs whose expression 
changes due to a SCI, the majority of their functions in response to injury remain 
unknown. There are, however, a few studies that have begun to unravel some of the 
functions of identified miRNAs during secondary trauma. While several miRNAs are 
associated with secondary damage, it is possible that understanding their function could 
lead to treatments for SCI in the mammal. miR-223 has been implicated at various stages 
of inflammation, but importantly is highly expressed in neutrophils that contribute to the 
early inflammatory response and contribute to secondary damage post SCI (Izumi et al., 
2011). Both miR-21 and miR-125b have been implicated in astrogliosis and the 
formation of the glial scar (Bhalala et al., 2012; Pogue et al., 2010). Downregulation of 
miR-21a has been associated with neural protection post SCI via the upregulation of its 
target, neurogenin (Jee et al., 2012).  
miRNAs have also been shown to mediate the differentiation of both neural stem 
cells and oligodendrocytes (Zhao et al., 2010). For example, the miRNAs let-7, miR-9 
and miR-124 have been shown to promote neural stem cell differentiation, while miR-25, 
miR-134 and miR-137 induce neural stem cell proliferation (Meza-Sosa et al., 2014). 
Expression of miR-132 is also associated with axonal extension in mouse DRGs during 
development, where its translational control over Rasa1 promotes outgrowth (Hancock et 
al., 2014b). This study along with others have identified multiple miRNAs that were 
present in extending axons (Iyer et al., 2014), which suggests a potential role for miRNAs 
in the promotion or inhibition of axonal regrowth post SCI. Thus, it is evident that 
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miRNAs are likely involved in virtually every step of secondary damage that occurs after 
a SCI in mammals. Understanding their role, as well as how their function and targets 
may differ in regenerative-competent vertebrates such as the zebrafish and newt could 
provide insight on how to combat these pathologies. 
MicroRNAs in Regeneration-Competent Species 
 There have been multiple studies that examine the role of miRNAs during 
appendage and organ regeneration in regeneration-competent species (Nakamura et al., 
2010; Thatcher et al., 2008; Tsonis et al., 2007; Witman et al., 2013; Yin et al., 2008), but 
relatively few have focused on tail and spinal cord regeneration (Sehm et al., 2009; Yu et 
al., 2011). The let-7 family of miRNAs has been implicated during lens regeneration in 
the newt (Tsonis et al., 2007). In particular, let-7b downregulation is necessary for stem 
cell proliferation during lens regrowth (Nakamura et al., 2010). Cardiac regeneration has 
been examined in both the newt and zebrafish. Witman et al., (2013) used a microarray to 
identify miRNAs that were expressed at various stages of heart regeneration in the newt, 
and found that miR-128 was elevated and targeted Islet1. In a similar study, Yin et al., 
(2012) demonstrated that miR-133 was downregulated during zebrafish cardiac 
regeneration, and experimental induction of this miRNA inhibited functional recovery. 
While these studies do not focus on tail or spinal cord regeneration, they are interesting as 
at least some of the processes are common to all types of epimorphic regeneration, 
including those associated with injury to the tail or spinal cord. These include 
inflammation, stem cell maintenance and anti-apoptotic functions. Of particular interest 
are studies that have examined limb/fin regeneration, as in this case there is formation of 
a blastema and specialized epithelium, as there is in tail regeneration in newts and 
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salamanders. Yin et al., (2008) and Thatcher et al., (2008) both examined miRNAs that 
were vital for caudal fin regeneration in zebrafish. miRNA 133a was found to be high in 
uninjured fins, but significantly downregulated in response to fin amputation (Yin et al., 
2008). It was hypothesized that perhaps miR-133a acts as a “regenerative break”, as it 
targets mps1, a kinase that regulates proliferation in the FGF signaling pathway. Thus 
levels of miR-133a are high when proliferation is not needed but downregulated to allow 
for re-entry into the cell cycle in response to injury. Similarly, Thatcher et al., (2008) 
found that miR-203 is downregulated in response to injury and targets lef1 in the Wnt 
signaling pathway. The authors speculated that miR-203 and miR-133a are both 
downregulated in response to injury to allow for the coordinated activation of these pro-
regenerative pathways. These data suggest that it may not necessarily be miRNA 
upregulation in response to injury that is important for regeneration, but in some cases 
their downregulation is vital to allow for the expression of genes required for functional 
recovery. Conversely, Holman et al., (2012) found that miR-21 is upregulated in the 
axolotl during limb regeneration, and was found to target Jagged to promote proliferation 
of mesenchyme cells. Interestingly, this miRNA is often associated with several cancers 
in humans, including breast, prostate, colon, pancreatic and esophageal. This fact is not 
surprising as processes required for the development of tumors, such as loss of cell cycle 
control or apoptotic factors, are similar to those required for the stages of regeneration. 
MicroRNAs and Spinal Cord Regeneration 
 Understanding the roles of miRNAs during tail and spinal cord regeneration in 
regenerative competent species such as the urodele and zebrafish are just starting to be 
examined, and relatively few studies have been published thus far. Sehm et al., (2009) 
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used a microarray to examine which miRNAs were differentially expressed in response to 
tail amputation in the axolotl. Of particular interest was miR-196, which was highly 
upregulated, and inhibition of this miRNA inhibited tail regeneration. It was found to be 
an upstream effector of BMP4 and Pax7, thus it is involved in the patterning of the 
regenerating spinal cord. As described above, there are two methods of studying SCI in 
regenerative competent species, tail amputation or transection. Yu et al., (2011) examined 
miRNA expression after a complete transection of the spinal cord near the brain stem in 
zebrafish. Upregulation of miR-133b was observed, and inhibition of this miRNA also 
inhibited locomotor recovery. In this study, miR-133b was found to target RhoA, a 
GTPase protein that is activated by MAIs binding to the Nogo receptor, which was 
described above. RhoA is a potent inhibitor of axonal outgrowth, and thus the 
upregulation of this miRNA is necessary to promote functional regeneration of the spinal 
cord. In a similar study, Diaz Quiroz et al., (2014) used microarray data to identify 
miRNAs that were differentially expressed after a complete transection of the spinal cord 
in the axolotl compared to rats. Of particular interest was miR-125b, which is highly 
expressed in the axolotls radial glial cells, but downregulated in response to SCI. miR-
125b was found to target Sema4D, a transmembrane axonal repulsion cue, and it is likely 
that this miRNA is involved in lack of glial scar formation as well as promotion of axonal 
regeneration (Diaz Quiroz et al., 2014). Again, these data are intriguing as it is clear that 
miRNAs are vital during epimorphic regeneration. However, to date there has been no 
research that examined miRNA expression in the newt after tail amputation or spinal cord 
transection, and none in any system (mammalian or regeneration-competent), that 
examine miRNAs as effectors of retinoid signaling in response to SCI. 
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1.06 Objectives 
 The main aim of this thesis was to uncover the potential role of miRNAs during 
tail and caudal spinal cord regeneration in the adult newt, and to determine whether they 
may either regulate and/or be regulated by retinoid signaling pathways during this 
process. There is evidence that miRNAs may be involved after an SCI in mammals, as 
well as regeneration of other structures in urodeles and fish. Furthermore, retinoid 
signaling has been shown to play a vital role in not only the ability of urodeles to recover 
from an SCI, but also the lack of recovery observed in mammals. Thus I hypothesized 
that miRNAs are involved during tail and spinal cord regeneration in newts, and that 
some of these miRNAs may be acting as up or downstream effectors of retinoid signaling 
during this process. Our model system was the eastern spotted newt, Notophthalmus 
viridescens, which is capable of regenerating limb, heart, lens, skin, tail and spinal cord 
tissue (Fig. 1.5). 
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Figure 1.6. The eastern spotted newt, Notophthalmus viridescens, which was used as the 
model system for every study in this thesis. 
 
 The first specific aim of this research was to determine which, if any, miRNAs are 
involved in spinal cord regeneration in the adult newt. Quantitative polymerase chain 
reaction (q-PCR) was used to amplify target miRNAs (miR-133a, miR-132, miR-124a 
and miR-203), and to observe their temporal pattern of expression during early tail 
regeneration. To determine in which tissues miRNAs 133a and 203 were expressed, in 
situ hybridization was used on tissue sections obtained from regenerates at early stages of 
regeneration. Finally, the function of these miRNAs was examined using the in vivo 
injection and electroporation of miRNA mimics and inhibitors. 
 My next objective was to determine which, if any miRNAs were specifically 
acting downstream of retinoid signaling. This was accomplished using a microarray 
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analysis comparing the expression of miRNAs in caudal tail regenerates to those in 
regenerates in which RARβ was inhibited by a selective antagonist, LE135. From this 
list, selected miRNAs were further examined to determine the spatial and temporal 
pattern of expression, as well as function, using the above techniques. 
 Inhibition of RARβ only examined miRNAs that were effectors of retinoid 
signaling, thus my final objective was to uncover other miRNAs that could be acting as 
effectors at any point during retinoid synthesis and signaling. To accomplish this, RA 
synthesis was inhibited using an inhibitor of RALDH2, diethylaminobenzaldehyde 
(DEAB), and again a microarray was used to identify miRNAs involved in this pathway. 
A selection of these miRNAs was then quantified temporally using q-PCR to lay the 
groundwork for future studies on their function. Overall, this thesis provides data for the 
first study of miRNA involvement in retinoid signaling during spinal cord repair in any 
model system. 
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CHAPTER TWO: 
RARβ2 expression is induced by the down-regulation of 
microRNA 133a during caudal spinal cord regeneration in the adult newt. 
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2.01 Abstract  
Adult urodele amphibians represent unique model organisms to study spinal cord 
regeneration. Trauma to the spinal cord induces an ependymal response, activating 
multipotent neural stem cells which contribute to the redifferentiation of both glia and 
neurons in the regenerate. The molecular events underlying this ependymal response are 
not completely understood, but likely involve coordinated global changes in gene 
expression. MicroRNAs (miRNAs) and retinoid signaling are postulated to orchestrate 
these patterns of gene expression in response to trauma. Our objectives were to determine 
the roles played by some miRNAs as potential regulators of retinoid signaling in this 
process. We found that the expression levels of miRNAs 133a, 203 and 124a are 
dysregulated during the first 21 days post amputation (dpa). Interestingly, these miRNAs 
are expressed primarily within the ependymoglia. We have shown in vitro, that a miR-
133a mimic targets the 3’ UTR of the newt RARβ transcript. Importantly, upregulation of 
this mimic in vivo led to a significant decline in RARβ protein at 14 dpa and inhibited 
regeneration. These data are the first to link miRNAs and retinoid signaling during spinal 
cord regeneration and provide support for miR-133a as an upstream regulator of RARβ 
expression in this process. 
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2.02 Introduction 
 Unlike adult mammals, the adult red spotted newt, N. viridescens, is capable of 
regenerating several types of tissue after injury, including the spinal cord (SC) (Chernoff 
et al., 2003; Diaz Quiroz and Echeverri, 2013; Mchedlishvili et al., 2012; Zukor et al., 
2011). After complete transection of the tail, a population of neural stem cells, the 
ependymoglial cells, from the damaged caudal SC, proliferate and extend caudally to 
initiate the regeneration of the missing tissues. This “ependymal response” is coincident 
with the formation of a regeneration blastema, composed of stem-like cells that have 
either de-differentiated from local stump tissues or have been recruited to the damaged 
area (Chernoff et al., 2003; Lee-Liu et al., 2013). The ependymoglial cells will ultimately 
contribute to the redifferentiation of spinal cord neurons and glial cells.   
 The molecular events that underlie this process are not well understood and likely 
involve global changes in gene expression. One factor that may be critical in this process 
is a biologically active metabolite of vitamin A, all-trans retinoic acid (RA) (Blum and 
Begemann, 2013; Maden, 2007). RA is known to modulate the growth and differentiation 
of many cell types and is an important morphogenetic molecule in the embryo (Duester, 
2008). It is abundant in the central nervous system (CNS) of vertebrates (Corcoran et al. 
2002; Malcolm Maden and Hind 2003), particularly in the developing spinal cord (Maden 
et al., 1998), and is required for normal development of the CNS (Maden, 2007; Zhao et 
al., 2008). The actions of RA on target cells are mediated by ligand activated nuclear 
transcription factors, the retinoic acid (RAR) and retinoid X (RXR) receptors, ultimately 
inducing a change in gene activity. At least four isoforms of RARs have been identified 
in regenerating newt tissues (Maden, 1996). It has been hypothesized that one of many 
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factors contributing to the inability of adult mammalian spinal cord neurons to regenerate 
is a post-embryonic inactivation of one or more of the RARs, particularly RARβ 
(Corcoran et al. 2002). In support of this hypothesis, it was shown that a specific RARβ 
agonist could overcome the inhibitory effects of myelin associated glycoprotein (MAG) 
on neurite outgrowth in vitro and could promote functional recovery in a rat spinal cord 
injury model (Agudo et al., 2010).  
 In adult spinal cord tissue of a regeneration-competent species such as the newt, 
RARβ expression is maintained and significantly increased in ependymoglial cells of the 
spinal cord tissue within the first 7 days following tail resection (Carter et al., 2011).  
Moreover, in vivo inhibition of retinoid signaling by administration of a selective 
antagonist for RARβ significantly inhibits spinal cord regeneration (Carter et al., 2011). 
 The multiple pathways either regulating or regulated by RA signaling during 
regeneration of the spinal cord in the newt remain to be elucidated. MicroRNAs 
(miRNAs), a class of small non-coding RNAs, are attractive candidates as both upstream 
and downstream effectors of RA signaling. They regulate their target gene expression 
post-transcriptionally by binding to complementary sequences in the 3’ UTRs of target 
mRNAs, leading to either their degradation or translational repression. Each miRNA can 
have multiple targets and can regulate complex signaling networks (Bhalala et al., 2013). 
Various miRNAs have recently been implicated as regulators of epimorphic regeneration 
of newt lens and hair cells (let-7), newt cardiac muscle (miR-128), fish fins (miR-133a 
and miR-203), as well as spinal cord regeneration in adult zebrafish (miR-133b) and 
axolotls (miR-196) (Sehm et al., 2009; Thatcher et al., 2008; Tsonis et al., 2007; Witman 
et al., 2013; Yin et al., 2008; Yu et al., 2011). However, no miRNAs have as yet been 
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shown to be involved in the regulation of retinoid signaling in regenerating spinal cords 
of an adult regeneration-competent species. In the present study, we demonstrate for the 
first time, a possible role for miR-133a in the regulation of retinoid signaling through the 
RARβ receptor subtype in the ependymoglial cells of the regenerating adult newt spinal 
cord. 
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2.03 Materials and Methods 
Animal Care and Surgery 
All procedures were approved by the Brock University Animal Care and Use 
Committee. Adult eastern spotted newts, Notophthalmus viridescens, were obtained from 
Boreal Science (St. Catharines, Ontario).  Animals were housed in plastic containers in 
dechlorinated water during the experiments, and were fed a diet of liver, brine shrimp or 
bloodworms three times a week. Prior to all surgical procedures, newts were 
anaesthetized by soaking in 0.1% tricaine methane sulfonate (MS-222, Sigma) pH 7.0 for 
10 minutes. Tails were amputated approximately 1 cm caudal to the cloaca, after which 
animals were placed on ice for approximately 20 minutes to recover. At each subsequent 
regenerative timepoint, the above procedure was repeated and blastemas were amputated 
approximately 1-3 mm rostral to the original site of amputation.  
RT-q-PCR 
 Isolated tissues from time 0, 7, 14 or 21 days post amputation (dpa) were 
immediately flash frozen in liquid nitrogen. Total RNA was extracted as outlined in the 
Animal Tissue RNA Purification Kit (Norgen Biotek) from uninjured amputated tail at 
time 0, or from whole blastema at 7, 14 or 21 dpa. Following a quality control test, cDNA 
was synthesized from 750 ng of RNA according to the SuperScript III Reverse 
Transcriptase Protocol (Invitrogen), using gene specific stem-loop primers (Varkonyi-
Gasic et al., 2007). Quantitative real time PCR (RT-q-PCR) was performed with a 20 µl 
reaction containing 5 µl of RNase free water, 10 µl of iQ SYBR Green Supermix 
(BioRad), 1 µl of forward and reverse primers, and 3 µl of cDNA. All reactions had three 
biological and three technical replicates, and were amplified according to the following 
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program: 95°C for 5 min, followed by 40 cycles of 95°C for 15 sec, 64°C for 15 sec and 
72°C for 45 sec. The reference genes used for normalization were 5s rRNA and newt 
Histone Acetyl Transferase. All aspects of the Minimum Information for Publication of 
Quantitative Real-Time q-PCR Experiments (MIQE) guidelines were adhered to for the 
above procedures (Taylor et al., 2010), including establishment of equal amplification 
efficiencies of all reference and target genes. Data were analyzed using the ΔΔCT method 
to determine relative expression changes of the target miRNAs during regeneration.  
Locked Nucleic Acid-in situ Hybridization 
 Following a modified version of the Nuovo et al. (2009) protocol, tissues isolated 
from the above timepoints were immediately fixed in neutral buffered formalin, then 
dehydrated, cleared, and embedded in paraffin. Cross sections 10 µm thick were placed 
on silane-coated slides, then digested with 200 µl of pepsin for 30 min at room 
temperature. Locked nucleic acid (LNA) probes labeled with digoxigenin complementary 
to miR-133a or miR-203 (Exiqon) were diluted with ISH buffer then applied to each 
section and incubated at 60°C for 5 min then overnight at 37°C. The slides were washed 
in 0.2X SSC with 2% BSA at 4°C for 5 min, and incubated with 100 µl of 
antidigoxigenin/alkaline phosphatase for 30 min at 37°C. Following a wash with 
detection buffer, slides were incubated with NBT/BCIP reagent at 37°C and 
counterstained with fast red. 
Mimic Injections and Imaging 
 miScript miRNA mimics against miR-133a 
(UUUGGUCCCCUUCAACCAGCUG) and control Scramble 
(TAACACGTCTATACGCCA) were used for functional analysis (Qiagen). 
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Oligonucleotides were diluted in water to make a 20 µM stock solution, then further 
diluted in PBS to make a 160 nM solution for injection.  A 10 µl unimetric syringe was 
used to inject 3 µl of mimic or scramble into the central canal of the spinal cord 
approximately one hour following amputation. Immediately after injection, 
electroporation was performed using a Grass SD9 Stimulator (Grass Instruments). 
Electrodes were placed on dampened filter paper on either side of the tail, and 5 pulses of 
25 V, 50 ms each with a 200 ms delay between pulses were given (Sehm et al., 2009). 
The above procedure was repeated 48 hours post-amputation with injection into the tail 
regenerate directly caudal to the spinal cord. At each timepoint during the first 21 dpa, 
regenerating tails were photographed using a dissecting microscope equipped with a 
Nikon DS-U2 camera and NIS Elements software. 
Western Blot Analysis 
 Tissues from animals injected with mimics were flash frozen in liquid N2 
immediately after collection, followed by homogenization in lysis buffer and 
centrifugation. The protein concentration in each sample’s supernatant was determined 
using the BCA protein assay (Pierce). Equivalent amounts of protein from each sample 
were run at 80 V for 2-3 hr on 12% resolving polyacrylamide gels, and then blotted to 
nitrocellulose membranes (BioRad).  Membranes were blocked in 3% non-fat skim milk 
powder/0.1% Tween20/PBS for 1 hr, then incubated with primary antibody (1:1000 
NvRARβ or 1:10,000 anti-Actin [Ab-Cam] in the above blocking solution) overnight at 
4°C.  The blots were incubated for 45 min in the dark with Alexa Flour 680 goat anti-
rabbit IgG (Invitrogen; 1:15,000 in the above blocking solution), then visualized using an 
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Odyssey Infrared Imaging System (LI-COR Biosciences). All Western blots included at 
least three biological replicates and two technical replicates. 
Cloning and Transfection 
 RARβ2 3’ UTR fragments were amplified from pooled tail RNA (isolated as 
described above) with the Advantage 2 PCR kit (Clontech) using primers with enzymatic 
cut sites. The restriction endonuclease used for the forward primer was Nhe1, and for the 
reverse primer, Sal1. This fragment was then cloned into the pmirGLO Dual Luciferase 
miRNA Target Expression Vector (Promega). The inserted fragment was confirmed by 
DNA sequencing. Human PC3 cells were used for transfection of the plasmid alone as 
well as for co-transfection with the miR-133a mimic or control scrambled oligonucleotide 
(Qiagen). Transfections were performed using Lipofectamine 2000 (Invitrogen) 
following the manufacturer’s protocol. 
Luciferase Assay 
Human prostatic cancer  (PC3) cells were seeded into 96 well white plates 
(Greiner Cellstar®, Sigma-Aldrich) in DMEM supplemented with high Glucose, non-
essential amino acids and 10% Fetal Bovine Serum (all Invitrogen). After reaching ~90% 
confluence 24 hours later, cells were co-transfected with 100 ng of reporter plasmid and 
either 20 pmol of miR-133a mimic or scrambled nucleotide, followed by 0.3 µl of 
Lipofectamine 2000. Forty-eight hours after co-transfection, the luciferase assay was 
performed using the Dual Glo Luciferase Assay System (Promega). Luminescence was 
measured using a Varian Cary Eclipse fluorescence spectrophotometer. There were 12 
replicates from each experimental group, in which firefly luciferase activity was 
normalized to the plasmids internal positive control, renilla luciferase activity. 
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Statistical Analysis 
 The data for the q-PCR assays were analyzed using a One-Way ANOVA with a 
Post Hoc Tukey test. Western blot data were analyzed using a two-tailed t test. The data 
for the Luciferase Assay were also analyzed using a One-Way ANOVA with a Post Hoc 
Tukey test. P-values less than 0.05 were considered statistically significant.  
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2.04 Results 
MicroRNA dysregulation during caudal spinal cord regeneration 
 Based on previous data in other model systems which supported roles for miR-
133a, miR-124a, miR-132 and miR-203 during epimorphic regeneration or CNS 
development (Cheng et al., 2009; Thatcher et al., 2008; Vo et al., 2005; Yin et al., 2008), 
we initially chose to examine the patterns of expression for each of these miRNAs during 
caudal spinal cord and tail regeneration in the adult newt using quantitative PCR. The 
expression levels of both miR-133a and miR-132 were significantly decreased compared 
to levels in unamputated adult tail tissues during the first three weeks following tail 
amputation (Figs. 2.1A and 2.1B). miR-133a levels were lowest at 14 days post 
amputation (dpa), declining to roughly 7% of the levels measured in the unamputated tail. 
miR-133a  expression remained low throughout the first 21 dpa.  
A significant, roughly 40%, decline in miR-132 transcript levels was first 
apparent at 14 dpa and was followed by a continual decline to approximately 37% of the 
levels measured in unamputated tails by 21 dpa (Fig. 2.1B). Conversely, miR-203 
expression appeared to gradually increase during the first three weeks post amputation, 
compared to initial control levels, peaking at more than a 3 fold increase by 21 dpa (Fig. 
2.1C). miR-124a is initially increased by more than two fold at 7 dpa before levels return 
to baseline at 21 dpa. The expression levels of three other variants of the miR-133 family 
(b, c and d) were examined and found to display an expression pattern similar to that 
observed for miR-133a (Fig. 2.2). This is not entirely unexpected since the entire miR-
133 family can be found within the same highly conserved cluster, which likely has co-
regulated expression (Tani et al. 2013). Furthermore, miRNAs within the 133 family 
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differ by only 1-3 nucleotides, almost exclusively at their 3’ ends and the seed regions of 
all family members are identical (miRBase.org). 
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Figure 2.1. The expression of miR-133a and miR-132 are down-regulated while miR-203 
and miR-124a are up-regulated within the first three weeks after tail amputation.  A) 
miR-133a was significantly down-regulated at 7, 14 and 21 dpa. B) miR-132 was 
significantly down-regulated at both 14 and 21 dpa. C) miR-203 was significantly 
increased at 14 and 21 dpa. D) miR-124a was significantly increased at 14 dpa. The 
normalizing gene used for A) was histone acetyl transferase, for (B-D), 5s rRNA. Error 
bars indicate standard error. *P<0.05, **P<0.01, ***P<0.001 (n=3). 
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Figure 2.2. Each member of the miR-133 family is down-regulated by 7 days post tail 
amputation. A) miR-133b, B) miR-133c and C) miR-133d were significantly 
downregulated at 7, 14 and 21 dpa vs. time 0. Error bars indicate standard error.  
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 (n=3). 
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miR-133a and miR-203 are expressed primarily in the ependymoglial cells of the spinal 
cord. 
 As mentioned previously, retinoid signaling through RARβ2 is required for 
functional repair of the newt spinal cord and expression of this receptor is prominent in 
the ependymoglial cells in the early post amputation stages in tail regenerates (Carter et 
al., 2011). All three of the miRNAs selected for study have components of the retinoid 
signaling pathway as putative target mRNAs (see Fig. 2.6A). Thus our next objective was 
to determine if these microRNAs were expressed in temporal and spatial patterns 
consistent with their putative role as regulators of retinoid signaling in tail and spinal cord 
regenerates.  
The tissue specific expression pattern of miR-133a and miR-203 were determined 
using locked-nucleic acid in situ hybridization (LNA-ISH). Both miRNAs were 
expressed primarily in the ependymal cells surrounding the central canal of the spinal 
cord (Figs. 2.3A, 2.3B, 2.4A). Moreover, the relative levels and time course of expression 
of both of these miRNAs in the ependymal cells as determined by LNA-ISH, mirror 
those measured in whole tail/spinal cord regenerate tissue as determined by q-PCR (Figs. 
2.3A and 2.3B; compare to Figs. 2.1A and 2.1C). The only other location within the 21 
dpa tail regenerates where we were able to detect expression of miR-133a was in 
mesenchymal precursors for osteocytes and chondrocytes in a regenerating vertebra (Fig. 
2.4A). This result is consistent with the recent finding that miR-133a has been shown to 
regulate mesenchymal cell lineage progression by selectively inhibiting the 
differentiation of chondrocytes and osteocytes in vitro (Zhang et al., 2012). 
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Figure 2.3. Both miR-133a and miR-203 are expressed in the ependymal cells 
surrounding the central canal of the spinal cord. A, B and C represent transverse sections. 
A) miR-133a expression (blue-purple positive signal) is high in the cytoplasm of 
ependymal cells rostral to the plane of amputation at time 0, then decreases by day 14 
before showing a slight increase at day 21 . B) The expression of miR-203 increases 
consistently from day 7 to 21 in comparison to unamputated tissues (day 0). C) Sections 
hybridized with a control scrambled probe show no hybridization signals in any tissues 
above background. Arrows in all figures represent examples of miR-133a positive cells. 
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Figure 2.4. miR-133a is primarily expressed in the ependymal tube in 21 day 
regenerates. A and B represent roughly mid-sagittal sections. A) miR-133a expression 
(arrows) is present within the ependymal tube 21 days after injury. There are also a few 
miR-133a -positive cells within the mesenchymal precursors for cartilage and bone 
(asterisks). B) Similar mid-sagittal section hybridized with the negative control scrambled 
nucleotide probe had no positive signal within either the ependymal tube or any other 
regenerate tissues. 
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miR-133a downregulation in the ependymoglial cells is necessary for spinal cord and tail 
regeneration. 
 To determine if the down-regulation of miR-133a we have detected by qPCR in 
vivo (Fig. 2.1A) is required for spinal cord and tail regeneration, we attempted to alter the 
level of this miRNA in ependymoglial cells in vivo and determine the morphological 
consequences of such alterations on tail and spinal cord regenerates.  
After injection and electroporation in vivo, mimic-based up-regulation of miR-
133a significantly decreased the rate and extent of tail regeneration compared to a 
control, scrambled miRNA injection (Figs. 2.5A, 2.5B, 2.5C). Up-regulation of miR-133a 
by injection and electroporation of the mimic at day 0 pa and again at day 2 pa was 
confirmed with qPCR at various time points after amputation and injection (Fig. 2.5D). 
There was a significant increase in miR-133a expression at 7 dpa compared to all other 
time points. Significantly, early mimic injection at 0 and 2 pa had no significant effect on 
miR-133a levels at any time point after 7 days. Thus the normal down-regulation of miR-
133a appears to be required within the first 7 dpa for normal regeneration of the spinal 
cord.  
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Figure 2.5. In vivo up-regulation of miR-133a significantly inhibits tail regeneration. A) 
miR-133a mimic injected tails over the first 21 dpa. Lack of regeneration, (caudal 
extension and blastema size) is most apparent by 21 dpa. B) Animals injected with a 
scrambled nucleotide probe exhibit normal regeneration. C) Measurements of regenerate 
tail length in mimic-133a injected animals show a significant decrease in outgrowth 
compared to the control-injected animals. D) Confirmation of mimic induced up-
regulation of miR-133a by q-PCR. At 7 dpa, miR-133a levels are significantly increased 
in tails from mimic injected regenerates compared to control, scrambled nucleotide 
injected regenerates.  Error bars indicate standard error. *P<0.05, **P<0.001, 
***P<0.001 (n=3). 
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miR-133a regulates RARβ2 expression in the ependymoglial cells of the regenerating tail 
and spinal cord. 
 We have previously demonstrated that an upregulation of RARβ2 in 
ependymoglial cells is a functional requirement for tail and caudal spinal cord 
regeneration in adult newts (Carter et al., 2011). However, neither the upstream effectors 
nor the downstream targets of retinoid signaling through this receptor in these tissues 
have been identified. Since in the present study, we found that miR-133a expression 
seems to be coincident both temporally and spatially with the expression profile of 
RARβ2 previously determined by Carter et al. (2011), we initiated a search of the 
miRanda (microrna.org) database to determine if RARβ2 or any other retinoid signaling 
pathway components were potential targets for miR-133a (Fig. 2.6A). Potential targets of 
miR-133a include CRABP 1B and the retinoid receptors RXRα, RARα and importantly, 
given our previous results, RARβ. A multiple sequence alignment revealed that the seed 
region of the mature zebrafish dre-miR-133a does have a putative binding site on the 
previously cloned 3’ UTR of the N. viridescens RARβ2 (Fig. 2.6B). Thus, we next 
determined the ability of miR-133a to inhibit expression of a reporter gene containing the 
3’-UTR of the newt RARβ transcript. After co-transfection of a miR-133a mimic and the 
reporter plasmid, pmir-GLO containing the firefly luciferase gene upstream of the newt 
RARβ 3’-UTR, into PC3 cells, the level of luciferase activity was significantly decreased 
by greater than 60% (Fig. 2.7). Co-transfection of the same reporter plasmid with a 
scrambled nucleotide had no significant effect on luciferase activity in the same cell line. 
PC3 cells do not express any detectable amounts of endogenous miR-133a under similar 
culture conditions (Tao et al., 2012). 
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Figure 2.6. A) Predicted targets of miRNAs 124a, 133a-d and 203 include components of 
the retinoid signaling pathway. B) Sequence alignment of the 3’ UTR of the N. 
viridescens RARβ2 mRNA with mature dre-miR-133a displays potential binding sites. 
Notably, the first complement includes the entire seed region of miR-133a. 
 
Figure 2.7. Newt RARβ mRNA is a direct target of miR133a in vitro. The pmiR-Glo 
luciferase reporter assay verified direct binding of miR-133a with putative binding sites 
on the 3’-UTR of newt RARβ mRNA. Control = Relative luciferase activity from the 
pmiR-Glo plasmid in PC3 cells containing the newt RARβ 3’-UTR in the absence of 
exogenous miR-133a. The addition of the miR133a mimic to the cells led to a 60% 
decline in luciferase activity while the addition of a scrambled nucleotide had no 
significant effect. N= 12 in all cases. *** p< .001. 
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 Given these results in vitro, our next aim was to determine whether newt RARβ2 
is a target of miR-133a in vivo. To do so, we compared the levels of RARβ2 protein, as 
determined by Western blotting, after injection and electroporation of a miR-133a mimic, 
to those measured after similar treatment with the control scrambled miRNA (Fig. 2.8A). 
RARβ2 protein levels were found to be lower in those tissues where miR-133a was 
upregulated at both 7 and 14 dpa, with the decrease at day 14 significant compared to 
control injected regenerates (Fig. 2.8B, p<0.001). The average level of RARβ protein at 
day 7 after mimic injection was also lower than that for the regenerates receiving the 
scrambled nucleic acid, however the p value was greater than 0.05  (n=3; P= 0.186). Thus 
together, our in vitro and in vivo data support the hypothesis that RARβ transcripts 
represent targets for miR-133a regulation within the ependymal cells of the regenerating 
caudal spinal cord in adult newt tails. 
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Figure 2.8. miR-133a targets RARβ in the newt tail during regeneration. A) Expression 
of RARβ was down-regulated at 14 dpa in response to mimic-based up-regulation of 
miR-133a. B) Histogram depicting changes in RARβ expression shown in (A). Levels of 
RARβ2 were significantly decreased 14 dpa in the mimic vs. control. The relative density 
of RARβ2 was determined by normalizing the RARβ2 signal density to the signal density 
of the control protein, actin. Error bars represent standard error. An unpaired t test was 
used to compare RARβ levels in control regenerates 14 dpa to 14 dpa miR-133a mimic-
injected regenerates. **P<0.001 (n=3). 
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2.05 Discussion  
 Due to their ability to target multiple mRNAs and thus regulate complex gene 
expression networks simultaneously, miRNAs are potentially critical regulators in the 
recovery from and repair of spinal cord injuries in regeneration-competent species such 
as urodele amphibians and zebrafish. Indeed, a number of groups have previously 
examined miRNA expression patterns during lens and tail regeneration in urodeles (Sehm 
et al., 2009; Tsonis et al., 2007), as well as during fin and spinal cord regeneration in 
zebrafish (Thatcher et al., 2008; Yin et al., 2008; Yu et al., 2011).  
 In the present study, we initially examined the levels of four microRNAs during 
the course of tail and caudal spinal cord regeneration in the adult newt. Two of these, 
miR-133a (as well as other members of the miR-133 family) and miR-132, were 
significantly downregulated during the first 21 days post amputation of the tail.  Two 
others were either continually (miR-203) or transiently (miR-124a) up-regulated during 
the course of tail regeneration. Our results with Q-PCR, in some cases are consistent with 
and in others, are inconsistent with published microarray analyses of miRNA expression 
in epimorphic regeneration of limbs (fins) or tail and spinal cord in regeneration-
competent species (Sehm et al., 2009; Yin et al., 2008; Yu et al., 2011). For example, we 
see a consistent but transient increase in miR-124a expression at 7 days after tail 
amputation in the adult newt, whereas Sehm et al. (2009) show a consistent decrease 
(confirmed by Q-PCR) at 3 days post amputation of the tail in the axolotl. It is possible 
that miR-124a is also downregulated in the newt tail at an earlier stage of regeneration 
and upregulated at a later stage in axolotl tail regeneration. In addition, our results were 
obtained in adult newts whereas their analyses were performed on relatively young 
	   57	  
axolotlss of between 2-3 cm. Differences in expression of miR-124a between these two 
urodele species would not be surprising, since the cellular mechanisms underlying 
regeneration have been shown to differ between these two urodele species in other tissues 
(Sandoval-Guzmán et al., 2014). In addition, previous studies on spinal cord regeneration 
support the concept that different cellular mechanisms may underlie SCI repair in these 
two urodele species (Chernoff et al., 2003; Zukor et al., 2011). 
 miR-124a expression is abundant in the vertebrate CNS and increases during 
development, reaching maximal levels in mature neurons (Cao et al., 2007; Cheng et al., 
2009; Lagos-Quintana et al., 2002).  Yu et al. (2008) have shown that overexpression of 
miR-124a in mouse PC19 cells and primary cortical neurons promotes neurite outgrowth 
by targeting mRNAs for proteins that mediate cytoskeletal dynamics. Others have shown 
that overexpression of miR-124a promotes the differentiation of neural stem cells and 
may play a role in the repair of spinal cords in a rat model of SCI (Xu et al., 2012). 
Curiously, the levels of miR-124a were found to decrease significantly between days 1 
and 7 after a compression trauma to the rat spinal cord. miR-124a was not detected by in 
situ hybridization around the injury site at day 7 post injury. Xu et al. (2012) did not 
determine the levels of miR-124a at any time points after 7 days. Perhaps the transient 
increase we observe in the levels of miR-124a at 7 days post amputation in the newt 
reflect an important difference between a regeneration competent and regeneration 
incompetent species with respect to the promotion of ependymal cell proliferation or 
neurite outgrowth in response to spinal cord injury in these two species.  Indeed, the newt 
spinal cord regenerative response at day 7 includes extensive ependymal cell proliferation 
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and extension of an ependymal tube and terminal bulb beyond the original amputation 
plane (Iten and Bryant, 1976). 
In our work, the expression of miR-133a significantly decreased in the 
ependymoglial cells of the newt caudal spinal cord compared to the expression levels in 
undamaged tail tissues. This downregulation of miR-133a is similar to that seen in 
regenerating zebrafish fins (Yin et al., 2008) and in regenerating spinal cord tissue in the 
axolotl by microarray analysis (Sehm et al., 2009).  In the zebrafish fin, miR-133a levels 
are initially high in unamputated fin tissue but are significantly reduced as early as 2 days 
after fin resection. This reduction in miR-133a was shown to be dependent upon an 
increase in fibroblast growth factor (FGF) signaling post-amputation as part of the 
regeneration program leading to blastema cell proliferation and redifferentiation of fin 
tissues. Yin et al. (2008) thus suggested that miR-133a acts as a “regenerative brake” 
within a complex regulatory circuit that must be “released” by FGF receptor activation.  
As a consequence, one predicted target of miR-133a, the monopolar spindle 1 (Mps1) 
kinase, an established regulator of zebrafish blastema cell proliferation (Poss et al., 2002), 
is active at the appropriate time and in the appropriate cells to promote blastema cell 
accumulation and subsequent redifferentiation.  
 More recently, Yu et al. (2011) have demonstrated that another miR-133 family 
member, miR-133b, is essential for functional recovery after spinal cord injury in adult 
zebrafish. miR-133b had earlier been shown to enhance muscle regeneration and reduce 
fibrotic tissue in a rat skeletal muscle injury model (Nakasa et al., 2010). Unlike our 
present results with miR-133a, however, Yu et al. (2011) found a significant increase in 
miR-133b expression, albeit in cell bodies of regenerating neurons within the nucleus 
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medial longitudinal fasciculus (NMLF) in the brainstem, as soon as 6 hours and as long 
as 7 days after spinal cord transection. This same increase was not seen at the injury site. 
One predicted target of miR-133b is the ras homolog A (RhoA) (Chiba et al., 2009), 
whose downregulation had been shown to enhance regrowth of the corticspinal tract and 
decrease tissue damage and cavity formation in a rat spinal cord injury model  (Fournier 
et al., 2003). Yu et al. (2011) provided evidence that altering the levels of miR-133b with 
an antisense morpholino oligonucleotide at 9 days after SC injury increased RhoA levels 
in the brain and spinal cord. We did not examine the effects of a downregulation of miR-
133a on RhoA levels at the injury site or in any tissues of the regenerate tail in the newt. 
It would be interesting to determine whether the decrease in miR-133a that we see after 7 
days post amputation in the newt tail is matched by a concomitant increase in RhoA 
levels at that stage.  
We have, however, demonstrated for the first time, indirectly, that miR-133a may 
target RARβ2 mRNA in ependymoglial cells in vivo.  A multiple sequence alignment 
revealed that the seed region of the dre-miR-133a has at least one and possibly three 
binding sites within the 3’ UTR of the cloned newt RARβ2. Indeed, results from our in 
vitro luciferase reporter assay confirm that the 3’ UTR of the newt RARβ2 gene 
represents a target for miR-133a since only a miR-133a mimic and not a scrambled 
nucleotide of equivalent length inhibited luciferase activity. When the same miR-133a 
mimic was injected and electroporated into the ependymal layer of the amputated cord at 
the site of injury at two time points within the first 48 hours after amputation, the levels 
of RARβ2 protein significantly decreased compared to those injected with scrambled 
nucleotides. Moreover, both the decrease in miR-133a levels seen in this study and the 
	   60	  
increase in RARβ2 protein we have seen in our previous work are, for the most part, 
spatially restricted to the ependymoglial cells rostral to the amputation plane. This is 
significant in that these cells may be multipotent neural stem cells that divide and migrate 
caudally as a consequence of injury to the tail in the axolotl, ultimately giving rise to both 
glial cells and neurons of the regenerated cord (Benraiss et al., 1996; Echeverri and 
Tanaka, 2002; Mchedlishvili et al., 2012). In support of this concept, at least one factor 
associated with pluripotency in stem cells, FGF2, is increased in radial glia cells in adult 
newt spinal cords after injury (Zhang et al., 2000). This may again represent the trigger 
necessary to unleash the “regenerative brake” established by miR-133a in the undamaged 
cord (Yin et al., 2008), leading to miR-133a down-regulation. As a consequence, RARβ2 
protein levels would increase in the ependymal cells as previously demonstrated by 
Carter et al. (2011). It is still unclear what genes are regulated downstream of RARβ2 in 
the ependymoglia within the first week post amputation of the newt tail. Some of these 
genes may include other miRNAs (Gudas, 2013). Indeed we have preliminary data 
identifying numerous miRNAs that are dysregulated in regenerating newt spinal cord and 
tail tissues as a consequence of inhibiting either retinoid signaling with a selective 
antagonist of RARβ2 or retinoic acid synthesis with the aldehyde dehydrogenase 
inhibitor, DEAB. Studies aimed at elucidating the spatial and temporal patterns of 
expression of some of these miRNAs, as well as their putative in vivo mRNA targets are 
underway. These will hopefully lead to a clearer picture of the complex signaling 
pathways underlying epimorphic regeneration in this species and highlight the role of 
retinoid signaling and miRNAs in neural stem cell activation and differentiation in these 
tissues. 
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CHAPTER THREE: 
MicroRNA dysregulation in response to RARβ2 inhibition reveals a negative 
feedback loop between microRNAs 1, 133a and RARβ2 during tail and spinal cord 
regeneration in the adult newt. 
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3.01 Abstract 
 The molecular events and pathways underlying epimorphic regeneration of the 
adult urodele amphibian tail and caudal spinal cord are not well understood. Two 
regulatory pathways that may intersect to regulate these complex events are microRNAs 
(miRNA) and retinoic acid (RA) signaling. Recent evidence supports a role for miR-133a 
targeting a specific retinoic acid receptor subtype (RARβ2) within the ependymoglial 
cells of the regenerating spinal cord in adult newts.  Given the dynamic nature of gene 
expression control by RA and the pleiotropic effects of miRNAs on multiple mRNA 
targets in this complex system, we chose to examine whether RA signaling through 
RARβ2 alters miRNA expression in tissues of the regenerating tail and spinal cord. A 
miRNA microarray screen identified 18 highly conserved miRNAs that were 
differentially expressed in regenerating tail and spinal cord tissues after inhibition of 
RARβ2 signaling with a selective antagonist, LE135. Using qPCR, the expression 
patterns of several of these miRNAs were found to be dysregulated in response to 
RARβ2 inhibition over the first 21 days of tail regeneration. Interestingly, miRNAs let-
7c, miR-1 and miR-223 were expressed within the ependymoglial cells surrounding the 
central canal of the spinal cord, coincident with the previously identified expression 
domain of RARβ2.  Altering the endogenous expression pattern of these three miRNAs, 
by injection and in vivo electroporation of specific mimics or inhibitors, led to a 
significant inhibition of regeneration by 21 days post amputation (dpa). Furthermore, we 
have shown that miR-1 targets the 3’ UTR of RARβ2 mRNA in vitro; and in vivo, 
mimic-based upregulation of miR-1 led to a significant decrease in RARβ2 protein. 
These and previous data suggest that miR-1 and miR-133a, both members of the same 
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miRNA gene cluster, may participate with RARβ2 in a negative feedback loop and 
contribute to the regulation of the ependymal response after tail amputation. 
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3.02 Introduction 
 Injury to the mammalian spinal cord often results in permanent deficits such as 
paralysis, and even premature death. The primary injury elicits immediate tissue damage, 
followed by the secondary injury, which consists of inflammation, glial scarring and 
white matter inhibitors (Abu-Rub et al., 2010). Together, these factors form a chemical 
and physical barrier that is inhibitory for axonal regrowth, and damaged axons are 
incapable of regenerating beyond the site of injury to promote functional recovery. Some 
species of urodele amphibians, such as the Eastern Red-Spotted newt, Notophthalmus 
viridescens, possess the remarkable ability to regenerate and recover function after a 
spinal cord injury (Butler and Ward, 1967, 1965; Chernoff et al., 2003; Diaz Quiroz and 
Echeverri, 2013; Iten and Bryant, 1976; Mchedlishvili et al., 2012; Zukor et al., 2011). 
The precise mechanisms that allow for spinal cord regeneration are poorly understood, 
and the identification of factors involved in creating an environment permissive for 
regrowth are active areas of research. 
 One such factor is all-trans retinoic acid (RA), a biologically active metabolite of 
vitamin A, which is vital during the patterning, development, and regeneration of the 
central nervous system (CNS) (Blum and Begemann, 2013; Duester, 2008; Maden, 2007; 
Monaghan and Maden, 2012). Traditionally, RA enters its target cell’s nucleus and binds 
to ligand activated nuclear transcription factors, the retinoic acid receptors (RARs) and 
retinoid X receptors (RXRs), inducing a change in gene expression. There are at least 
three subtypes of RARs and RXRs (α,β, and γ), each with multiple isoforms (Maden et 
al., 1998). It is abundant throughout the developing CNS, particularly within the spinal 
cord (Duester, 2008; Maden, 2007). It may also act as a chemotactic factor in the 
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developing CNS, as it has been shown to stimulate directed neurite outgrowth in 
embryonic mouse dorsal root ganglia (DRGs), specifically through the RARβ receptor 
subtype (Corcoran et al., 2000). This receptor subtype may also mediate neurite 
outgrowth in vitro and some functional regeneration after spinal cord injury in rats 
postnatally (Agudo et al., 2010; Wong et al., 2006; Ping K Yip et al., 2006).   
 In urodele amphibians capable of regenerating lost structures, RA has been shown 
to play a role in proximal-distal repatterning in regenerating limbs (Pecorino et al., 1996), 
as well as enhancing the proliferation and differentiation of the wound epithelium and 
blastema mesenchyme (Maden et al., 1998; Viviano and Brockes, 1996). In the newt, 
exogenous RA has been shown to act as a chemoattractant for adult spinal cord neurites 
in vitro, an effect also mediated by RARβ (Dmetrichuk et al., 2005). Expression of 
RARβ in the adult newt is localized to the ependymoglial cells surrounding the central 
canal of the spinal cord prior to injury, and is upregulated within these cells by 7 days 
post tail amputation (Carter et al., 2011). These ependymoglial cells represent an 
important progenitor source for both neural and non-neuronal cells during the 
regeneration process in urodele spinal cord and brain (Echeverri and Tanaka, 2002; 
Kirkham et al., 2014; Maden, 2013).  The fact that RARβ expression is enhanced in these 
neural stem cells following tail and caudal spinal cord regeneration support a putative 
role for this nuclear receptor in the control of neural progenitor cell proliferation and 
neurite guidance during caudal tail regeneration.  
 Very little research to date has focused on the factors that act upstream or 
downstream of RARβ-mediated retinoid signaling during the ependymal response in 
caudal spinal cord regeneration. Recently, microRNAs (miRNAs) have been implicated 
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in neural regeneration in this and other species (Diaz Quiroz et al., 2014; Sehm et al., 
2009). miRNAs represent a class of small, non-coding RNAs approximately 22 
nucleotides in length. They act post-transcriptionally to regulate gene expression by 
binding to the 3’ UTR of their target mRNA (Bhalala et al., 2013). Each miRNA can 
have multiple target mRNAs, allowing them to regulate complex signaling pathways, 
such as those that are active during regeneration, when global changes in gene expression 
occur rapidly in response to injury. For example, miRNAs have been implicated during 
the regeneration of the newt lens (let-7), newt cardiac muscle (miR-128), zebrafish fin 
(miR-133a and miR-203), zebrafish spinal cord (miR-133b) as well as axolotl spinal cord 
(miR-125b and miR-196) (Diaz Quiroz et al., 2014; Sehm et al., 2009; Thatcher et al., 
2008; Tsonis et al., 2007; Witman et al., 2013; Yin and Poss, 2008; Yu et al., 2011). Most 
recently, we have demonstrated that miR-133a is expressed in the ependymoglial cells of 
the uninjured spinal cord of the adult newt, and that it is significantly downregulated in 
response to caudal tail amputation (Lepp and Carlone, 2014). Furthermore, we provided 
evidence that miR-133a targets the 3’ UTR of newt RARβ2 in ependymoglial cells, and 
that experimental upregulation of miR-133a in vivo delays tail regeneration by inhibiting 
RARβ2 expression (similar to treatment with LE135- a RARβ-selective antagonist 
(Carter et al., 2011)). In the present study, our main objective was to determine, by 
microarray analysis, which miRNAs may act as downstream effectors of RARβ2-
mediated retinoid signaling in the regenerating newt tail and spinal cord. We found 18 
miRNAs that were significantly up- or downregulated in response to RARβ2 inhibition. 
Importantly, we provide evidence in vivo for a role for three of these (miR-1, miR-223 
and let-7) miRNAs in the ependymoglial cells during the early stages of tail and spinal 
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cord regeneration. Additional evidence is provided in support of a negative feedback loop 
that may involve both miR-1 and miR-133a, resulting in the maintenance of RARβ2 
expression within the ependymoglia during caudal spinal cord regeneration. 
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3.03 Materials and Methods 
Animal Handling and Surgery 
All procedures were approved by the Brock University Animal Care and Use 
Committee. Adult eastern spotted newts, Notopthalmus viridescens, were purchased from 
Boreal Science (St. Catharines, Ontario). Newts were housed in plastic containers with 
dechlorinated water on a 12 hr. light-dark cycle and were fed liver, brine shrimp and 
blood worms three times a week. Newts were anaesthetized by immersion in 0.1% 
tricaine methane sulfonate (MS-222, Sigma), pH 7.0, for 10 minutes prior to any surgical 
procedures. Amputation of tails was performed approximately 1 cm caudal to the cloaca, 
which was followed by 20 minutes on ice for recovery. When each regenerative 
timepoint was reached, newts were again anaesthetized, and blastemas were collected by 
cutting the regenerate 1-3 mm rostral to the original plane of amputation.  
LE135 Treatment 
 Once animals regained consciousness post tail amputation, they were immediately 
placed in a dechlorinated water bath containing either 10-6 M LE135 in DMSO, an RARβ 
selective antagonist (a kind gift from H. Kagechika, Tokyo), or 0.01% DMSO, the 
vehicle control (Carter et al., 2011). The solution bath was changed twice weekly, and 
animals were maintained in these treatments for up to 21 days. Tail regenerates were then 
surgically removed at various timepoints as described above for microarray analysis and 
qPCR. We have previously shown that regardless of whether LE135 is applied via bath 
application or by implantation of AG1-X2 beads into the central canal of the cut end of 
the spinal cord, tail regeneration is inhibited to the same degree and RARβ2 expression is 
downregulated in the regenerate tissues by 21 days pa (Carter et al., 2011). 
	   70	  
 
Microarray Analysis 
Two days post amputation, blastemas were isolated from animals within each 
treatment group (DMSO or LE135) and immediately flash frozen in liquid nitrogen. 
Following homogenization, total RNA was isolated from the tissues at various timepoints 
using the Animal Tissue RNA Purification Kit (Norgen Biotek, St. Catharines, Ontario). 
RNA quality was confirmed via spectrophotometry and gel electrophoresis, and three 
blastemas from each treatment were pooled for testing. The microarray analysis was 
outsourced to LC Sciences (Houston, Texas). The platform used for miRNA microarrays 
by LC Sciences is the µParaflo®Microfluidic Biochip, with in situ synthesized probes. 
Total RNA (2 µg) from each treatment group was hybridized to its own custom Cy3 chip 
to allow for statistical comparison between the DMSO and LE135 treated blastema RNA. 
Each chip contained probes complementary to the known miRNAs of Danio rerio, 
Xenopus laevis and Xenopus tropicalis, amounting to 265 miRNAs in total, which did not 
include the endogenous chip controls (Sanger miRBase Release 16.0). Each detection 
probe on each chip was tested in triplicate. Regression based mapping was used to 
subtract background from the array data, which was then normalized using a locally-
weighted scatter plot smooth (LOWESS) filter. Clustering and statistical analysis were 
also performed by LC Sciences, and only signals that were differentially expressed at a 
significant level (p<0.01) were considered for further study. 
miRNA Quantification (RT-qPCR) 
  Tissue was isolated at one of four timepoints, 0, 7, 14 or 21 days post tail 
amputation (dpa) and immediately flash frozen in liquid nitrogen. These tissues were 
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homogenized and RNA was extracted as described above. Using 750 ng of total RNA, 
cDNA was synthesized using gene specific stem-loop primers (Varkonyi-Gasic et al., 
2007), in accordance with the SuperScript III Reverse Transcriptase kit (Invitrogen). 
Quantitative real time PCR (qPCR) was run using iQ SYBR Green Supermix (BioRad) 
on a CFX Connect Real-Time System (BioRad). A 20 µl reaction was used which 
contained the following; 5 µl of RNase free water, 10 µl of iQ SYBR Green Supermix, 1 
µl of forward and reverse primers and 3 µl of cDNA. The following program was used 
for amplification; 95° for 5 min, followed by 40 cycles of 95° for 15 sec, annealing temp 
for 15 sec (64° for miR-1, miR-26a and miR-133a; 66° for miR-145 and let-7c; 68° for 
miR-223 and miR-1306). All reactions were run with three biological and three technical 
replicates, and were normalized to two reference genes (5s rRNA and β-actin), and 
analysed using the ΔΔCT method. The Minimum Information for Publication of 
Quantitative Real-Time qPCR Experiments (MIQE) were adhered to for the above 
experiments (Taylor et al., 2010). The primers used for gene specific cDNA synthesis as 
well as qPCR are listed in Table 1: 
Table 3.1. Primer sequences for cDNA synthesis and qPCR. 
     RT-miR-145: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGGGATT 
     RT-miR-223: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGGGGTAT 
     RT-miR-1: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACATACATA 
     RT-let-7c: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCATA 
     RT-miR-26a: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCCTAT 
     RT-miR-1306: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACCA 
     RT-miR-133a: 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCTGG 
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     Forward-miR-145: GCCGCGTCCAGTTTTCCCAGG 
     Forward-miR-223: GCCGCTGTCAGTTTGTCAAATACC 
     Forward-miR-1: GCCGCTGGAATGTAAAGAAG 
     Forward-let-7c: GCCGCTGAGGTAGTAGGTTG 
     Forward-miR-26a: GCCGCTTCAAGTAATCCAGG 
     Forward-miR-1306: GCCGCTTGGCTCTGGTGG 
     Forward-miR-133a: GCCGCTTTGGTCCCCTTCA 
     Reverse: GTGCAGGGTCCGAGGT 
 
Locked Nucleic Acid in situ Hybridization  
 
Uninjured tail tissue, as well as blastemas from 7, 14 and 21 dpa were isolated and 
immediately fixed in neutral buffered formalin. Following ethanol dehydration, clearing 
and infiltration, tissues were embedded in paraffin, 10 µm sections were obtained and 
floated onto silane-coated slides. A modified version of the methods of Nuovo et al. 
(2009) was followed for in situ hybridization using locked nucleic acid (LNA) probes 
tagged with digoxigenin complementary to let-7c, miR-1 or miR-223 (Exiqon). Sections 
were first digested with 200 µl of pepsin for 30 min at room temperature, followed by a 
10 min wash with 0.1 M triethanolamine (TEA), a 10 min wash with TEA and acetic 
anhydride, and 4 washes with PBS. Slides were incubated with 125 pmol of probe for 5 
min at 60°C, and hybridized overnight at 50°C. Following a wash in 0.2X SSC with 2% 
BSA at 4°C for 5 min, sections were incubated with 100 µl of antidigoxigenin/alkaline 
phosphatase (Roche) at 37°C for 30 min. After a brief wash in detection buffer, slides 
were held at 37°C with NBT/BCIP (Enzo Life Sciences) while being monitored for 
colorimetric change prior to counterstaining with Fast Red (Enzo Life Sciences) and 
fixation with Permount. 
Inhibitor and Mimic Injections 
A scrambled sequence oligonucleotide control (TAACACGTCTATACGCCA), 
LNA inhibitor against miR-223 (TGGGGTATTTGACAAACTGA) (Exiqon), or 
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miScript mimics against miR-1 (UGGAAUGUAAAGAAGUAUGUAU) and let-7c 
(UGAGGUAGUAGGUUGUAUGGUU) (Qiagen) were used for in vivo functional 
analyses. RNase free water was added to each oligonucleotide to make a 20 µM stock 
solution, which was then further diluted in PBS to 200 nM. In order to allow for any 
bleeding to subside, injections did not take place until at least 1 hour after amputation. A 
10 µl unimetric syringe was used to inject 3 µl of scramble, mimic or inhibitor into the 
central canal of the spinal cord. In vivo electroporation was performed immediately 
following injection. Briefly, dampened filter paper was placed on either side of the tail 
underneath flat circular electrodes, then 5 pulses of 25 V, 50 ms each with a 200 ms delay 
was applied using a Grass SD9 Stimulator (Grass Instruments). Injections and 
electroporations were repeated at 2 dpa and 6 dpa into the blastema, directly distal to the 
ependymal bulb. Prior to isolating tissue at each timepoint, regenerates were 
photographed using a dissecting microscope equipped with a Nikon DS-U2 camera and 
NIS Elements software. Alteration of total miRNA levels after the application of mimics 
or inhibitors was confirmed using qPCR for each timepoint. 
Western Blotting 
Tissue from animals injected with the miR-1 mimic were collected at 7, 14 and 21 
dpa and immediately flash frozen. Following homogenization in lysis buffer and 
centrifugation for 30 min at 4°C, the total protein concentration of each sample’s 
supernatant was determined using the BCA protein assay (Pierce). 20 µg of protein from 
each sample were run for 2 hours at 80 V on 12% mini-PROTEAN precast acrylamide 
gels (BioRad). Following blotting to nitrocellulose (BioRad), membranes were blocked in 
3% non-fat skim milk powder/0.1% Tween20/PBS for 1 hr. Membranes were then 
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incubated with primary antibody, 1:1000 NvRARβ2 (custom antibody, Pacific 
Immunology), or 1:500 anti-α-Tubulin (Developmental Studies Hybridoma Bank, The 
University of Iowa), in blocking solution for 12 hours at 4°C. Blots were then incubated 
with 1:15000 secondary antibody, Alexa Flour 680 goat anti-rabbit IgG (Invitrogen) (for 
RARβ2) or Alexa Flour 680 goat anti-mouse IgG (Invitrogen) (for Tubulin) for 45 min. 
An Odyssey Infrared Imaging System (LI-COR Biosciences) was used to obtain blot 
images. The analysis was comprised of three biological and two technical replicates. 
Cloning, Transfection and Luciferase Assay 
The 3’ UTR of RARβ2 was previously amplified and cloned into the pmirGLO 
Dual Luciferase miRNA Target Expression Vector (Promega), using the restriction 
endonucleases Nhe1 and Sal1 (Lepp and Carlone, 2014). The cells used for transfection 
were from a Human PC3 cell line, seeded into 96 well plates (Greiner Cellstar, Sigma-
Aldrich), using DMEM supplemented with non-essential amino acids, high glucose and 
10% Fetal Bovine Serum (Invitrogen). The transfection agent used was Lipofectamine 
2000 according to the manufacturers protocol. 100 ng of the plasmid was transfected into 
each well, once the cells reached ~90% confluence. Samples were co-transfected with 
either 20 pmol of miR-1 mimic (Qiagen) or scrambled oligonucleotide (Exiqon). After 48 
hrs, Firefly and Renilla luciferase activities were determined using the Dual Glo 
Luciferase Assay System (Promega) with a Varian Cary Eclipse fluorescence 
spectrophotometer. Each of the three experimental groups (plasmid alone, plasmid & 
mimic, plasmid & scramble) was replicated 12 times, and firefly luciferase activity was 
normalized to the internal Renilla luciferase activity for analysis. 
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Statistical Analysis 
A two-tailed student’s t-test was used to compare DMSO and LE135 relative 
expression for the miRNA probe repeats on each custom microarray chip. Data for all 
qPCR studies were analyzed using a One-Way ANOVA with a Post Hoc Tukey test. The 
length of regenerates and Western Blot data from the injections studies were analyzed 
using a two-tailed t-test to compare mimic/inhibitor with matched controls. The firefly 
luciferase activity was also analyzed using a One-Way ANOVA with a Post Hoc Tukey 
test. P<0.05 was considered statistically significant for most studies; for the microarray 
analysis, P<0.01 was considered significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   76	  
3.04 Results 
Microarray expression profiling of miRNAs as putative targets of retinoid signaling 
 Just as miRNAs can regulate complex patterns of gene expression post-
transcriptionally, their expression may in turn be controlled transcriptionally by the 
activities of various signaling pathways. Thus, to determine which, if any, miRNAs were 
putative effectors (either indirectly or directly) of retinoid signaling through RARβ2, a 
miRNA microarray analysis was conducted. Pooled RNA samples were isolated from tail 
regenerates 48 hours after transection and treatment with either LE135, an RARβ-
selective antagonist, or the vehicle control (a 1:1 (v:v) mixture of DMSO and EtOH). It 
has previously been demonstrated that treatment with LE135 inhibited tail and caudal 
spinal cord regeneration in the newt and significantly downregulated RARβ2 protein 
levels by 21 dpa (Carter et al., 2011). miRNA profiling was outsourced through LC 
Sciences, using a probe set that included 265 miRNAs from Danio rerio, Xenopus laevis 
and Xenopus tropicalis.  
Eighteen miRNAs were significantly (p< 0.01) differentially expressed when 
comparisons between treatment groups were analyzed after background subtraction and 
normalization (Figs. 3.1A, 3.1B). Interestingly, miR-133a displayed a significant 
upregulation after LE135 treatment, suggesting that RARβ2 signaling may negatively 
regulate the expression of this miRNA in the regenerating tail. This was somewhat 
surprising since we had previously demonstrated that miR-133a acts upstream of, and 
directly targets RARβ2 in the ependymal cells of the tail during spinal cord regeneration 
(Lepp and Carlone, 2014).  
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Figure 3.1. miRNA expression is dysregulated by inhibition of RARβ signaling during 
tail regeneration in newts. A) Microarray heat map expression profile depicting relative 
expression levels of the 18 miRNAs that were significantly different between DMSO 
(control) and LE135-treated 2 dpa regenerates (P<0.01). Rows represent miRNAs of 
interest and columns represent tests run, where a green signal indicates downregulation 
while a red is indicative of an upregulation. B) The signal intensities for each treatment 
group for the 18 miRNAs that were significantly differentially expressed in the 
microarray screen. Each chip was run in triplicate. 
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Among other miRNAs identified by this analysis, of particular interest were miR-
1, miR-26a, miR-145, miR-223, miR-1306 and let-7c. Each of these miRNAs has been 
implicated previously in the regulation of apoptosis, inflammation and stem cell 
maintenance or proliferation, all cellular functions associated with epimorphic 
regeneration (Kyritsis et al., 2012; Liu et al., 2009; Melton et al., 2010; Morin et al., 
2008; Nakanishi et al., 2010; Petrie et al., 2014). 
MicroRNA expression is dysregulated in response to inhibition of RARβ2 signaling. 
Next, using RT-qPCR, expression profiles for each of the seven miRNAs listed 
above were established at 7, 14 and 21 dpa for tail regenerates from both LE135 and 
DMSO treated animals (Fig. 3.2). With the exception of let-7c, miR-1306, miR-223 and 
miR-145, the expression profiles of each of the remaining 4 miRNAs (miR-1, miR-26a, 
and miR-133a) were consistent with the microarray data obtained from RNA isolated at 2 
dpa, displaying the same pattern of dysregulation in expression levels between treatment 
groups (Figs. 3.2A-D, 3.2F). The levels of let-7c and miR-223 (p<0.05), as well as miR-
26a and miR-1 (p<0.01), were significantly higher in regenerates treated with LE135 at 
14 dpa compared to those treated with DMSO (Fig. 3.2A-D). The levels of expression for 
both miR-1306 and miR-145 were not significantly different between treatment groups at 
any time-point examined (Fig. 3.2E, 3.2G). miR-133a levels are significantly higher 
(compared to DMSO treatment) in regenerates from animals treated with LE135 at 21 
dpa (p<0.01) but not at 14 dpa, although a similar (but not statistically significant, p< 
0.0539) trend is apparent  at day 14 as well (Fig. 3.2F).  
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Figure 3.2. Expression profile for seven miRNAs at various regeneration time points. 
Regenerates were obtained from animals treated with DMSO or 10-6 M LE135. Graphical 
representation of qPCR analyses for A) let-7c, B) miR-1, C) miR-26a, D) miR-223, E) 
miR-1306, F) miR-133a and G) miR-145 at 7, 14 and 21 dpa normalized to time 0. Error 
bars indicate standard error. * P<0.05, **P<0.01 (n=3). 
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These results are intriguing as Carter et al., (2011) had previously demonstrated 
that RARβ2 expression is significantly upregulated by 14 dpa, particularly within the 
ependymal layer of the caudal spinal cord, in the regenerating tail in this species. Thus, 
by experimentally inhibiting retinoid signaling via RARβ2 with LE135, the levels of 
miRNAs let-7c, miR-1, miR-26a, miR-223 and miR-133a are maintained at abnormally 
high levels at 14 or 21 dpa. The regeneration stage-specific increase in RARβ2 by day 14 
in tail regenerates (Carter et al., 2011) may thus contribute, under normal circumstances, 
to either a sustained (miR-1, miR-133a and miR-223) or transient (let-7c and miR-26a) 
decrease in the expression of these miRNAs after 14 dpa (Figs. 3.2 A-D, F). This could, 
in turn, contribute to an increase in the abundance of their specific target mRNAs.  
let-7c, miR-1 and miR-223 are expressed within the ependymal cell layer of the spinal 
cord. 
 Our data demonstrate that the normal (after DMSO treatment) patterns of 
expression of some of these miRNAs change temporally, either coincident with or 
subsequent to, the upregulation of RARβ2 (Fig. 3.2) (Carter et al., 2011). Thus, our next 
objective was to determine whether the spatial patterns of expression of these miRNAs 
were consistent with their putative role as targets of RARβ2-mediated retinoid signaling. 
Since we had previously established that miR-133a is expressed in the ependymoglial 
cells of the regenerating spinal cord (Lepp and Carlone, 2014), we chose to concentrate in 
this study on let-7c, miR-1 and miR-223. Indeed, both miR-1 and miR-223 have been 
reported in other systems to be involved in the regulation of inflammation (Bhalala et al., 
2013; Izumi et al., 2011; Nakanishi et al., 2010; Strickland et al., 2011), while let-7c is 
involved in the regulation of stem cell renewal (Melton et al., 2010). Not only are these 
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processes necessary for epimorphic tail regeneration in the newt, but retinoid signaling 
has also been implicated in both inflammation and stem cell maintenance in other 
systems (Choschzick et al., 2014; Galli et al., 2013; Sarang et al., 2014). In order to 
characterize their spatial pattern of expression, digoxygenin labeled LNA probes against 
let-7c, miR-1 and miR-223 were used for in situ hybridization on tissue sections of 
normal, uninjured (untreated with either DMSO or LE135) or regenerating tails at 7, 14 
and 21 dpa. As can be seen in Figs. 3.3, 3.4 and 3.5, expression of each of these miRNAs 
is apparent in the ependymoglial cells immediately surrounding the central canal of the 
spinal cord in those tissues within an area 1 mm rostral to the original amputation plane. 
It would appear that expression is localized to the nuclei of these cells, however the 
nuclei of ependymal cells are very large, and it is difficult to discern whether expression 
is in fact nuclear or cytoplasmic. However, recent evidence suggests that miRNAs 
localized to the nucleus can still function in a similar manner as they would in the 
cytoplasm (Roberts, 2014). Regardless of whether these miRNAs are within the 
cytoplasm or nuclei, they are associated, almost exclusively, with ependymoglial cells. 
These same cells had previously been shown to contain the highest levels of RARβ2 at 
both 7 and 14 dpa by Carter et al., (2011). 
 A scrambled oligonucleotide was used as a negative control, and only background 
staining was evident within the ependymal cells at any time points examined (Fig. 3.6). 
let-7c expression is present within the ependymal cells in uninjured tails and appears to 
increase by 7 dpa (Figs. 3.3A, 3.3B), followed by a decrease to almost background levels 
by 14 and 21 dpa (Figs. 3.3C, 3.3D). Similarly, miR-1 expression is high within the 
majority of ependymal cells in the intact tail and spinal cord, but then drops off in these 
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same cell types by 7 dpa and is undetectable by days 14 and 21 dpa (Fig. 3.4). Expression 
of miR-223 on the other hand, is virtually undetectable in the ependymoglial layer at the 
time of injury, but increases by 7 dpa  
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Figure 3.3. Expression of let-7c is downregulated by 14 dpa and confined to the 
ependymal cells surrounding the central canal of the spinal cord. A blue-purple positive 
signal is indicated by arrows on cross-sections of tail tissues at time 0 (A), 7 dpa (B), 14 
dpa (C) and 21 dpa (D).   Scale = 200 µm 
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Figure 3.4. miR-1 expression is downregulated in ependymal cells after amputation of 
the tail. (A) Expression is abundant in the ependymal cells at the time of amputation 
(arrows indicate positive blue signal), but downregulated at 7 and 14 dpa (B, C). By 21 
dpa, expression has started to increase again (D), but does not appear to reach the levels 
seen at day 0. Cross sections, Scale bar = 200 µm.
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Figure 3.5. Expression of miR-223 is upregulated in the ependymal cells after tail 
amputation. (A) Expression of miR-223 is low at 0 dpa, but upregulated by 7 dpa within 
these ependymal cells (B). There is still some expression (although less abundant than at 
7 dpa) evident at 14 and 21 days within these cells (C, D). Cross-sections, Scale bar = 
200 µm.
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Figure 3.6. Tissues hybridized with a control, scrambled oligonucleotide probe show 
only background signal on cross sections taken from regenerates at 0 dpa (A), 7 dpa (B), 
14 dpa (C) and 21 dpa (D). Cross-sections, Scale bar = 200 µm.
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(Fig. 3.5A, 3.5B), and gradually diminishes to background levels by 21 dpa in these cells 
(Figs. 3.5C, 3.5D).  
The relative stage-specific pattern of expression of each of these miRNAs as 
determined by LNA in situ hybridization in normal regenerates are consistent with the 
patterns determined by q-PCR from regenerates treated with DMSO (Compare Fig. 3.2 to 
Fig. 3.3, 3.4, 3.5). Furthermore, each of these miRNA levels are diminished beyond 14 
dpa, at a stage when the expression of RARβ2 is highest within ependymal tissues of the 
regenerating tail and caudal spinal cord. Taken together, these data provide support for 
miR-1, let-7c and miR-223 functioning downstream of and being negatively regulated by 
RARβ2-mediated retinoid signaling.  
The stage-specific downregulation of miR-1 and let-7c and the upregulation of miR-223 
within the first 14 dpa are required for spinal cord and tail regeneration. 
 To determine if the normal downregulation of miR-1 and let-7, or upregulation of 
miR-223 that we have detected in ependymoglial cells in vivo are required for tail and 
spinal cord regeneration, we attempted to experimentally alter the concentrations of these 
miRNAs in vivo. Injections into the central canal of the spinal cord followed by in vivo 
electroporation of either synthetic oligonucleotide mimics for miR-1 or let-7c, or an 
inhibitor of mature miR-223, were carried out immediately after tail amputation and were 
repeated at both 2 dpa and 6 dpa beneath the wound epithelium, immediately distal to the 
regenerating ependymal bulb. 
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Figure 3.7. In vivo injection of let-7c and miR-1 mimics or miR-223 inhibitors 
significantly inhibits tail regeneration. (A-D) Micrographs showing the extent of tail 
regeneration over the first 21 dpa after in vivo injection and electroporation of (A) a let-
7c mimic, (B) a miR-1 mimic or (C) a miR-223 inhibitor. (D) Tail regeneration was 
unaffected by the injection of a scrambled oligonucleotide. In all cases, regenerate 
lengths were shorter in animals injected with mimics or inhibitor compared to those 
injected with the scrambled oligonucleotide. Scale bar = 1 mm.
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Figure 3.8. Graphical representation of mean regenerate tail lengths after in vivo 
injection and electroporation of (Ai) a let-7c mimic, and (Aii) a miR-1 mimic,  (Aiii) a 
miR-223 inhibitor compared to regenerate lengths after injection of a scrambled 
oligonucleotide. Error bars indicate standard error. B) Confirmation of mimic-induced 
upregulation of let-7c and miR-1 by qPCR. (Bi) let-7c (Bii) miR-1 (Biii) miR-223, 
although the relative expression levels of miR-223 were consistently lower after injection 
of the miR-223 inhibitor than those from regenerates after injection of a scrambled 
oligonucleotide at all times points examined, these differences were not statistically 
significant.  Error bars indicate standard error. * P<0.05, **P<0.01, ***P<0.001 (n=3). 
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Following injection and electroporation at these timepoints, upregulation of both 
let-7c and miR-1 caused a significant decrease (p<0.001 for miR-1, p<0.01 for let-7c) in 
tail regenerate length by 21 dpa, compared to regenerates in animals receiving equivalent 
injections of a scrambled oligonucleotide (Figs. 3.7A, 3.7B, 3.7D, 3.8Ai, 3.8Aii). 
Similarly, injection of the miR-223 inhibitor led to a significant (p<0.05) decrease in the 
length of tail regenerates at 21 dpa compared to those animals receiving the scrambled 
oligonucleotide (Figs. 3.7C, 3.7D, 3.8Aiii). In vivo alterations of target miRNAs at each 
timepoint after injection and electroporation of each mimic or inhibitor were confirmed 
by qPCR (Fig. 3.8B). Thus, it appears that the downregulation of miR-1 and let-7c after 
time 0, and the upregulation of miR-223 at day 7 previously observed by q-PCR and 
LNA-ISH, are required for normal regeneration of the spinal cord and tail. 
miR-1 targets the 3’-UTR of the newt RARβ2 mRNA in vitro.   
The temporal and spatial patterns of expression for miR-1 and miR-133a are very 
similar, with both being abundant within the ependymal layer of the unamputated tail 
followed by a significant downregulation within the same tissues by 14 dpa (Fig. 3.4) 
(Lepp and Carlone, 2014). We have recently demonstrated that miR-133a targets the 3’-
UTR of Notophthalmus viridescens RARβ2 in an in vitro luciferase expression assay 
(Lepp and Carlone, 2014). Moreover, in vivo injection and electroporation of a miR-133a 
mimic led to a significant decline in RARβ2 levels by 14 dpa. This mimic-induced 
downregulation of RARβ2 in turn significantly inhibited tail and spinal cord regeneration 
(Lepp and Carlone, 2014).  
 Given these previous results, and the fact that miR-1 and miR-133a are contained 
within the same gene cluster (Wystub et al., 2013), and may be expressed coordinately, 
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our next objective was to determine whether miR-1 also targets RARβ2. Indeed, many 
messenger RNAs are targeted by multiple miRNAs, just as many miRNAs may target 
multiple messenger RNAs (Bhalala et al., 2013). A search of the miRanda database 
(microrna.org), and a multiple sequence alignment demonstrated that there are several 
potential binding sites for miR-1 on the previously cloned 3’ UTR of the newt RARβ2 
(Fig. 3.9) (Carter et al., 2011). 
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Figure 3.9. Newt RARβ2 mRNA contains three potential binding sites for miR-1. A 
sequence alignment of the 3’-UTR of the newt RARβ2 mRNA sequence with mature the 
mature Danio rerio miR-1 revealed three potential binding sites *. The first binding site 
includes sequences from the seed region of miR-1.  
 
 
Figure 3.10. The 3’ UTR of newt RARβ2 is a direct target of miR-1 in vitro. The pmiR-
Glo luciferase reporter assay verified direct binding of miR-1 with putative binding sites 
on the 3’-UTR of newt RARβ2 mRNA after normalization to the internal Renilla 
luciferase activity. Control= Relative luciferase activity from the pmiR-Glo plasmid in 
PC3 cells containing the newt RARβ2 3’-UTR in the absence of exogenous miR-1. The 
addition of the miR-1 mimic to the cells led to a 56% decline in luciferase activity while 
the addition of a scrambled nucleotide had no significant effect. This decline in activity 
was significantly different from both the control and scramble-treated cells (***P< 0.001 
in comparison to the control and scrambled)(n=12 for each condition). 
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Our first step in determining whether RARβ2 is a target of miR-1 was to test the 
ability of miR-1 to bind to and inhibit expression of a reporter gene containing the 3’ 
UTR of newt RARβ2. Human PC3 cells were transfected with the pmirGLO Dual 
Luciferase plasmid containing the newt RARβ2-3’UTR downstream of the firefly 
luciferase gene, and co-transfected with the miR-1 mimic (used in the functional studies 
above) or a scrambled oligonucleotide (as a control). Co-transfection of the reporter 
plasmid with the miR-1 mimic caused a significant decrease in firefly luciferase activity 
(Fig. 3.10), compared to the control cultures containing the reporter plasmid but without 
the miR-1 mimic (56% reduction, p<0.001). There was no significant difference in 
normalized firefly luciferase activity between cultures co-transfected with plasmid alone 
and those cultured with plasmid and scrambled oligonucleotide (8% reduction, p<0.219, 
Fig. 3.10). Thus, miR-1 binds to the 3’-UTR of the newt RARβ2, leading to translational 
inhibition in vitro.  
 To determine if miR-1 targets the newt RARβ2 mRNA in vivo, we examined the 
effect of miR-1 mimic injection on the levels of RARβ2 protein in tail regenerates using a 
Western Blot analysis (Fig. 3.11A). Mimic-based upregulation of miR-1 caused a 
significant decrease in RARβ2 levels at 7 dpa (p<0.05), 14 dpa (p<0.05) and 21 dpa 
(p<0.01) compared to regenerates receiving the scrambled oligonucleotide (Fig. 3.11B).  
These data support a role for both miR-1 and miR-133a in the translational 
regulation of RARβ2 protein in the regenerating adult newt tail. Elevated levels of both 
miRNAs in the unamputated tail may function coordinately to suppress RARβ2 
expression in the ependymal cells of the intact spinal cord. Following injury, decreases in 
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the levels of these miRNAs by 14 dpa may thus contribute to an increase in the 
abundance and/or stability of mRNA transcripts encoding RARβ2. In turn, based upon 
our microarray data, this increase in RARβ2 may contribute to an ongoing suppression of 
miR-1 and miR-133a expression, thus maintaining sufficient RARβ2 expression to 
promote ependymal cell proliferation, formation of the ependymal bulb and tail 
regeneration (Carter et al., 2011). 
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Figure 3.11. RARβ2 is a target of miR-1 in the newt during tail regeneration. A) Western 
blots of RARβ2 and tubulin proteins from tail regenerates at various time points after 
amputation and injection of either an miR-1 mimic or scrambled oligonucleotide. RARβ2 
has an apparent M.W. of approximately 50.5 kDa, in confirmation of the previous results 
of Carter et al., (2011). B) Graphical representation of the relative densities shown in (A) 
determined by comparing the RARβ2 signal to the normalizing control, tubulin. Levels of 
RARβ2 were significantly decreased in mimic-treated regenerates at 7, 14 and 21 dpa 
versus the control. Error bars represent standard error. *P<0.05, **P<0.01 (n=3 for each 
condition). 
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3.05 Discussion 
Inhibition of retinoid signaling leads to dysregulation of numerous miRNAs in the 
regenerating newt tail. 
The cellular and molecular mechanisms that underlie the ability of a regeneration-
competent species, such as the adult newt, to regenerate functional tissue after caudal 
spinal cord transection remain largely elusive. Recently, efforts to identify factors 
coordinating this complex epimorphic process have focused on the role played by 
miRNAs, since they have been shown to regulate complex signaling pathways by 
targeting multiple mRNAs for degradation in other systems. Several studies have in fact 
examined the role of miRNAs during epimorphic regeneration of a variety of tissues. 
These include the let-7 family of miRNAs in lens regeneration (Nakamura et al., 2010; 
Tsonis et al., 2007), miR-128 and miR-133 in cardiac regeneration in the newt (Witman 
et al., 2013) and zebrafish (Yin et al., 2012) and miR-21, miR-133a and miR-203 in limb 
and fin regeneration in the axolotl and zebrafish  (Thatcher et al., 2008; Yin and Poss, 
2008; Holman et al., 2012).   
In response to tail amputation in the axolotl, miR-196 is upregulated, targeting 
Pax-7 and BMP4 to aid in the patterning of the regenerating spinal cord (Sehm et al., 
2009). More recently, Diaz Quiroz et al., (2014) employing a microarray approach 
comparing miRNAs expressed in axolotl and rat spinal cords after transection, 
determined that precise levels of miR-125b within the ependymoglia cells post-injury are 
required for functional recovery. In this study, the authors identified Sema4D as a 
potential target for this miRNA in vivo. We did not detect miR-125b in our microarray as 
a microRNA dysregulated after inhibition of retinoid signaling through RARβ. However 
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we have recently determined that a related microRNA, miR-125a, is significantly 
downregulated after inhibition of retinoic acid synthesis with DEAB in the regenerating 
newt tail (unpublished). It will be of interest to determine the cell-type specific pattern of 
expression and putative target(s) of miR-125a in the newt. 
The miR-133 family of miRNAs has also been shown to be involved in mediating 
gene expression post-transcriptionally during spinal cord regeneration. For example, Yu 
et al. (2011) found that upregulation of miR-133b promotes axonal outgrowth by 
targeting an inhibitor of this process, RhoA in the zebrafish. More recently, we have 
provided evidence that miR-133a downregulation in ependymoglia cells in the newt 
promotes caudal tail and spinal cord regeneration by maintaining retinoid signaling 
through RARβ2 in these cells (Lepp and Carlone, 2014).  
The previous study represented the first to examine miRNA regulation of RARβ2-
mediated retinoid signaling in any tissues during epimorphic regeneration in either 
vertebrates or invertebrates. None however, have attempted to determine the effects of 
retinoid signaling on the regulation of expression of miRNAs as target genes during this 
regenerative phenomenon. In the present study, we have utilized a microarray approach 
to identify at least 18 miRNAs that may represent either direct or indirect targets of 
RARβ2 signaling during caudal spinal cord regeneration in the newt. In confirmation of 
the microarray data, q-PCR analysis revealed that the expression of four of these 
miRNAs, miR-1, miR-26a, miR-223, and let-7c, was significantly altered at 14 days post 
tail amputation (dpa) after treatment with LE135, a selective RARβ antagonist. It is 
interesting to note that Carter et al., (2011) had previously shown that RARβ2 expression 
in ependymoglial cells of the newt spinal cord is significantly upregulated between 7 and 
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14 dpa. Thus is it not surprising that inhibition of retinoid signaling through that receptor 
subtype would have its greatest effect on potential downstream targets, including those 
miRNAs listed above, during this regenerative time period.  
Each of the four miRNAs shown to be differentially expressed in response to 
RARβ inhibition at 14 dpa have been linked to the pleiotropic control of processes in 
other systems, but are also thought to contribute to the epimorphic regeneration of the 
newt tail and spinal cord. For example, in the mouse, during both development and in the 
adult CNS, miR-26a is expressed in astrocytes and neurons (Saugstad, 2010; Smirnova et 
al., 2005) and may function in neuronal differentiation by suppressing RNA polymerase 
II C-terminal domain small phosphatases (CTDSPs), which normally repress neuronal 
gene expression in neural stem cells (Dill et al., 2012). Thus the generation of mature 
miR-26a/b is required for neuronal differentiation. Zhu et al. (2012) have shown that 
miR-26 a/b inhibits cell proliferation in mouse primary fibroblasts by targeting CDK6 
and cyclin E1, leading to a decrease in the phosphorylated form of pRb protein, thus 
blocking the G1/S transition. In our study, miR-26a levels are initially high in the 
unamputated tail and then decrease by 14 dpa and begin to rise again by 21 dpa. This 
pattern is consistent with a role for this miRNA in maintaining the differentiated state in 
the unamputated tail, and, in response to increased expression of RARβ2 after tail 
amputation, its downregulation provides an environment permissive for cellular 
proliferation and maintenance of the neuronal stem cell state (or as cells with transit-
amplifying characteristics, Kirkham et al., 2014) as the ependymoglial outgrowth 
continues. Later on in the regeneration process, the observed increased expression of 
miR-26a could be associated with the onset of neuronal, myogenic or osteogenic 
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differentiation as witnessed in human cord blood unrestricted stem cells (Trompeter et al., 
2013). 
We saw a similar pattern of expression to that of miR-26a with another putative 
RARβ2 downstream target, miR-145. Among the targets of miR-145 are superoxide 
dismutase-2 (SOD2) (Bhalala et al., 2013; Saugstad, 2010), and the anti-apoptotic factor, 
Bcl2 (Liu et al., 2009). Human ES cells express miR-145 after treatment with exogenous 
RA, suppressing expression of Oct4, Sox2 and Kruppel-like factor-4 (Klf4) (Jain et al., 
2012). The precise role of this miRNA in the regeneration of the tail and spinal cord is 
unclear since both its cell-type specific pattern of expression and its putative target(s) in 
this system remain to be identified.  
 Expression of miR-223 was initially upregulated in response to tail amputation, 
with a more than 4 fold increase by 7 dpa compared to the levels measured in the 
unamputated time 0 tail and spinal cord. miR-223 levels then decreased significantly by 
14 dpa and remained lower than those seen in the unamputated tail throughout the 
remainder of the regeneration period studied. miR-223 was initially identified due to its 
ability to modulate the differentiation of various hematopoietic lineages (Taïbi et al., 
2014). In the mammalian SCI model, miR-223 has been linked to the early post-injury 
inflammatory response (Nakanishi et al., 2010; Strickland et al., 2011; Yunta et al., 
2012), and has been shown to  be  present in neutrophils (Izumi et al., 2011), monocytes 
and macrophages (Taïbi et al., 2014). miR-223 has also been shown to regulate obesity-
associated adipose tissue inflammation by targeting Pknox1 and thus regulating 
macrophage polarization and enhancing alternative anti-inflammatory responses in mice 
(Zhuang et al., 2012).  The critical role of macrophage infiltration has recently been 
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examined during the early phases of epimorphic regeneration of the axolotl limb (Godwin 
et al., 2013) and zebrafish caudal fin (Petrie et al., 2014). In the axolotl limb, 
simultaneous induction of inflammatory and anti-inflammatory markers appear within the 
first 24 hours pa (Godwin et al., 2013). Zukor et al., (2011) have also shown that 
macrophages are present by at least 14 days of spinal cord regeneration in the newt. 
These macrophages are often associated with regenerating axons. It would be interesting 
to determine whether miR-223 is expressed in newt macrophages and whether it targets 
the newt homolog of Pknox1 in this complex, temporally regulated inflammatory/anti-
inflammatory process.  Since in the present study, miR-223 expression was found to be 
upregulated in ependymoglial cells at day 7, as determined by LNA in situ hybridization, 
it would also be critical, in future studies, to determine the interplay between retinoid 
signaling and miR-223 on the regulation of macrophage/ependymoglial interactions 
during the regeneration process. 
In contrast to the upregulation of miR-223, both miR-1 and let-7c were 
consistently downregulated in response to injury during the first 21 dpa. As with miR-
223, the expression of both of these microRNAs was prominent within ependymoglial 
cells and their relative abundance in these cells reflected the tissue levels as determined 
by q-PCR at similar regeneration stages. The fact that these three miRNAs are expressed 
in the same tissues and at similar regenerative stages as RARβ2 (Carter et al., 2011) is 
significant and supports our microarray data demonstrating either a direct or indirect 
effect on expression levels of these microRNAs after inhibition of RARβ signaling. 
Additional support comes from in vitro studies on embryonic stem cells (ESCs)/smooth 
muscle cells (SMCs) from mice, human peripheral blood, and human primary blast cells, 
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demonstrating that addition of RA alters the expression of these three miRNAs (Fazi et 
al., 2005; Huang et al., 2010; Saumet et al., 2009; Xie et al., 2011; Zardo et al., 2012).  
The precise roles of miR-1 and let-7c as targets of RARβ signaling during spinal 
cord regeneration remains to be determined. Let-7c has been shown to be involved in 
mouse ESC renewal (Melton et al., 2010) and its expression can be induced by 
exogenous addition of RA to human NB-4 cells (Saumet et al., 2009). Let-7 family 
members are downregulated during the process of dedifferentiation in the dorsal iris 
pigmented epithelial cells (PECs) after lentectomy in the adult newt (Tsonis et al., 2007). 
More recently, gain and loss-of-function analyses have provided evidence that up-
regulation of let-7b controls proliferation of both dorsal and ventral PECs in the 
regenerating newt lens (Nakamura et al., 2010). Our results indicate that let-7c expression 
is also downregulated by 7 dpa within the ependymal layer of the regenerating spinal 
cord and is maintained at a low level in these cells for the remaining two weeks of our 
analysis. This downregulation may be consistent, at least initially, with a role for let-7c in 
this system to maintain cells in a stem cell-like proliferative state within the ependymal 
tube.  Further studies are required to determine its precise function and specific target 
mRNAs in these cell types during the regeneration process. 
In mammalian models of spinal cord injury, miR-1 has been shown to contribute 
to an anti-inflammatory reaction by targeting annexin (Bhalala et al., 2013; Liu et al., 
2009), as well as  to induce apoptosis (Strickland et al., 2011). In vitro, both miR-1 and 
miR-133a/b regulate the myoblast-to-myocyte differentiation process by targeting 
myogenic differentiation antigen-1 and myogenin among others (van Rooij et al., 2008). 
Georgantas et al., (2014) have recently proposed that cytokine signaling may inhibit 
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myoblast differentiation by the suppression of miRs-1, 133a and 206, thus providing a 
link between the inflammatory response and muscle degeneration characteristic of the 
early phases of tail regeneration. In the present study however, we restricted our analysis 
of the expression of these microRNAs to those events occurring after 7 days post injury, a 
time when muscle degeneration in the tail has subsided and blastema mesenchyme 
proliferation is prominent distal to the wound site (Butler and Ward, 1967; Chernoff et 
al., 2003; Diaz Quiroz and Echeverri, 2013; Iten and Bryant, 1976). miR-1 expression is 
lowest at 14 dpa in our study, at a time when RARβ2 expression is upregulated compared 
to time 0 (Carter et al., 2011). At this regeneration stage, the ependymal tube extends 
distally within the blastema as both ependymoglial and blastema cells continue to 
proliferate. The basement membrane within the proximal portion of the epidermis has 
begun to form at this point, and a cartilaginous rod extends beneath the ependymal tube, 
providing support to it and regenerating axons (Iten and Bryant, 1976). 
Although each of these miRNAs may have multiple targets within the newt during 
tail and caudal spinal cord regeneration, including the ones suggested above, we were 
interested in determining whether any of our identified miRNAs had components of the 
retinoid signaling pathway as potential targets. Since both miR-1 and retinoic acid 
signaling have been widely reported to be important regulators of inflammation, 
apoptosis and muscle degeneration in mammalian tissues (Bak et al., 2008; Bhalala et al., 
2013; Saugstad, 2010; Strickland et al., 2011), and since their expression patterns are 
coincident spatially but inversely correlated temporally, we decided to focus our attention 
on RARβ2 as a potential target of miR-1. Although scant evidence exists that miRNAs 
target RARs (Nervi and Grignani, 2014), an in silico analysis in miR-base (TargetScan 
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Human 6.2) revealed that several miRNAs, including miR-1 and miR-133a, are 
complementary to sites within the 3’-UTR of the RARβ mRNA transcript.  We have 
previously provided evidence that miR-133a targets newt RARβ2 both in vitro and in 
vivo (Lepp and Carlone, 2014). Furthermore, miR-1 and miR-133a are encoded within 
the same gene cluster and may be regulated in a coordinated fashion (Kusakabe et al., 
2013) as they appear to be in the present study. Both miR-1 and miR-133a are 
significantly more abundant in uninjured spinal cord tissue compared to the levels seen in 
ependymal cells after 7 dpa. Conversely, as mentioned above, RARβ2 expression 
increases significantly above the levels in unamputated spinal cord tissue by 7 dpa (Carter 
et al., 2011). Taken together, these data are suggestive of a negative feedback loop in 
which miR-1 and miR-133a are expressed in ependymoglial cells in the unamputated tail 
to contribute to the suppression of RARβ2 expression (Fig. 3.12). In response to injury, 
concomitant with an increase in RARβ2 in ependymoglial cells, miR-1 and miR-133a  
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Figure 3.12. Potential model depicting the involvement of miR-133a, miR-1 and RARβ2 
during tail and caudal spinal cord regeneration in the adult newt. In response to injury, 
miR-133a and miR-1 are downregulated by an unknown factor, which allows for an 
increase in RARβ2 expression. This forms a putative negative feedback loop to maintain 
the upregulated RARβ2, which in turn may be involved in the activation of the 
ependymal response, inflammation, and contribute to the establishment of a permissive 
environment for regeneration. 
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levels diminish significantly. Since our data strongly support the 3’-UTR of RARβ2 as a 
target for both miR-1 (this study) as well as miR-133a in vitro and in vivo, (Lepp and 
Carlone, 2014), their downregulation could contribute to the maintenance of RARβ2 
signaling in the ependymal layer of the cord which is essential for continual ependymal 
outgrowth, neuronal differentiation and ultimately tail regeneration (Carter et al., 2011). 
These data represent the first evidence in support of a negative feedback loop, albeit 
indirectly, between retinoid signaling and miRNAs in spinal cord regeneration in a 
regeneration-competent model organism. Future studies are aimed at determining 
whether any of the miRNAs that we have identified have retinoic response elements 
(RAREs) as part of their gene regulatory sequences or whether other effector molecules 
mediate the effects of RARβ2 signaling on the expression of these miRNAs indirectly.  
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CHAPTER FOUR: 
Inhibition of retinoic acid synthesis promotes microRNA dysregulation during 
caudal spinal cord regeneration in the adult newt. 
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4.01 Abstract 
 Retinoic acid signaling is involved in the patterning and differentiation of the 
central nervous system, the maintenance of the neuronal differentiated state after 
development, and is actively involved in regeneration of the nervous system in the adult 
(Blum and Begemann, 2013; Maden, 2007). Inhibition of retinoic acid synthesis during 
development leads to deficits in spinal cord and hindbrain formation in mammalian 
embryos (Duester, 2008). However the effects of retinoic acid synthesis inhibition during 
spinal cord regeneration in a species capable of recovery from a spinal cord injury (SCI) 
remain unknown. We have previously shown that inhibition of retinoid signaling via the 
retinoic acid receptor, RARβ, during caudal spinal cord regeneration in the adult newt 
leads to microRNA dysregulation. That study only examined those microRNAs affected 
by a decline in retinoid signaling through RARβ, and thus potentially excluded 
microRNAs regulated by other retinoid X or RAR type receptors. Our main objective for 
this study was to examine the effect of inhibiting retinoic acid synthesis on microRNA 
expression during caudal spinal cord and tail regeneration in the adult newt. Using a 
microarray, we identified 4,426 miRNAs expressed in two treatment groups, treatments 
with either the retinaldehyde dehydrogenase inhibitor diethylaminobenzaldehyde 
(DEAB), or with the vehicle control, DMSO. Of these miRNAs, 367 had statistically 
significant differential expression between the treatment groups, and only 61 of these 
miRNAs had high relative signal intensities (>500) in the treatment, control, or both 
groups. Six of these miRNAs were chosen for further profiling based on known roles in 
either inflammation, apoptosis or protection against oxidative damage. RT-qPCR 
analyses of these six miRNAs confirmed dysregulated expression in response to retinoid 
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synthesis inhibition by DEAB treatment over the first two weeks post amputation. These 
data provide the framework for future studies to uncover the potential roles of each of 
these miRNAs. A more thorough understanding of which miRNAs are regulated by the 
retinoid signaling pathway during regeneration, as well as their targets and downstream 
functions may contribute to unraveling the complex pathways that provide a permissive 
environment for tail regeneration in the newt. 
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4.02 Introduction  
Retinoid signaling has been implicated in regeneration and recovery from a spinal 
cord injury, where the re-activation of processes from development such as stem cell 
differentiation, axonal outgrowth and patterning to re-establish functional connections are 
critical. For example, spinal cord explants from mouse embryos exhibit neurite outgrowth 
in response to RA treatment in vitro, but this response is absent in adult spinal cord 
explants (Corcoran et al., 2002). Although adult mouse spinal cord explants showed no 
neurite outgrowth in response to treatment with RA, when transduced with a lentiviral 
vector containing the gene for RARβ2, outgrowth occurred in vitro similar to that seen 
with the cultured embryonic explants (Corcoran et al., 2002). Furthermore, neurons 
treated with a selective agonist of RARβ2 (CD2019) are capable of neurite outgrowth in 
vitro through an inhibitory environment containing myelin-associated glycoprotein 
(MAG) (Agudo et al., 2010). These data suggest that a lack of RARβ2 expression in the 
adult CNS may be responsible for the lack of neurite outgrowth observed in mammals 
after a SCI.  
Species capable of regenerating spinal cords after a SCI, such as the adult newt, 
exhibit neurite outgrowth in vitro from spinal cord explants treated with RA, and this 
effect is specifically mediated by RARβ (Dmetrichuk et al., 2005). These animals not 
only have RARβ2 expression throughout the CNS into adulthood, but RARβ2 expression 
is upregulated in response to caudal tail amputation (Carter et al., 2011). Inhibition of 
RARβ2 signaling in caudal spinal cords after tail amputation by a specific antagonist, 
LE135, leads to inhibition of tail and spinal cord regeneration (Carter et al., 2011).  
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The effectors of RARβ2-mediated retinoid signaling, which contribute to 
functional tail and spinal cord regeneration, are just beginning to be uncovered. We have 
previously demonstrated that several miRNAs are not only acting downstream of RARβ2 
signaling, but at least two miRNAs, miR-1 and miR-133a, may also target RARβ2 (See 
Chapters 2 and 3 of this thesis). However, focusing on RARβ2 alone does not provide a 
complete picture of retinoid signaling and miRNA involvement in this pathway during 
tail regeneration. While five RAR isoforms have been identified in regenerating newt 
tissue (Carter et al., 2011; Maden and Hind, 2003), RARβ is the only one of these 
receptor subtypes currently demonstrated to be involved in regeneration (Carter et al., 
2011; Dmetrichuk et al., 2005). Retinoids can act through numerous receptor 
heterodimers, thus by focusing solely on miRNAs downstream of RARβ2 numerous 
miRNAs may be overlooked. It is possible that retinoid signaling is playing multiple roles 
during regeneration, and could also be involved in inflammation and stem cell 
maintenance. Our main objective here was to determine which, if any, miRNAs were 
affected by the inhibition of retinoid signaling at one of the first steps in the signaling 
pathway, the synthesis of the ligand all trans RA. By inhibiting the activity of 
retinaldehyde dehydrogenase (RALDH) and thus the synthesis of RA from retinaldehyde, 
we should be able to determine a more precise and total picture of the role of miRNAs 
and RA signaling in spinal cord regeneration in the newt.  
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4.03 Materials and Methods 
Animal Care and Surgery 
 Adult eastern spotted newts, Notophthalmus viridescens, were used for all 
experiments and were purchased from Boreal Scientific (St. Catharines, ON). For the 
duration of the study, newts were housed in plastic containers in dechlorinated water, and 
were fed brine shrimp, bloodworms and liver three times a week. For surgical procedures, 
animals were anaesthetized by bathing for 10 minutes in 0.1% tricaine methane sulfonate 
(MS-222, Sigma), pH 7.0. The tails of anaesthetized animals were amputated 
approximately 1 cm caudal to the cloaca, after which they recovered on ice for 20 
minutes. Blastemas were collected at each timepoint by repeating the above anesthetic 
procedure, then transecting the regenerate tissue approximately 1-2 mm rostral to the 
original cut site. All animal care and surgery procedures were approved by the Brock 
University Animal Care and Use Committee.  
DEAB Treatment 
 Immediately after recovery post surgery, animals were placed in a bath containing 
dechlorinated tap water and either 10-6 M diethylaminobenzaldehyde (DEAB), an 
inhibitor of retinaldehyde dehydrogenase (RALDH), or 0.01% DMSO (the vehicle 
control) for up to 14 days. This concentration was successfully used via bath application 
to completely inhibit RALDH activity in zebrafish embryos by Neto et al., (2012). 
Solutions were changed twice a week and newts were fed and maintained following the 
above housing protocol. 
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Microarray Analysis 
 Blastemas were isolated and immediately flash frozen from regenerates 4 days 
post amputation (dpa) and after treatment with either DEAB or DMSO. Total RNA was 
isolated from homogenized blastemas in each treatment group using the Animal Tissue 
RNA Purification Kit (Norgen Biotek), RNA was quantified and purity assessed by a 
combination of gel electrophoresis and NanoDrop spectrophotometry (Thermo 
Scientific). Triplicate samples from each treatment were pooled, and the concentration of 
each was determined to ensure there was a minimum of 2 µg. Microarray analysis was 
outsourced to LC Sciences (Houston, TX).  The samples were initially size-fractioned, 
then each treatment sample was hybridized to its own custom Cy3 chip containing 4,426 
miRNA probes (known miRNAs of Danio rerio, Xenopus tropicalis, Xenopus laevis, 
Homo sapiens, Mus musculus), and 73 controls from miRBase 20. Hybridization was 
performed on the µParaflo®Microfluidic Biochip platform, which contains in situ 
synthesized probes in triplicate that are complementary for each target miRNA. Images 
were collected of the chips using a laser scanner (GenePix 4000B, Molecular Device), 
signals were background subtracted and normalized using a LOWESS filter (locally-
weighted regression). Statistical analysis included a two-tailed Student’s T test and was 
also performed by LC Sciences to compare the two treatment groups, and only signals 
that were significantly different between the two groups (p<0.01), were considered for 
further study. 
RT-qPCR 
 Regenerate tissue containing up to 2 mm of proximal tail stump was acquired at 
the time points 0, 7 and 14 dpa, and immediately flash frozen in liquid nitrogen. RNA 
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was isolated as described above and cDNA was synthesized using gene specific stem-
loop primers (Varkonyi-Gasic et al., 2007) with the SuperScript III Reverse Transcriptase 
Kit (Invitrogen) with 350 ng of total RNA. Real time qPCR was carried out on a CFX 
Connect Real-Time System (BioRad), using iQ SYBR Green Supermix (BioRad) in a 20 
µl reaction (10 µl of iQ SYBR Supermix, 5 µl of RNase free water, 1 µl of forward and 
reverse primers and 3 µl of cDNA). Each reaction was run with three biological and three 
technical replicates on the following program; 95°C for 5 min, followed by 40 cycles of 
95°C for 15 sec, 55° for 15 sec and 72° for 45 sec, then each reaction ended with a melt 
curve analysis. Following normalization to two reference genes (α-Tubulin, β-Actin), the 
ΔΔCT method was used to determine the relative expression changes of each miRNA for 
each treatment and timepoint. The Minimum Information for Publication of Quantitative 
Real-Time qPCR Experiments (MIQE) guidelines were followed for all RT-qPCR 
experiments (Taylor et al., 2010). The following primers were used for stem-loop cDNA 
synthesis (RT primers), as well as qPCR: 
RT-miR-125a gtcgtatccagtgcagggtccgaggtattcgcactggatacgaccacagg 
RT-miR-21-5p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacctggaag 
RT-miR-149-3p gtcgtatccagtgcagggtccgaggtattcgcactggatacgaccacc 
RT-miR-23a gtcgtatccagtgcagggtccgaggtattcgcactggatacgacggaa 
RT-miR-205 gtcgtatccagtgcagggtccgaggtattcgcactggatacgaccagac 
RT-miR-206 gtcgtatccagtgcagggtccgaggtattcgcactggatacgacccaca 
dre-miR-125a cgctgggagagacccttaa 
has-miR-21-5p gccgcagtgtagtatgggca 
mmu-miR-149-3p gcgagggagggacgggg 
xla-miR-23a gcatcacattgccagggau 
dre-miR-205 cgctccttcattccaccg 
dre-miR-206 gccgctggaatgtaaggaag 
has-miR21-5p 2 cgcagtgtagtatgggca 
Reverse gtgcagggtccgaggt 
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Statistical Analysis 
 Data for the miRNA microarray chip repeats were analyzed using a Student’s 
two-tailed t-test (p<0.01). A one-way ANOVA with a Post Hoc Tukey test (p<0.05) was 
used to analyze all qPCR data. Unless otherwise indicated, all analyses were run in 
triplicate.  
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4.04 Results 
DEAB treatment inhibits tail and caudal spinal cord regeneration. 
 It has previously been demonstrated that LE135, an RARβ-selective antagonist, 
inhibits normal caudal regeneration of the newt tail after transection (Carter et al., 2011), 
and leads to dysregulation of miRNA expression in response to injury (Chapter 3). 
However, since RARβ represents one of a number of receptor subtypes which may 
mediate RA’s effects, my aim in this study was to determine the possible effects of 
inhibiting RA synthesis in vivo on miRNA expression during tail regeneration. To 
accomplish this, immediately after recovery from surgery at time 0, newts were placed in 
a 10-6 M solution of either DEAB, a potent inhibitor of the enzyme RALDH, or DMSO 
(vehicle control). Bath application of DEAB significantly inhibited normal tail 
regeneration, in some cases so severely that the tail tissues actually retracted rostrally 
away from the site of injury and the vertebral column was visible at the stump of the tail 
(Fig. 4.1B). Significant inhibition of tail regeneration was observed at both 14 and 21 
dpa, but not at 7 dpa (Fig. 4.1C). This is not surprising, as less than 1 mm of tissue 
regeneration had occurred in both control and treatment groups (0.5683 mm in DMSO, 
0.5137 mm in DEAB) so a significant difference would be very difficult to observe. 
However this does not mean that DEAB was not causing changes in early regeneration at 
the molecular level. It is clear that retinoid signaling is required for tail regeneration, a 
result in agreement with previous research which showed that LE135 treatment had a 
similar, albeit less severe effect (Carter et al., 2011). The severity of regeneration 
inhibition observed here is not surprising given that multiple pathways could be affected 
by the inhibition of retinoid signaling.  
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Figure 4.1. Bath application of DEAB, an inhibitor of the enzyme RALDH, inhibits tail 
regeneration. DEAB had no significant effect on tail regenerate length or blastema 
formation at day 7 pa compared to DMSO treatment (A, B). However by 14 and 21 days 
pa, DEAB significantly inhibited caudal regeneration (A, B, C). Error bars indicate 
standard error, ** P<0.01 (n=3). Scale bars = 1 mm. 
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Treatment with DEAB causes widespread miRNA dysregulation early in regeneration. 
 Our next specific question was to determine which miRNAs are affected by 
inhibition of RA synthesis. We have previously demonstrated that 18 miRNAs are 
affected by inhibition of RARβ signaling in tail regenerates (Chapter 3). We outsourced a 
microarray to LC Sciences (Houston, TX) with pooled total RNA from day 4 regenerates 
treated with either DEAB or DMSO, as explained above. miRNA expression was 
detected for each of the 4,426 probes tested, of which 367 miRNAs were significantly 
different between groups (p<0.01). A relative signal intensity above 35 is considered a 
positive test sample by LC Sciences, however for the purposes of this study we decided 
to focus only on reporter probes that had high signal intensity (>500) in the control, 
treatment, or both group’s chips. This narrowed down the list of 367 to just 61 miRNAs 
to focus on for further examination (Table 4.1). Notably, miR-1, let-7c and miR-133a, 
were all on the “high expression” list, and were also the focus of my previous research 
(Chapters 2 & 3).  
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Table 4.1. Reporter probes which detected high miRNA expression, a signal intensity 
greater than 500, on the microarray in the control, treatment, or both groups at 4 dpa. The 
value given indicates the signal intensity for that tested group, and those in bold indicate 
significant differential expression between treatment and control groups. Filled boxes 
indicate the miRNAs chosen for further study. Reporter probes included dre (Danio 
rerio), xla (Xenopus laevis), xtr (Xenopus tropicalis), hsa (Homo sapiens) and mmu (Mus 
musculus). 
 
Reporter Name (miRNA) DMSO Signal Intensity DEAB Signal Intensity 
dre-miR-1 1,307 800 
dre-miR-125a 1,500 709 
dre-miR-125c 620 236 
mmu-miR-149-3p 725 904 
dre-miR-206 1,156 188 
dre-miR-214 538 276 
xtr-miR-26 241 670 
dre-miR-26a 244 622 
has-miR-3141 391 641 
mmu-miR-341-5p 42,435 55,555 
has-miR-4690-5p 1,765 2,621 
has-miR-5096 282 1,186 
mmu-miR-5112 26 1,260 
mmu-miR-5126 744 1,127 
mmu-miR-7028-5p 1,432 13,379 
mmu-miR-705 419 542 
mmu-miR-709 297 793 
mmu-miR-7082-5p 298 925 
mmu-miR-7116-5p 353 20,643 
dre-let-7a 2,097 1,454 
dre-let-7b 662 585 
dre-let-7c 1,412 1,088 
has-let-7d-5p 1,694 1,153 
xtr-let-7e 1,186 667 
has-let-7e-5p 621 526 
dre-let-7f 1,369 978 
xtr-miR-1a 1,105 643 
has-miR-125a-5p 597 276 
xla-miR-133a 682 112 
dre-miR-133a-3p 880 221 
xla-miR-133b 697 181 
dre-miR-133b-3p 794 212 
mmu-miR-133b-5p 49,751 39,048 
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xtr-miR-133c 986 227 
xla-miR-133d 587 152 
dre-miR-203a 702 1,053 
has-miR-203a 371 746 
dre-miR-203b-3p 417 742 
dre-miR-205 561 288 
has-miR-21-5p 736 586 
xla-miR-23a 558 489 
xtr-miR-23b 439 517 
mmu-miR-3064-3p 519 390 
has-miR-3591-3p 554 375 
has-miR-3613-3p 20,072 15,496 
has-miR-3960 333 670 
has-miR-4267 3,489 961 
has-miR-4324 640 179 
mmu-miR-434-3p 343 578 
has-miR-4459 551 803 
has-miR-466 627 545 
has-miR-4668-5p 14,697 6,281 
has-miR-4734 1,135 2,833 
has-miR-6087 3,489 3,728 
has-miR-6089 244 590 
has-miR-6090 518 990 
mmu-miR-6239 397 507 
mmu-miR-7081-5p 4,308 1,135 
mmu-miR-7239-3p 1,798 238 
has-miR-7847-3p 232 503 
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miRNAs are differentially regulated in response to retinoid signaling inhibition. 
 Among the miRNAs identified in the microarray above, of particular interest due 
to roles in previous studies were miR-21-5p, miR-23, miR-125a, miR-149-3p, miR-205, 
miR-206, miR-434-3p and miR-709 (Table 4.1). High levels of expression were seen in 
both the control and treatment groups for miR-125a, miR-21-5p and miR-149-3p and all 
three have been previously shown to act as anti-apoptotic regulatory RNAs (Ding et al., 
2013; Rebane and Akdis, 2013; Yunta et al., 2012). miR-125a and miR-21-5p have also 
been associated with anti-inflammatory properties (Strickland et al., 2011; Yunta et al., 
2012). Expression was low (<500) after DEAB treatment but high in the DMSO control 
for miR-23, miR-205 and miR-206. miR-23 has previously been found to target Fas, an 
apoptotic factor that is involved in reactive oxygen species-mediated cell death (Lin et al., 
2011). Thus miR-23 may promote protection from oxidative damage. During the 
development of breast cancer, miR-205 has been found to target phosphatase and tensin 
homolog (PTEN) and inhibit apoptosis (Sun et al., 2014). Finally, miR-206 has been 
shown to decrease proliferation in mouse skeletal muscle satellite cells by targeting the 
paired-box transcription factor Pax7 (Chen et al., 2010), and also target the anti-
inflammatory annexin2, and free radical destroying superoxide dismutase (SOD1) in 
adult rats post-SCI (Liu et al., 2009).  
miRNAs that are highly expressed after DEAB treatment but not after control 
DMSO treatment include miR-434-3p and miR-709. Expression of miR-434-3p is 
associated with an increase in neural stem cell (NSC) differentiation in brain derived rat 
neurons (Jovičić et al., 2013). miR-709 has been found to target the Brother of the 
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Regulator of Imprinted Sites (BORIS) (Tamminga et al., 2008), an important factor in 
regulation of DNA methylation. 
 Of these miRNAs, we chose to further investigate six that had a high signal from 
the microarray; miR-21-5p, miR-23, miR-125a, miR-149-3p, miR-205, miR-206. Each of 
these miRNAs were chosen because they have been previously implicated in other 
processes that are also involved in regeneration, including inflammation, apoptosis, and 
protection from oxidative damage (Ding et al., 2013; Lin et al., 2011; Yunta et al., 2012). 
Although only miR-125a, miR-149-3p and miR-206 had significant differences in signal 
between treatment groups in the microarray, miR-205, miR-21-5p and miR-23a were also 
chosen due to their demonstrated roles in regeneration-associated functions in other 
species. An expression profile for each of these miRNAs was established for each 
treatment group at time 0, 4, 7 and 14 dpa using RT-qPCR (Fig 4.2). With the exception 
of miR-149-3p, the pattern of expression of each of these miRNAs matched the 
expression profile observed at 4 dpa in our microarray. miR-21, miR-125a, miR-205 and 
miR-206 were upregulated in response to tail amputation (Fig. 4.1A, B, D, F). 
Specifically, miR-21 was significantly upregulated in DMSO control regenerates very 
early post amputation. Treatment with DEAB abolished this upregulation at 4 dpa, and 
expression was maintained at a constant level for the subsequent 10 days in both control 
and treatment groups. miR-125a and miR-205 were both upregulated in response to 
injury as well, and their expression remained high in the control DMSO regenerates for 
the first 7 days. Again, the level of expression was significantly decreased by DEAB 
treatment for these miRNAs, at days 4 and 14 for miR-125a and days 4 and 7 for miR-
205. 
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 Expression of miR-23 remained constant for the first 7 dpa, and a slight decrease 
in expression, although an insignificant one, was observed at 14 dpa (P = 0.2705) (Fig. 
4.1C). There were no significant differences between the control and treatment groups for 
miR-23, which is not surprising considering there was no significant difference observed 
in the microarray either for this miRNA. miR-149-3p was downregulated compared to 
time 0 in both the control and treatment groups, but only significantly in the 14 dpa 
control regenerates (Fig. 4.2E). An interesting trend was that 4 out of 6 of the miRNAs 
examined were at least initially upregulated in response to injury, but by 14 dpa, all six of 
these miRNAs were either downregulated compared to time 0, or returned to time 0 
levels of expression. We have previously seen miRNA dysregulation in response to 
inhibition of RARβ signaling at day 14, a stage at which RARβ2 levels are normally 
increased in ependymal cells during spinal cord regeneration. The putative targets of 
these miRNAs remain unknown, and studies are currently underway in our lab to 
examine not only the targets of these miRNAs, but also to examine their temporal and 
spatial expression patterns at later time points (21-35 dpa).  
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Figure 4.2. Relative normalized expression of six miRNAs determined by RT-qPCR in 
uninjured tissue and at three timepoints post amputation in regenerates from DEAB and 
control DMSO animals. A) miR-21 B) miR-125a C) miR-23 D) miR-205 E) miR-149-3p 
and F) miR-206. Error bars indicate standard error, * P<0.05 (n=3). 
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4.05 Discussion 
 
 The present study demonstrates, for the first time, that suppressing retinoic acid 
synthesis, via inhibition of retinaldehyde dehydrogenase (RALDH), leads to miRNA 
dysregulation as well as a reduction of tail and caudal spinal cord regeneration. While we 
provide evidence that treatment with DEAB significantly reduces the length of tail 
regenerates, the mechanism by which this decrease in RA acts on regeneration remains 
unclear. It is possible that the lack of regeneration observed can be attributed to 
interference with the epithelial-mesenchyme transition occurring during ependymal cell 
outgrowth, as retinoid signaling has been associated with this transition in neural crest 
cells (NCCs) during mouse development (Paschaki et al., 2012). Alternatively, retinoid 
signaling has also been associated with ependymal tube formation during urodele tail 
regeneration (Carter et al., 2011), as well as axonal guidance and neurite outgrowth in 
both mammals and urodeles in vivo and in vitro (Agudo et al., 2010; Corcoran et al., 
2002, 2000; Dmetrichuk et al., 2005; So et al., 2006; Ping K Yip et al., 2006). Thus, the 
effects of inhibiting RALDH that we see here are likely pleiotropic, and lead to the 
overall inhibition of caudal tail and spinal cord regeneration. 
 Knock out experiments with mouse embryos have provided extensive phenotypic 
data demonstrating the consequences of RALDH inhibition on CNS development. 
Molotkova et al., (2007) found that Raldh3 -/- mouse embryos had a complete lack of 
neuronal differentiation in the developing forebrain. Furthermore, mice null for Rdh10 
also had defects in hindbrain patterning, as well as a lack of RA synthesis in the meninges 
(Chatzi et al., 2013). In Raldh2 -/- mouse embryos, where maternally supplemented RA is 
required to avoid lethality, the phenotype of the rescued embryos displays dorsal spinal 
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cord deficits, as well as inhibition of neuronal stem cell proliferation (Paschaki et al., 
2012). Thus, retinoid signaling is a requirement for the normal development of the 
mammalian CNS, and deficiencies in RA due to mutations in RA synthesis genes leads to 
deficits in both brain and spinal cord formation.  
Bath application of DEAB has also been used on zebrafish embryos to examine 
the effects of RA deficiencies on eye development (Le et al., 2012). Application of 
DEAB for just 2 hours on embryos that were 9 hours post fertilization was sufficient to 
cause microphthalmia that persisted for the remainder of development.  Le et al., (2012) 
found that DEAB treatment effectively abolished RA synthesis, but did not cause 
immediate degradation of existing RA. Fin regeneration is inhibited in developing 
zebrafish larvae following treatment with DEAB, due to reduced mesenchymal 
proliferation (Blum and Begemann, 2013; Neto et al., 2012). 
This is the first study to use any treatment of DEAB on the adult newt, and 
although it is likely that it is disrupting RA synthesis through RALDH inhibition due to 
its selectivity, further study is required to verify its specificity for RALDH2 in this 
species. The earliest tissue isolated in this study after beginning DEAB treatment was 4 
dpa, which should provide ample time for any remaining RA to be degraded if its 
treatment is as potent as that observed by Le et al., (2012). In the present study I have not 
determined the effect of DEAB treatment on ependymal cell or tail blastema 
mesenchymal cell proliferation. Such a study could provide valuable information 
regarding the mechanism by which DEAB interferes with tail and caudal spinal cord 
regeneration in the newt.  
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 In addition to demonstrating that inhibition of RA synthesis in the adult newt 
prevents tail regeneration, we also offer the first comprehensive profile of miRNA 
expression in response to inhibition of RA synthesis. Our microarray identified 4,426 
miRNAs with varying levels of expression in response to DEAB treatment. The 
microarray we used is an established method for miRNA identification and is highly 
sensitive, with high probe quality as well as high stringency hybridization conditions. The 
enhanced detection sensitivity of this array, paired with the high level of conservation of 
miRNA sequences among distantly related species (Ha and Kim, 2014), provides 
confidence in the data generated by this microarray. Of the identified miRNAs, only 61 
had high levels of expression in the control, treatment, or both groups (signal intensity 
>500). Many of these miRNAs, including but not limited to, miR-21-5p, miR-23, miR-
125a, miR-149-3p, miR-205 and miR-206 have been previously implicated in other 
process that are involved in regeneration, including inflammation, apoptosis and 
protection from oxidative damage (Ding et al., 2013; Lin et al., 2011; Liu et al., 2009; 
Yunta et al., 2012). While only these six miRNAs were chosen for further analysis in this 
study, this microarray provides an excellent base for continued studies on numerous other 
miRNAs and their potential roles in retinoid signaling during spinal cord regeneration. 
 The differential expression of these six miRNAs which were identified with the 
microarray was then confirmed using qPCR, at various times during the first 14 days of 
regeneration in control and DEAB treated regenerates. As outlined in the results, each of 
these miRNAs displayed a different pattern of expression in response to injury, but just 4 
out of the 6 miRNAs had significantly different expression between treatment groups. 
This result is not entirely surprising, as only 3 of the 6 miRNAs chosen had significant 
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differential signals detected in the microarray, the remaining 3 miRNAs were chosen 
solely based on their potential regulator-related roles in other systems. While these results 
are intriguing, the spatial pattern of expression, as well as putative target of each of these 
miRNAs remains to be determined. Thus, the precise role of each of these miRNAs 
during tail and spinal cord regeneration remains to be determined. 
 Previous research has provided evidence that miR-206 may be involved in 
recovery from both a muscular injury and SCI. Chen et al., (2010) identified a sharp 
downregulation of miR-206 in response to a cardiotoxin-induced muscle injury in mice, 
and found that it targeted Pax7 in muscle satellite cells to repress proliferation. 
Alternatively, Liu et al., (2009) examined miR-206 expression following SCI in rats, 
which was initially downregulated in the first 24 hours post injury, but returned to 
baseline by 7 days post injury. Predicted targets of miR-206 in the rat were the anti-
inflammatory factors annexin A2 and SOD-1, as well as the anti-apoptotic factor Bcl2-2 
(Liu et al., 2009). Although miR-206 is downregulated in both of these mammalian 
studies in response to an injury, we observed the opposite in the newt in response to tail 
amputation. miR-206 was initially trending toward upregulation during the first 7 dpa 
(albeit not significantly, p < 0.0798), and treatment with DEAB prevented any change in 
expression. Thus the role of this miRNA remains elusive. However it is possible that it is 
involved in proliferation in response to injury in the newt as it is in mammalian satellite 
muscle cells.  
An upregulation was also observed for miR-125a in response to injury; it was 
significantly upregulated at 4 and 7 dpa, but downregulated by day 14 in the control 
group. Little information exists on the role that miR-125a plays in response to SCI in any 
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system. However, Diaz Quiroz et al., (2014) recently examined the role of another 
miRNA from the same family, miR-125b. In response to a complete spinal cord 
transection in axolotls, miR-125b was downregulated in the radial glial cells surrounding 
the central canal of the spinal cord in the first 7 dpi. miR-125b was found to target 
Sema4D, and the precise expression pattern of miR-125b is required for the establishment 
of a permissive environment for axonal regeneration as well as lack of glial scar 
formation (Diaz Quiroz et al., 2014). The opposite pattern is seen in the present study for 
miR-125a, and although these miRNAs are related, it is possible that miR-125a has a 
completely different function in the newt in response to tail amputation. While the mature 
seed sequence of these two miRNAs is identical, there are seven bases that differ at the 3’ 
end (miRbase.org). Considering that sister miRNAs often have completely different 
expression patterns, localization and targets (Ha and Kim, 2014), it is not completely 
surprising that a different pattern of expression was observed here. 
 In contrast to the upregulation seen with miR-206 and miR-125a, miR-149-3p 
demonstrated significantly lower expression at 14 dpa compared to time 0. miR-149-3p 
has previously been identified as an anti-apoptotic factor. In human blood it has been 
found to target Puma, a pro-apoptotic modulator (Ding et al., 2013). We observed a 
downregulation of miR-149-3p, so it is unlikely that it is targeting Puma in the newt 
because this would lead to an increase in apoptosis. However, this miRNA may still be 
involved in apoptosis, but likely has a different target. 
Similar to miR-125a, miR-205 was significantly upregulated at both 4 and 7 dpa, 
but downregulated by day 14. In silico analysis suggests that miR-205 may target RARα 
(Nervi and Grignani, 2014). The expression pattern of RARα in the newt has not been 
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examined, but in the zebrafish, its expression is required for cardiomyocyte proliferation 
and heart regeneration (Blum and Begemann, 2013). No studies are available examining 
the role of RARα in tail or spinal cord regeneration in the newt. Future studies could 
examine not only its expression, but also whether it represents an in vivo miR-205 target.  
Previous studies have also shown that miR-23 is upregulated in response to RA 
treatment in acute promyelocytic leukemia (APL) cells in vitro (Careccia et al., 2009; 
Saumet et al., 2009). The promoter region of miR-23 was found to have a promyelocytic 
leukemia (PML)-RARα binding site in these cells. The ability of RA to induce the 
expression of this miRNA remains unclear in the newt, as no significant difference in 
expression was observed in response to DEAB treatment. The potential target of this 
miRNA during regeneration also remains elusive. 
Of particular interest was miR-21, which has previously been implicated as a 
modulator of the retinoid signaling pathway (Terao et al., 2011). In response to RA 
treatment in breast cancer cells in vitro, ligand-activated RARα leads to an upregulation 
of miR-21 in these cells, which in turn leads to an increase in proliferation (Terao et al., 
2011). It has also been predicted to act as an anti-inflammatory and anti-apoptotic factor 
in response to SCI in mammals (Rebane and Akdis, 2013; Yunta et al., 2012).  
In addition to miR-21 having previously been linked to retinoid signaling as well 
as inflammation and apoptosis, it has also been implicated during limb regeneration in the 
axolotl. In response to limb amputation, miR-21 is upregulated in the axolotl blastema 
but not stump tissue by 17 dpa, and was found to target Jagged1, an important patterning 
factor during development (Holman et al., 2012). We also found that miR-21 is 
upregulated very early during tail regeneration in the adult newt. More recent research 
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from our lab has shown that it is upregulated in untreated animals later during 
regeneration (days 28 and 35) (Rozema, 2014). Expression of Jagged mRNA was found 
to be quite high in uninjured tissue, and levels slowly decrease, with significant 
downregulation by days 28 and 35 (Rozema, 2014). Current studies are underway to 
confirm Jagged as a putative target of miR-21 in the newt tail during regeneration. 
Overall, the data presented here have laid the groundwork for many future studies 
examining miRNAs as key players in the regulation of the complex network of retinoid 
signaling components that are critical for tail regeneration in the newt. 
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The overall aim of this thesis was to determine the role played by miRNAs during 
caudal tail and spinal cord regeneration in the adult newt, and to determine which 
miRNAs may be either effectors or regulators of the retinoid signaling pathway in this 
regeneration-permissive system. I have demonstrated that many miRNAs are 
dysregulated not only in response to a SCI in the adult newt, but also in response to 
impaired retinoid signaling. Interestingly, not only do two of these miRNAs, miR-133a 
and miR-1, appear to target the retinoid receptor RARβ2, but inhibition of retinoid 
signaling with a RARβ selective antagonist also impairs the stage specific 
downregulation of these miRNAs during regeneration. These data are indicative of a 
negative feed back loop, albeit a potentially indirect one.  
I also aimed to examine which miRNAs were affected by inhibiting RA synthesis 
during tail and caudal spinal cord regeneration. This analysis provided a significant list of 
miRNAs whose expression is dysregulated, and provides a foundation for future studies 
on their putative roles during caudal tail and spinal cord regeneration. 
MicroRNA dysregulation in response to caudal tail amputation. 
 My first aim was to determine if any miRNAs were differentially expressed in the 
adult newt tail in response to amputation. I identified several miRNAs that were 
dysregulated in response to injury, including miR-124a, miR-132, miR-203 and miR-
133a. Expression of miR-133a was localized to the ependymal cells surrounding the 
central canal of the spinal cord, and was high prior to injury but downregulated in 
response to tail amputation. RARβ2 was identified as a target of miR-133a, which is also 
localized to the ependymal cells in the adult newt spinal cord, and upregulated in 
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response to injury (Carter et al., 2011). Finally, mimic-based upregulation of miR-133a 
led to a decrease in RARβ2 levels and inhibition of regeneration. These data suggest that 
the downregulation of miR-133a in response to injury is required for the upregulation of 
RARβ2 for normal tail and caudal spinal cord regeneration. 
MicroRNAs 133a and 1 act downstream of RARβ2. 
 My next specific aim was to determine which, if any, miRNAs were acting 
downstream of RARβ2-mediated retinoid signaling during tail regeneration. Eighteen 
miRNAs were significantly differentially expressed between the LE135 treatment and 
DMSO control groups, many with known roles in other systems that are associated with 
processes required for regeneration (eg., inflammation, apoptosis, proliferation and stem 
cell maintenance). Surprisingly, miR-133a was identified in this microarray, suggesting 
that it is not only acting upstream of RARβ2 signaling, but may also be a downstream 
effector of this signaling cascade.  
At various timepoints during regeneration, miR-1, let-7c and miR-223 were 
localized to the nuclei of ependymal cells. miR-223 was transiently upregulated during 
the first 7 dpa, while miR-1 and let-7c were both downregulated in response to injury. 
RARβ2 was identified as a predicted target or miR-1, which was interesting as it belongs 
to the same genetic cluster as miR-133a (Georgantas et al., 2014; Wystub et al., 2013), 
and shares a very similar expression pattern during tail regeneration. RARβ2 was verified 
as a target of miR-1, and it would appear that together, miR-1 and miR-133a maintain 
basal levels of RARβ2 in the adult newt tail and spinal cord until they are downregulated 
in response to injury. 
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Widespread differential miRNA expression in response to RA synthesis inhibition. 
While the above study determined which miRNAs were potentially acting as 
effectors downstream of RARβ2-mediated retinoid signaling, it is possible that other 
miRNAs may be involved in regulating other aspects of retinoid signaling. My next 
objective was to determine which miRNAs were differentially expressed in response to 
inhibition of retinoid synthesis during regeneration. To accomplish this, I again used a 
microarray, however this time I compared tissue treated with diethylaminobenzaldehyde 
(DEAB), a potent inhibitor of retinaldehyde dehydrogenase (RALDH2). Thus in this 
study, most, if not all RA synthesis should be inhibited with DEAB treatment. This 
microarray revealed 4,426 miRNAs that were differentially expressed in response to RA 
synthesis inhibition, and six were chosen for further profiling. Over the first 14 dpa, miR-
23 expression levels did not change significantly temporally or between treatment and 
control groups. Conversely, miR-21 was significantly upregulated early after injury by 4 
dpa compared to time 0, while both miR-205 and miR-25a were significantly upregulated 
by 7 dpa compared to time 0, but significantly downregulated from 7 to 14 dpa. Finally, 
both miR-149-3p and miR-206 were significantly downregulated at 14 dpa, for miR-149-
3p relative to time 0, while miR-206 is significantly downregulated from day 7. 
Unraveling the role of each of these miRNAs during tail and spinal cord regeneration, 
and their association with the retinoid signaling pathway may provide a clearer picture of 
the complex molecular events underlying epimorphic regeneration in adult urodeles.  
Perspectives. 
 It is clear that not only are miRNAs essential for tail and spinal cord regeneration 
in the newt, but that they play an integral role as effectors and mediators of retinoid 
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signaling through RARβ during this process. The precise role that each of these miRNAs 
play during regeneration is yet to be uncovered, and in reality may never be fully 
understood due to their pleiotropic effects on multiple targets. Will an understanding of 
the role of miRNAs as effectors of retinoid signaling be sufficient to develop therapies 
capable of overcoming the complex inhibitory environment that exists in the adult 
mammalian CNS after injury? This is not likely. It is unfortunately not one single cascade 
that contributes to the inhibitory environment for spinal cord regeneration in the mammal, 
but as discussed earlier in this thesis, a complex series of events that lead to secondary 
damage and scar formation.  
In order to achieve functional regeneration after an SCI in mammals, several 
obstacles need to be overcome including inflammation, glial scar formation and non-
permissive myelin associated inhibitors. A lack of retinoid signaling has been implicated 
in many of these events that leads to the inhibitory environment observed in mammals 
after SCI. For example, RA has been implicated as an anti-inflammatory factor, as 
treatment with high doses of RA in the rat lead to a reduction in the production of pro-
inflammatory cytokines post-SCI (van Neerven et al., 2010). The expression of RARβ 
has been shown to overcome inhibition of neurite outgrowth by myelin-associated 
inhibitors (MAIs) both in vitro and in vivo by directly repressing the Nogo receptor Ngr 
(Agudo et al., 2010; Puttagunta and Di Giovanni, 2011). Furthermore, not only has our 
lab demonstrated that RA is capable of directing neurite outgrowth from adult newt spinal 
cord explants through RARβ-mediated signaling (Dmetrichuk et al., 2005), but that 
RARβ2 is necessary for the ependymal response after SCI in this species (Carter et al., 
2011). Inhibition of RARβ leads to an inhibition in tail regeneration, and this may be due 
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to a lack of an ependymal response, as the ependymal tube fails to form (Carter et al., 
2011). 
 
 
Figure 5.1. Proposed model of how miR-133a and miR-1 promote caudal spinal cord 
regeneration in adult newts. Downregulation of miR-133a and miR-1 in response to 
injury allows for an increase in RARβ2 expression. This forms a negative feedback loop 
to maintain this high RARβ2 expression, which may affect inflammation, activate the 
ependymal response, and direct neurite outgrowth despite an inhibitory environment. 
 
Thus, the observed downregulation of both miR-133a and miR-1 may be required 
for the upregulation of RARβ during tail and caudal spinal cord regeneration in the adult 
newt. It is unknown what is regulating the miRNA dysregulation observed here in 
response to injury, but if this downregulation does not occur, RARβ expression may not 
be upregulated and tail regeneration would be inhibited (Fig. 5.1). It is possible that the 
increase in RARβ is required to initiate the ependymal response, where ependymal cells 
become reactive and proliferate to form the ependymal tube (Chernoff et al., 2003; Lee-
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Liu et al., 2013). The increase in RARβ may also be involved in mediating inflammation 
to maintain a beneficial response rather than an inhibitory one. Finally, the upregulation 
of RARβ as a result of miR-1 and miR-133a downregulation may contribute to not only 
directed neurite outgrowth during regeneration, but also the intrinsic ability to overcome 
inhibitory MAIs. 
Thus if a single, or cocktail, of miRNAs such as miR-1/133a was found to 
regulate retinoid signaling in a regenerative competent species its use as a treatment 
strategy in a regeneration-incompetent species might be warranted. Recent work by Diaz 
Quiroz et al., (2014) represented the first of its kind to examine and compare the pattern 
of expression and function of a miRNA, miR-125b, in the mammalian and urodele SCI 
models. These types of studies will be increasingly useful to develop miRNA-based 
therapeutic strategies for SCI. The possibility that miR-133a and miR-1 are targeting 
other genes in addition to RARβ cannot be ruled out, as miRNAs often have multiple 
targets.  Overall these data provide a framework for future studies that elucidate the 
mechanisms that allow for functional spinal cord regeneration in this regeneration-
competent urodele species. 
 
 
 
 
 
 
 
	   140	  
References  
Abu-Rub, M., McMahon, S., Zeugolis, D.I., Windebank, A., Pandit, A., 2010. Spinal 
cord injury in vitro: modelling axon growth inhibition. Drug Discov. Today 15, 
436–43. doi:10.1016/j.drudis.2010.03.008 
Agudo, M., Yip, P., Davies, M., Bradbury, E., Doherty, P., McMahon, S., Maden, M., 
Corcoran, J.P.T., 2010. A retinoic acid receptor β agonist (CD2019) overcomes 
inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the 
injured adult spinal cord. Neurobiol. Dis. 37, 147–155. 
doi:10.1016/j.nbd.2009.09.018 
Anthony, D.C., Couch, Y., 2014. The systemic response to CNS injury. Exp. Neurol. 
258, 105–11. doi:10.1016/j.expneurol.2014.03.013 
Bak, M., Silahtaroglu, a, Moller, M., Christensen, M., Rath, M.F., Skryabin, B., 
Tommerup, N., Kauppinen, S., 2008. MicroRNA expression in the adult mouse 
central nervous system. Rna-a Publ. Rna Soc. 14, 432–444. doi:10.1261/rna.783108 
Balmer, J.E., 2002. Gene expression regulation by retinoic acid. J. Lipid Res. 43, 1773–
1808. doi:10.1194/jlr.R100015-JLR200 
Barnabé-Heider, F., Göritz, C., Sabelström, H., Takebayashi, H., Pfrieger, F.W., Meletis, 
K., Frisén, J., 2010. Origin of new glial cells in intact and injured adult spinal cord. 
Cell Stem Cell 7, 470–82. doi:10.1016/j.stem.2010.07.014 
Bauduin, B., Lassalle, B., Boilly, B., 2000. Stimulation of axon growth from the spinal 
cord by a regenerating limb blastema in newts. Dev. Brain Res. 119, 47–54. 
Bauduin, B., Lassalle, B., Boilly, B., 2000. Stimulation of axon growth from the spinal 
cord by a regenerating limb blastema in newts. Brain Res. Dev. Brain Res. 119, 47–
54. 
Benraiss, A., Caubit, X., Arsanto, J.P., Coulon, J., Nicolas, S., Le Parco, Y., Thouveny, 
Y., 1996. Clonal cell cultures from adult spinal cord of the amphibian urodele 
Pleurodeles waltl to study the identity and potentialities of cells during tail 
regeneration. Dev. Dyn. 205, 135–49. doi:10.1002/(SICI)1097-
0177(199602)205:2<135::AID-AJA5>3.0.CO;2-J 
Bhalala, O.G., Pan, L., Sahni, V., McGuire, T.L., Gruner, K., Tourtellotte, W.G., Kessler, 
J. a, 2012. microRNA-21 Regulates Astrocytic Response Following Spinal Cord 
Injury. J. Neurosci. 32, 17935–17947. doi:10.1523/JNEUROSCI.3860-12.2012 
Bhalala, O.G., Srikanth, M., Kessler, J.A., 2013. The emerging roles of microRNAs in 
CNS injuries. Nat. Rev. Neurol. 9, 328–39. doi:10.1038/nrneurol.2013.67 
	   141	  
Blum, N., Begemann, G., 2013. The roles of endogenous retinoid signaling in organ and 
appendage regeneration. Cell. Mol. Life Sci. 70, 3907–27. doi:10.1007/s00018-013-
1303-7 
Butler, E.G., Ward, M.B., 1965. Reconstitution of the spinal cord following ablation in 
urodele larvae. J. Exp. Zool. 160, 47–65. 
Butler, E.G., Ward, M.B., 1967. Reconstitution of the spinal cord after ablation in adult 
Triturus. Dev. Biol. 15, 464–86. 
Cao, X., Pfaff, S.L., Gage, F.H., 2007. A functional study of miR-124 in the developing 
neural tube. Genes Dev. 21, 531–6. doi:10.1101/gad.1519207 
Careccia, S., Mainardi, S., Pelosi, A., Gurtner, A., Diverio, D., Riccioni, R., Testa, U., 
Pelosi, E., Piaggio, G., Sacchi, A., Lavorgna, S., Lo-Coco, F., Blandino, G., 
Levrero, M., Rizzo, M.G., 2009. A restricted signature of miRNAs distinguishes 
APL blasts from normal promyelocytes. Oncogene 28, 4034–40. 
doi:10.1038/onc.2009.255 
Carter, C., Clark, A., Spencer, G., Carlone, R., 2011. Cloning and expression of a retinoic 
acid receptor β2 subtype from the adult newt: Evidence for an early role in tail and 
caudal spinal cord regeneration. Dev. Dyn. 240, 2613–2625. 
doi:10.1002/dvdy.22769 
Chatzi, C., Cunningham, T.J., Duester, G., 2013. Investigation of retinoic acid function 
during embryonic brain development using retinaldehyde-rescued Rdh10 knockout 
mice. Dev. Dyn. 242, 1056–65. doi:10.1002/dvdy.23999 
Chen, J.-F., Tao, Y., Li, J., Deng, Z., Yan, Z., Xiao, X., Wang, D.-Z., 2010. microRNA-1 
and microRNA-206 regulate skeletal muscle satellite cell proliferation and 
differentiation by repressing Pax7. J. Cell Biol. 190, 867–79. 
doi:10.1083/jcb.200911036 
Cheng, L.-C., Pastrana, E., Tavazoie, M., Doetsch, F., 2009. miR-124 regulates adult 
neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 12, 399–408. 
doi:10.1038/nn.2294 
Chernoff, E. a G., Sato, K., Corn, A., Karcavich, R.E., 2002. Spinal cord regeneration: 
Intrinsic properties and emerging mechanisms. Semin. Cell Dev. Biol. 13, 361–368. 
doi:10.1016/S1084 
Chernoff, E. a G., Stocum, D.L., Nye, H.L.D., Cameron, J.A., 2003. Urodele spinal cord 
regeneration and related processes. Dev. Dyn. 226, 295–307. 
doi:10.1002/dvdy.10240 
	   142	  
Chiba, Y., Tanabe, M., Goto, K., Sakai, H., Misawa, M., 2009. Down-regulation of miR-
133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am. J. 
Respir. Crit. Care Med. 180, 713–9. doi:10.1164/rccm.200903-0325OC 
Choschzick, I., Hirseland, E., Cramer, H., Schultz, S., Leppert, J., Tronnier, V., Zechel, 
C., 2014. Responsiveness of stem-like human glioma cells to all-trans retinoic acid 
and requirement of retinoic acid receptor isotypes α, β and γ. Neuroscience 279, 44–
64. doi:10.1016/j.neuroscience.2014.07.078 
Corbin, R., Olsson-Carter, K., Slack, F., 2009. The role of microRNAs in synaptic 
development and function. BMB Rep. 42, 131–135. 
Corcoran, J., 2002. Retinoic acid receptor beta2 and neurite outgrowth in the adult mouse 
spinal cord in vitro. J. Cell Sci. 115, 3779–3786. doi:10.1242/jcs.00046 
Corcoran, J., Maden, M., 1999. Nerve growth factor acts via retinoic acid synthesis to 
stimulate neurite outgrowth. Nat. Neurosci. 2, 307–8. doi:10.1038/7214 
Corcoran, J., Shroot, B., Pizzey, J., Maden, M., 2000. The role of retinoic acid receptors 
in neurite outgrowth from different populations of embryonic mouse dorsal root 
ganglia. J Cell Sci 113 ( Pt 1, 2567–2574. 
Corcoran, J., So, P.-L., Barber, R.D., Vincent, K.J., Mazarakis, N.D., Mitrophanous, 
K.A., Kingsman, S.M., Maden, M., 2002. Retinoic acid receptor beta2 and neurite 
outgrowth in the adult mouse spinal cord in vitro. J. Cell Sci. 115, 3779–86. 
Corcoran, J., So, PL, Barber, RD, Vinvent, KJ, Mazarakis, D, Mitrophanous, KA, 
Kingsman, SM, Maden, M., 2002. Retinoic acid receptor beta2 and neurite 
outgrowth in the adult mouse spinal cord in vitro. J. Cell Sci. 115, 3779–3786. 
doi:10.1242/jcs.00046 
Cregg, J.M., DePaul, M.A., Filous, A.R., Lang, B.T., Tran, A., Silver, J., 2014. 
Functional regeneration beyond the glial scar. Exp. Neurol. 253, 197–207. 
doi:10.1016/j.expneurol.2013.12.024 
Davis, B.M., Ayers, J.L., Koran, L., Carlson, J., Anderson, M.C., Simpson, S.B., 1990. 
Time course of salamander spinal cord regeneration and recovery of swimming: 
HRP retrograde pathway tracing and kinematic analysis. Exp. Neurol. 108, 198–213. 
De Rivero Vaccari, J.P., Minkiewicz, J., Wang, X., De Rivero Vaccari, J.C., German, R., 
Marcillo, A.E., Dietrich, W.D., Keane, R.W., 2012. Astrogliosis involves activation 
of retinoic acid-inducible gene-like signaling in the innate immune response after 
spinal cord injury. Glia 60, 414–421. doi:10.1002/glia.22275 
	   143	  
Diaz Quiroz, J.F., Echeverri, K., 2013. Spinal cord regeneration: where fish, frogs and 
salamanders lead the way, can we follow? Biochem. J. 451, 353–64. 
doi:10.1042/BJ20121807 
Diaz Quiroz, J.F., Tsai, E., Coyle, M., Sehm, T., Echeverri, K., 2014. Precise control of 
miR-125b levels is required to create a regeneration-permissive environment after 
spinal cord injury: a cross-species comparison between salamander and rat. Dis. 
Model. Mech. 7, 601–11. doi:10.1242/dmm.014837 
Dill, H., Linder, B., Fehr, A., Fischer, U., 2012. Intronic miR-26b controls neuronal 
differentiation by repressing its host transcript, ctdsp2. Genes Dev. 26, 25–30. 
doi:10.1101/gad.177774.111 
Ding, S.-L., Wang, J.-X., Jiao, J.-Q., Tu, X., Wang, Q., Liu, F., Li, Q., Gao, J., Zhou, Q.-
Y., Gu, D.-F., Li, P.-F., 2013. A pre-microRNA-149 (miR-149) genetic variation 
affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis. 
J. Biol. Chem. 288, 26865–77. doi:10.1074/jbc.M112.440453 
Dmetrichuk, J.M., Spencer, G.E., Carlone, R.L., 2005. Retinoic acid-dependent attraction 
of adult spinal cord axons towards regenerating newt limb blastemas in vitro. Dev. 
Biol. 281, 112–120. doi:10.1016/j.ydbio.2005.02.019 
Donnelly, D.J., Popovich, P.G., 2008. Inflammation and its role in neuroprotection, 
axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 
209, 378–88. doi:10.1016/j.expneurol.2007.06.009 
Duester, G., 2008. Retinoic acid synthesis and signaling during early organogenesis. Cell 
134, 921–31. doi:10.1016/j.cell.2008.09.002 
Echeverri, K., Tanaka, E.M., 2002. Ectoderm to mesoderm lineage switching during 
axolotl tail regeneration. Science 298, 1993–6. doi:10.1126/science.1077804 
Ermakova, O.N., Ermakov, A.M., Tiras, K.P., Lednev, V. V,. [Retinoic acid as a 
regulator of planarian morphogenesis]. Ontogenez 40, 449–55. 
Farrar, N.R., Dmetrichuk, J.M., Carlone, R.L., Spencer, G.E., 2009. A novel, 
nongenomic mechanism underlies retinoic acid-induced growth cone turning. J. 
Neurosci. 29, 14136–42. doi:10.1523/JNEUROSCI.2921-09.2009 
Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M.L., Nervi, C., Bozzoni, I., 
2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A 
and C/EBPalpha regulates human granulopoiesis. Cell 123, 819–31. 
doi:10.1016/j.cell.2005.09.023 
Filous, A.R., Tran, A., Howell, C.J., Busch, S. a, Evans, T. a, Stallcup, W.B., Kang, S.H., 
Bergles, D.E., Lee, S.-I., Levine, J.M., Silver, J., 2014. Entrapment via Synaptic-
	   144	  
Like Connections between NG2 Proteoglycan+ Cells and Dystrophic Axons in the 
Lesion Plays a Role in Regeneration Failure after Spinal Cord Injury. J. Neurosci. 
34, 16369–84. doi:10.1523/JNEUROSCI.1309-14.2014 
Fiore, R., Siegel, G., Schratt, G., 2008. MicroRNA function in neuronal development, 
plasticity and disease. Biochim. Biophys. Acta - Gene Regul. Mech. 1779, 471–478. 
doi:10.1016/j.bbagrm.2007.12.006 
Fitch, M.T., Doller, C., Combs, C.K., Landreth, G.E., Silver, J., 1999. Cellular and 
molecular mechanisms of glial scarring and progressive cavitation: in vivo and in 
vitro analysis of inflammation-induced secondary injury after CNS trauma. J. 
Neurosci. 19, 8182–8198. 
Fournier, A.E., Takizawa, B.T., Strittmatter, S.M., 2003. Rho Kinase Inhibition Enhances 
Axonal Regeneration in the Injured CNS. J. Neurosci. 23, 1416–1423. 
Fujita, Y., Yamashita, T., 2014. Axon growth inhibition by RhoA/ROCK in the central 
nervous system. Front. Neurosci. 8, 338. doi:10.3389/fnins.2014.00338 
Galli, R., Paone, A., Fabbri, M., Zanesi, N., Calore, F., Cascione, L., Acunzo, M., 
Stoppacciaro, A., Tubaro, A., Lovat, F., Gasparini, P., Fadda, P., Alder, H., Volinia, 
S., Filippini, A., Ziparo, E., Riccioli, A., Croce, C.M., 2013. Toll-like receptor 3 
(TLR3) activation induces microRNA-dependent reexpression of functional RARβ 
and tumor regression. Proc. Natl. Acad. Sci. U. S. A. 110, 9812–7. 
doi:10.1073/pnas.1304610110 
Georgantas, R.W., Streicher, K., Greenberg, S.A., Greenlees, L.M., Zhu, W., Brohawn, 
P.Z., Higgs, B.W., Czapiga, M., Morehouse, C.A., Amato, A., Richman, L., Jallal, 
B., Yao, Y., Ranade, K., 2014. Inhibition of myogenic microRNAs 1, 133, and 206 
by inflammatory cytokines links inflammation and muscle degeneration in adult 
inflammatory myopathies. Arthritis Rheumatol. (Hoboken, N.J.) 66, 1022–33. 
doi:10.1002/art.38292 
Giger, R.J., Hollis, E.R., Tuszynski, M.H., 2010. Guidance molecules in axon 
regeneration. Cold Spring Harb. Perspect. Biol. 2. 
Gilbert, S.F., 2000. Regeneration. 
Godwin, J.W., Pinto, A.R., Rosenthal, N. a, 2013. Macrophages are required for adult 
salamander limb regeneration. Proc. Natl. Acad. Sci. U. S. A. 110, 9415–20. 
doi:10.1073/pnas.1300290110 
Gudas, L.J., 2013. Retinoids induce stem cell differentiation via epigenetic changes. 
Semin. Cell Dev. Biol. 24, 701–5. doi:10.1016/j.semcdb.2013.08.002 
	   145	  
Ha, M., Kim, V.N., 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 
15, 509–24. doi:10.1038/nrm3838 
Han, L., Wen, Z., Lynn, R.C., Baudet, M.-L., Holt, C.E., Sasaki, Y., Bassell, G.J., Zheng, 
J.Q., 2011. Regulation of chemotropic guidance of nerve growth cones by 
microRNA. Mol. Brain 4, 40. doi:10.1186/1756-6606-4-40 
Hancock, M.L., Preitner, N., Quan, J., Flanagan, J.G., 2014a. MicroRNA-132 Is Enriched 
in Developing Axons , Locally Regulates Rasa1 mRNA , and Promotes Axon 
Extension 34, 66–78. doi:10.1523/JNEUROSCI.3371-13.2014 
Hancock, M.L., Preitner, N., Quan, J., Flanagan, J.G., 2014b. MicroRNA-132 is enriched 
in developing axons, locally regulates Rasa1 mRNA, and promotes axon extension. 
J. Neurosci. 34, 66–78. doi:10.1523/JNEUROSCI.3371-13.2014 
Harty, M., Neff, A.W., King, M.W., Mescher, A.L., 2003. Regeneration or scarring: An 
immunologic perspective. Dev. Dyn. 226, 268–279. doi:10.1002/dvdy.10239 
Helfer, G., Ross, A.W., Russell, L., Thomson, L.M., Shearer, K.D., Goodman, T.H., 
McCaffery, P.J., Morgan, P.J., 2012. Photoperiod regulates vitamin A and Wnt/β-
catenin signaling in F344 rats. Endocrinology 153, 815–24. doi:10.1210/en.2011-
1792 
Hill, D.S., Ragsdale, C.W., Brockes, J.P., 1993. Isoform-specific immunological 
detection of newt retinoic acid receptor delta 1 in normal and regenerating limbs. 
Development 117, 937–45. 
Holman, E.C., Campbell, L.J., Hines, J., Crews, C.M., 2012. Microarray Analysis of 
microRNA Expression during Axolotl Limb Regeneration. PLoS One 7, e41804. 
doi:10.1371/journal.pone.0041804 
Huang, H., Xie, C., Sun, X., Ritchie, R.P., Zhang, J., Chen, Y.E., 2010. miR-10a 
contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. 
Chem. 285, 9383–9. doi:10.1074/jbc.M109.095612 
Hui, S.P., Monaghan, J.R., Voss, S.R., Ghosh, S., 2013. Expression pattern of Nogo-A, 
MAG, and NgR in regenerating urodele spinal cord. Dev. Dyn. 242, 847–60. 
doi:10.1002/dvdy.23976 
Hunter, K.I.M., Maden, M., Summerbell, D., Eriksson, U.L.F., Holder, N., 1991. 
Retinoic acid stimulates neurite outgrowth in the amphibian spinal cord 88, 3666–
3670. 
Iten, L.E., Bryant, S. V, 1976. Stages of tail regeneration in the adult newt, 
Notophthalmus viridescens. J. Exp. Zool. 196, 283–92. doi:10.1002/jez.1401960303 
	   146	  
Iyer, A.N., Bellon, A., Baudet, M., 2014. microRNAs in axon guidance 8, 1–14. 
doi:10.3389/fncel.2014.00078 
Izumi, B., Nakasa, T., Tanaka, N., Nakanishi, K., Kamei, N., Yamamoto, R., Nakamae, 
T., Ohta, R., Fujioka, Y., Yamasaki, K., Ochi, M., 2011. MicroRNA-223 expression 
in neutrophils in the early phase of secondary damage after spinal cord injury. 
Neurosci. Lett. 492, 114–118. doi:10.1016/j.neulet.2011.01.068 
Jain, A.K., Allton, K., Iacovino, M., Mahen, E., Milczarek, R.J., Zwaka, T.P., Kyba, M., 
Barton, M.C., 2012. p53 regulates cell cycle and microRNAs to promote 
differentiation of human embryonic stem cells. PLoS Biol. 10, e1001268. 
doi:10.1371/journal.pbio.1001268 
Jee, M.K., Jung, J.S., Im, Y. Bin, Jung, S.J., Kang, S.K., 2012. Silencing of miR20a is 
crucial for Ngn1-mediated neuroprotection in injured spinal cord. Hum. Gene Ther. 
23, 508–20. doi:10.1089/hum.2011.121 
Jovičić, A., Roshan, R., Moisoi, N., Pradervand, S., Moser, R., Pillai, B., Luthi-Carter, 
R., 2013. Comprehensive expression analyses of neural cell-type-specific miRNAs 
identify new determinants of the specification and maintenance of neuronal 
phenotypes. J. Neurosci. 33, 5127–37. doi:10.1523/JNEUROSCI.0600-12.2013 
Kim, V.N., Han, J., Siomi, M.C., 2009. Biogenesis of small RNAs in animals. Nat. Rev. 
Mol. Cell Biol. 10, 126–139. doi:10.1038/nrm2632 
Kirkham, M., Hameed, L.S., Berg, D.A., Wang, H., Simon, A., 2014. Progenitor cell 
dynamics in the Newt Telencephalon during homeostasis and neuronal regeneration. 
Stem cell reports 2, 507–19. doi:10.1016/j.stemcr.2014.01.018 
Kosik, K.S., 2006. The neuronal microRNA system. Nat. Rev. Neurosci. 7, 911–920. 
doi:10.1038/nrn2037 
Kusakabe, R., Tani, S., Nishitsuji, K., Shindo, M., Okamura, K., Miyamoto, Y., Nakai, 
K., Suzuki, Y., Kusakabe, T.G., Inoue, K., 2013. Characterization of the compact 
bicistronic microRNA precursor, miR-1/miR-133, expressed specifically in Ciona 
muscle tissues. Gene Expr. Patterns 13, 43–50. doi:10.1016/j.gep.2012.11.001 
Kyritsis, N., Kizil, C., Zocher, S., Kroehne, V., Kaslin, J., Freudenreich, D., Iltzsche, A., 
Brand, M., 2012. Acute inflammation initiates the regenerative response in the adult 
zebrafish brain. Science 338, 1353–6. doi:10.1126/science.1228773 
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., Tuschl, T., 2002. 
Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735–9. 
	   147	  
Lang, B.T., Wang, J., Filous, A.R., Au, N.P.B., Ma, C.H.E., Shen, Y., 2014. Pleiotropic 
molecules in axon regeneration and neuroinflammation. Exp. Neurol. 258, 17–23. 
doi:10.1016/j.expneurol.2014.04.031 
Le, H.-G.T., Dowling, J.E., Cameron, D.J., 2012. Early retinoic acid deprivation in 
developing zebrafish results in microphthalmia. Vis. Neurosci. 29, 219–28. 
doi:10.1017/S0952523812000296 
Lee-Liu, D., Edwards-Faret, G., Tapia, V.S., Larraín, J., 2013. Spinal cord regeneration: 
Lessons for mammals from non-mammalian vertebrates. Genesis 51, 529–544. 
doi:10.1002/dvg.22406 
Lepp, A.C., Carlone, R.L., 2014. RARβ2 expression is induced by the down-regulation of 
microRNA 133a during caudal spinal cord regeneration in the adult newt. Dev. Dyn. 
doi:10.1002/dvdy.24210 
Lin, H., Qian, J., Castillo, A.C., Long, B., Keyes, K.T., Chen, G., Ye, Y., 2011. Effect of 
miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest. 
Ophthalmol. Vis. Sci. 52, 6308–14. doi:10.1167/iovs.10-6632 
Liu, N.-K., Wang, X.-F., Lu, Q.-B., Xu, X.-M., 2009. Altered microRNA expression 
following traumatic spinal cord injury. Exp. Neurol. 219, 424–9. 
doi:10.1016/j.expneurol.2009.06.015 
Maden, M., 1996. Retinoids in patterning: chimeras win by a knockout. Curr. Biol. 6, 
790–3. 
Maden, M., 2007. Retinoic acid in the development, regeneration and maintenance of the 
nervous system. Nat. Rev. Neurosci. 8, 755–765. doi:10.1038/nrn2212 
Maden, M., 2013. Who needs stem cells if you can dedifferentiate? Cell Stem Cell 13, 
640–1. doi:10.1016/j.stem.2013.11.020 
Maden, M., n.d. Retinoids as endogenous components of the regenerating limb and tail. 
Wound Repair Regen. 6, 358–65. 
Maden, M., Hind, M., 2003. Retinoic acid, a regeneration-inducing molecule. Dev. Dyn. 
226, 237–44. doi:10.1002/dvdy.10222 
Maden, M., Keen, G., Jones, G.E., 1998. Retinoic acid as a chemotactic molecule in 
neuronal development. Int. J. Dev. Neurosci. 16, 317–322. 
Mchedlishvili, L., Mazurov, V., Tanaka, E.M., 2012. Reconstitution of the central 
nervous system during salamander tail regeneration from the implanted 
neurospheres. Methods Mol. Biol. 916, 197–202. doi:10.1073/pnas.1116738109 
	   148	  
Melton, C., Judson, R.L., Blelloch, R., 2010. Opposing microRNA families regulate self-
renewal in mouse embryonic stem cells. Nature 463, 621–6. 
doi:10.1038/nature08725 
Meza-Sosa, K.F., Pedraza-Alva, G., Pérez-Martínez, L., 2014. microRNAs: key triggers 
of neuronal cell fate. Front. Cell. Neurosci. 8, 175. doi:10.3389/fncel.2014.00175 
Molotkova, N., Molotkov, A., Duester, G., 2007. Role of retinoic acid during forebrain 
development begins late when Raldh3 generates retinoic acid in the ventral 
subventricular zone. Dev. Biol. 303, 601–10. doi:10.1016/j.ydbio.2006.11.035 
Monaghan, J.R., Maden, M., 2012. Visualization of retinoic acid signaling in transgenic 
axolotls during limb development and regeneration. Dev. Biol. 368, 63–75. 
doi:10.1016/j.ydbio.2012.05.015 
Morin, R.D., O’Connor, M.D., Griffith, M., Kuchenbauer, F., Delaney, A., Prabhu, A.-L., 
Zhao, Y., McDonald, H., Zeng, T., Hirst, M., Eaves, C.J., Marra, M.A., 2008. 
Application of massively parallel sequencing to microRNA profiling and discovery 
in human embryonic stem cells. Genome Res. 18, 610–21. doi:10.1101/gr.7179508 
Muramatsu, R., Ueno, M., Yamashita, T., 2009. Intrinsic regenerative mechanisms of 
central nervous system neurons. Biosci. Trends 3, 179–183. 
Nakamura, K., Maki, N., Trinh, A., Trask, H.W., Gui, J., Tomlinson, C.R., Tsonis, P. a., 
2010. MiRNAs in newt lens regeneration: Specific control of proliferation and 
evidence for miRNA networking. PLoS One 5, e12058. 
doi:10.1371/journal.pone.0012058 
Nakanishi, K., Nakasa, T., Tanaka, N., Ishikawa, M., Yamada, K., Yamasaki, K., Kamei, 
N., Izumi, B., Adachi, N., Miyaki, S., Asahara, H., Ochi, M., 2010. Responses of 
microRNAs 124a and 223 following spinal cord injury in mice. Spinal cord  Off. J. 
Int. Med. Soc. Paraplegia 48, 192–196. doi:10.1038/sc.2009.89 
Nakasa, T., Ishikawa, M., Shi, M., Shibuya, H., Adachi, N., Ochi, M., 2010. Acceleration 
of muscle regeneration by local injection of muscle-specific microRNAs in rat 
skeletal muscle injury model. J. Cell. Mol. Med. 14, 2495–505. doi:10.1111/j.1582-
4934.2009.00898.x 
Nervi, C., Grignani, F., 2014. RARs and microRNAs. Subcell. Biochem. 70, 151–79. 
doi:10.1007/978-94-017-9050-5_8 
Neto, a., Mercader, N., Gomez-Skarmeta, J.L., 2012. The osr1 and osr2 genes act in the 
pronephric anlage downstream of retinoic acid signaling and upstream of wnt2b to 
maintain pectoral fin development. Development 139, 301–311. 
doi:10.1242/dev.074856 
	   149	  
Nieto-Diaz, M., Esteban, F.J., Reigada, D., Muñoz-Galdeano, T., Yunta, M., Caballero-
López, M., Navarro-Ruiz, R., Del Águila, A., Maza, R.M., 2014. MicroRNA 
dysregulation in spinal cord injury: causes, consequences and therapeutics. Front. 
Cell. Neurosci. 8, 53. doi:10.3389/fncel.2014.00053 
Nuovo, G.J., Elton, T.S., Nana-Sinkam, P., Volinia, S., Croce, C.M., Schmittgen, T.D., 
2009. A methodology for the combined in situ analyses of the precursor and mature 
forms of microRNAs and correlation with their putative targets. Nat. Protoc. 4, 107–
115. doi:10.1038/nprot.2008. 
Panayiotou, E., Malas, S., 2013. Adult spinal cord ependymal layer: a promising pool of 
quiescent stem cells to treat spinal cord injury. Front. Physiol. 4, 340. 
doi:10.3389/fphys.2013.00340 
Paschaki, M., Lin, S.C., Wong, R.L.Y., Finnell, R.H., Dollé, P., Niederreither, K., 2012. 
Retinoic acid-dependent signaling pathways and lineage events in the developing 
mouse spinal cord. PLoS One 7, e32447. doi:10.1371/journal.pone.0032447 
Pecorino, L.T., Entwistle, A., Brockes, J.P., 1996. Activation of a single retinoic acid 
receptor isoform mediates proximodistal respecification. Curr. Biol. 6, 563–9. 
Petrie, M.A., Suneja, M., Faidley, E., Shields, R.K., 2014. A minimal dose of electrically 
induced muscle activity regulates distinct gene signaling pathways in humans with 
spinal cord injury. PLoS One 9, e115791. doi:10.1371/journal.pone.0115791 
Pogue, a. I., Cui, J.G., Li, Y.Y., Zhao, Y., Culicchia, F., Lukiw, W.J., 2010. Micro RNA-
125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci. 
Lett. 476, 18–22. doi:10.1016/j.neulet.2010.03.054 
Poss, K.D., Nechiporuk, A., Hillam, A.M., Johnson, S.L., Keating, M.T., 2002. Mps1 
defines a proximal blastemal proliferative compartment essential for zebrafish fin 
regeneration. Development 129, 5141–9. 
Prince, D.J., Carlone, R.L., 2003. Retinoic acid involvement in the reciprocal 
neurotrophic interactions between newt spinal cord and limb blastemas in vitro. Dev. 
Brain Res. 140, 67–73. 
Puttagunta, R., Di Giovanni, S., 2011. Retinoic acid signaling in axonal regeneration. 
Front. Mol. Neurosci. 4, 59. doi:10.3389/fnmol.2011.00059 
Rebane, A., Akdis, C. a., 2013. MicroRNAs: Essential players in the regulation of 
inflammation. J. Allergy Clin. Immunol. 132, 15–26. doi:10.1016/j.jaci.2013.04.011 
Roberts, T.C., 2014. The MicroRNA Biology of the Mammalian Nucleus 1–8. 
doi:10.1038/mtna.2014.40 
	   150	  
Rochel, N., Moras, D., 2014. Architecture of DNA Bound RAR heterodimers. Subcell. 
Biochem. 70, 21–36. doi:10.1007/978-94-017-9050-5_2 
Romero, R., Bueno, D., 2001. Disto-proximal regional determination and intercalary 
regeneration in planarians, revealed by retinoic acid induced disruption of 
regeneration. Int. J. Dev. Biol. 45, 669–73. 
Sahni, V., Mukhopadhyay, A., Tysseling, V., Hebert, A., Birch, D., Mcguire, T.L., Stupp, 
S.I., Kessler, J. a, 2010. BMPR1a and BMPR1b signaling exert opposing effects on 
gliosis after spinal cord injury. J. Neurosci. 30, 1839–1855. 
doi:10.1523/JNEUROSCI.4459-09.2010 
Sandoval-Guzmán, T., Wang, H., Khattak, S., Schuez, M., Roensch, K., Nacu, E., Tazaki, 
A., Joven, A., Tanaka, E.M., Simon, A., 2014. Fundamental differences in 
dedifferentiation and stem cell recruitment during skeletal muscle regeneration in 
two salamander species. Cell Stem Cell 14, 174–87. doi:10.1016/j.stem.2013.11.007 
Sarang, Z., Joós, G., Garabuczi, É., Rühl, R., Gregory, C.D., Szondy, Z., 2014. 
Macrophages engulfing apoptotic cells produce nonclassical retinoids to enhance 
their phagocytic capacity. J. Immunol. 192, 5730–8. doi:10.4049/jimmunol.1400284 
Saugstad, J.A., 2010. MicroRNAs as effectors of brain function with roles in ischemia 
and injury, neuroprotection, and neurodegeneration. J. Cereb. Blood Flow Metab. 
30, 1564–76. doi:10.1038/jcbfm.2010.101 
Saumet, A., Vetter, G., Bouttier, M., Portales-Casamar, E., Wasserman, W.W., Maurin, 
T., Mari, B., Barbry, P., Vallar, L., Friederich, E., Arar, K., Cassinat, B., 
Chomienne, C., Lecellier, C.-H., 2009. Transcriptional repression of microRNA 
genes by PML-RARA increases expression of key cancer proteins in acute 
promyelocytic leukemia. Blood 113, 412–21. doi:10.1182/blood-2008-05-158139 
Sehm, T., Sachse, C., Frenzel, C., Echeverri, K., 2009. miR-196 is an essential early-
stage regulator of tail regeneration, upstream of key spinal cord patterning events. 
Dev. Biol. 334, 468–480. doi:10.1016/j.ydbio.2009.08.008 
Shearer, M.C., Niclou, S.P., Brown, D., Asher, R. a., Holtmaat, A.J.G.D., Levine, J.M., 
Verhaagen, J., Fawcett, J.W., 2003. The astrocyte/meningeal cell interface is a 
barrier to neurite outgrowth which can be overcome by manipulation of inhibitory 
molecules or axonal signalling pathways. Mol. Cell. Neurosci. 24, 913–925. 
doi:10.1016/j.mcn.2003.09.004 
Silver, J., Miller, J.H., 2004. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 
146–156. doi:10.1038/nrn1326 
	   151	  
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., Wulczyn, F.G., 2005. 
Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 
21, 1469–77. doi:10.1111/j.1460-9568.2005.03978.x 
So, P.-L., Yip, P.K., Bunting, S., Wong, L.-F., Mazarakis, N.D., Hall, S., McMahon, S., 
Maden, M., Corcoran, J.P.T., 2006. Interactions between retinoic acid, nerve growth 
factor and sonic hedgehog signalling pathways in neurite outgrowth. Dev. Biol. 298, 
167–75. doi:10.1016/j.ydbio.2006.06.027 
Strickland, E.R., Hook, M. a., Balaraman, S., Huie, J.R., Grau, J.W., Miranda, R.C., 
2011. MicroRNA dysregulation following spinal cord contusion: Implications for 
neural plasticity and repair. Neuroscience 186, 146–160. 
doi:10.1016/j.neuroscience.2011.03.063 
Sun, E.-H., Zhou, Q., Liu, K.-S., Wei, W., Wang, C.-M., Liu, X.-F., Lu, C., Ma, D.-Y., 
2014. Screening miRNAs related to different subtypes of breast cancer with 
miRNAs microarray. Eur. Rev. Med. Pharmacol. Sci. 18, 2783–8. 
Taïbi, F., Metzinger-Le Meuth, V., Massy, Z.A., Metzinger, L., 2014. miR-223: An 
inflammatory oncomiR enters the cardiovascular field. Biochim. Biophys. Acta 
1842, 1001–9. doi:10.1016/j.bbadis.2014.03.005 
Tamminga, J., Kathiria, P., Koturbash, I., Kovalchuk, O., 2008. DNA damage-induced 
upregulation of miR-709 in the germline downregulates BORIS to counteract 
aberrant DNA hypomethylation. Cell Cycle 7, 3731–6. 
Tanaka, E.M., Weidinger, G., 2008. Micromanaging regeneration. Genes Dev. 22, 700–5. 
doi:10.1101/gad.1660508 
Tani, S., Kuraku, S., Sakamoto, H., Inoue, K., Kusakabe, R.,. Developmental expression 
and evolution of muscle-specific microRNAs conserved in vertebrates. Evol. Dev. 
15, 293–304. doi:10.1111/ede.12039 
Tao, J., Wu, D., Xu, B., Qian, W., Li, P., Lu, Q., Yin, C., Zhang, W., 2012. microRNA-
133 inhibits cell proliferation, migration and invasion in prostate cancer cells by 
targeting the epidermal growth factor receptor. Oncol. Rep. 27, 1967–75. 
doi:10.3892/or.2012.1711 
Taylor, S., Wakem, M., Dijkman, G., Alsarraj, M., Nguyen, M., 2010. A practical 
approach to RT-qPCR-Publishing data that conform to the MIQE guidelines. 
Methods 50, S1–5. doi:10.1016/j.ymeth.2010.01.005 
Terao, M., Fratelli, M., Kurosaki, M., Zanetti, A., Guarnaccia, V., Paroni, G., Tsykin, A., 
Lupi, M., Gianni, M., Goodall, G.J., Garattini, E., 2011. Induction of miR-21 by 
retinoic acid in estrogen receptor-positive breast carcinoma cells: biological 
	   152	  
correlates and molecular targets. J. Biol. Chem. 286, 4027–42. 
doi:10.1074/jbc.M110.184994 
Thatcher, E.J., Patton, J.G., 2010. Small RNAs have a big impact on regeneration 1–6. 
Thatcher, E.J., Paydar, I., Anderson, K.K., Patton, J.G., 2008. Regulation of zebrafish fin 
regeneration by microRNAs. Proc. Natl. Acad. Sci. U. S. A. 105, 18384–18389. 
Trompeter, H.-I., Dreesen, J., Hermann, E., Iwaniuk, K.M., Hafner, M., Renwick, N., 
Tuschl, T., Wernet, P., 2013. MicroRNAs miR-26a, miR-26b, and miR-29b 
accelerate osteogenic differentiation of unrestricted somatic stem cells from human 
cord blood. BMC Genomics 14, 111. doi:10.1186/1471-2164-14-111 
Tsonis, P.A., Call, M.K., Grogg, M.W., Sartor, M.A., Taylor, R.R., Forge, A., Fyffe, R., 
Goldenberg, R., Cowper-Sal-lari, R., Tomlinson, C.R., 2007. MicroRNAs and 
regeneration: Let-7 members as potential regulators of dedifferentiation in lens and 
inner ear hair cell regeneration of the adult newt. Biochem. Biophys. Res. Commun. 
362, 940–5. doi:10.1016/j.bbrc.2007.08.077 
Valinezhad Orang, A., Safaralizadeh, R., Kazemzadeh-Bavili, M., 2014. Mechanisms of 
miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-
Specific Upregulation. Int. J. Genomics 2014, 970607. doi:10.1155/2014/970607 
Van Neerven, S., Mey, J., Joosten, E. a, Steinbusch, H.W., van Kleef, M., Marcus, M. a 
E., Deumens, R., 2010. Systemic but not local administration of retinoic acid 
reduces early transcript levels of pro-inflammatory cytokines after experimental 
spinal cord injury. Neurosci. Lett. 485, 21–5. doi:10.1016/j.neulet.2010.08.051 
Van Rooij, E., Liu, N., Olson, E.N., 2008. MicroRNAs flex their muscles. Trends Genet. 
24, 159–66. doi:10.1016/j.tig.2008.01.007 
Varkonyi-Gasic, E., Wu, R., Wood, M., Walton, E.F., Hellens, R.P., 2007. Protocol: a 
highly sensitive RT-PCR method for detection and quantification of microRNAs. 
Plant Methods 3, 12. doi:10.1186/1746-4811-3-12 
Viviano, C.M., Brockes, J.P., 1996. Is retinoic acid an endogenous ligand during urodele 
limb regeneration? Int. J. Dev. Biol. 40, 817–22. 
Vo, N., Klein, M.E., Varlamova, O., Keller, D.M., Yamamoto, T., Goodman, R.H., 
Impey, S., 2005. A cAMP-response element binding protein-induced microRNA 
regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 102, 16426–
16431. 
Witman, N., Heigwer, J., Thaler, B., Lui, W.O., Morrison, J.I., 2013. MiR-128 regulates 
non-myocyte hyperplasia, deposition of extracellular matrix and Islet1 expression 
	   153	  
during newt cardiac regeneration. Dev. Biol. 383, 253–263. 
doi:10.1016/j.ydbio.2013.09.011 
Wong, L.-F., Yip, P.K., Battaglia, A., Grist, J., Corcoran, J., Maden, M., Azzouz, M., 
Kingsman, S.M., Kingsman, A.J., Mazarakis, N.D., McMahon, S.B., 2006. Retinoic 
acid receptor beta2 promotes functional regeneration of sensory axons in the spinal 
cord. Nat. Neurosci. 9, 243–50. doi:10.1038/nn1622 
Wystub, K., Besser, J., Bachmann, A., Boettger, T., Braun, T., 2013. miR-1/133a clusters 
cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels 
during embryonic heart development. PLoS Genet. 9, e1003793. 
doi:10.1371/journal.pgen.1003793 
Xie, C., Huang, H., Sun, X., Guo, Y., Hamblin, M., Ritchie, R.P., Garcia-Barrio, M.T., 
Zhang, J., Chen, Y.E., 2011. MicroRNA-1 regulates smooth muscle cell 
differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 20, 205–10. 
doi:10.1089/scd.2010.0283 
Xie, F., Zheng, B., 2008. White matter inhibitors in CNS axon regeneration failure. Exp. 
Neurol. 209, 302–12. doi:10.1016/j.expneurol.2007.07.005 
Xu, W., Li, P., Qin, K., Wang, X., Jiang, X., 2012. miR-124 regulates neural stem cells in 
the treatment of spinal cord injury. Neurosci. Lett. 529, 12–7. 
doi:10.1016/j.neulet.2012.09.025 
Yin, V.P., Lepilina, A., Smith, A., Poss, K.D., 2012. Regulation of zebrafish heart 
regeneration by miR-133. Dev. Biol. 365, 319–327. 
doi:10.1016/j.ydbio.2012.02.018 
Yin, V.P., Poss, K.D., 2008. New regulators of vertebrate appendage regeneration. Curr. 
Opin. Genet. Dev. 18, 381–386. doi:10.1016/j.gde.2008.06.008 
Yin, V.P., Thomson, J.M., Thummel, R., Hyde, D.R., Hammond, S.M., Poss, K.D., 2008. 
Fgf-dependent depletion of microRNA-133 promotes appendage regeneration in 
zebrafish. Genes Dev. 22, 728–733. doi:10.1101/gad.1641808 
Yip, P.K., Wong, L.-F., Pattinson, D., Battaglia, A., Grist, J., Bradbury, E.J., Maden, M., 
McMahon, S.B., Mazarakis, N.D., 2006. Lentiviral vector expressing retinoic acid 
receptor beta2 promotes recovery of function after corticospinal tract injury in the 
adult rat spinal cord. Hum. Mol. Genet. 15, 3107–18. doi:10.1093/hmg/ddl251 
Yip, P.K., Wong, L.F., Pattinson, D., Battaglia, a, Grist, J., Bradbury, E.J., Maden, M., 
McMahon, S.B., Mazarakis, N.D., 2006. Lentiviral vector expressing retinoic acid 
receptor beta2 promotes recovery of function after corticospinal tract injury in the 
adult rat spinal cord. Hum Mol Genet 15, 3107–3118. doi:10.1093/hmg/ddl251 
	   154	  
Yu, Y.M., Gibbs, K.M., Davila, J., Campbell, N., Sung, S., Todorova, T.I., Otsuka, S., 
Sabaawy, H.E., Hart, R.P., Schachner, M., 2011. MicroRNA miR-133b is essential 
for functional recovery after spinal cord injury in adult zebrafish. Eur. J. Neurosci. 
33, 1587–1597. doi:10.1111/j.1460-9568.2011.07643.x 
Yunta, M., Nieto-Diaz, M., Esteban, F.J., Caballero-Lopez, M., Navarro-Ruiz, R., 
Reigada, D., Pita-Thomas, D.W., del Aguila, a, Munoz-Galdeano, T., Maza, R.M., 
2012. MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS 
One 7, e34534. doi:10.1371/journal.pone.0034534 
Zardo, G., Ciolfi, A., Vian, L., Starnes, L.M., Billi, M., Racanicchi, S., Maresca, C., Fazi, 
F., Travaglini, L., Noguera, N., Mancini, M., Nanni, M., Cimino, G., Lo-Coco, F., 
Grignani, F., Nervi, C., 2012. Polycombs and microRNA-223 regulate human 
granulopoiesis by transcriptional control of target gene expression. Blood 119, 
4034–46. doi:10.1182/blood-2011-08-371344 
Zhang, F., Clarke, J.D., Ferretti, P., 2000. FGF-2 Up-regulation and proliferation of 
neural progenitors in the regenerating amphibian spinal cord in vivo. Dev. Biol. 225, 
381–91. doi:10.1006/dbio.2000.9843 
Zhang, Y., Xie, R.-L., Gordon, J., LeBlanc, K., Stein, J.L., Lian, J.B., van Wijnen, A.J., 
Stein, G.S., 2012. Control of mesenchymal lineage progression by microRNAs 
targeting skeletal gene regulators Trps1 and Runx2. J. Biol. Chem. 287, 21926–35. 
doi:10.1074/jbc.M112.340398 
Zhao, J.J., Sun, D.G., Wang, J., Liu, S.R., Zhang, C.Y., Zhu, M.X., Ma, X., 2008. 
Retinoic acid downregulates microRNAs to induce abnormal development of spinal 
cord in spina bifida rat model. Child’s Nerv. Syst. 24, 485–492. 
doi:10.1007/s00381-007-0520-5 
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.S., Xin, 
M., Wang, F., Appel, B., Lu, Q.R., 2010. MicroRNA-Mediated Control of 
Oligodendrocyte Differentiation. Neuron 65, 612–626. 
doi:10.1016/j.neuron.2010.02.018 
Zhou, X., He, X., Ren, Y., 2014. Function of microglia and macrophages in secondary 
damage after spinal cord injury. Neural Regen. Res. 9, 1787–1795. 
doi:10.4103/1673-5374.143423 
Zhu, Y., Lu, Y., Zhang, Q., Liu, J.-J., Li, T.-J., Yang, J.-R., Zeng, C., Zhuang, S.-M., 
2012. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition 
by activating the pRb protein. Nucleic Acids Res. 40, 4615–25. 
doi:10.1093/nar/gkr1278 
Zhuang, G., Meng, C., Guo, X., Cheruku, P.S., Shi, L., Xu, H., Li, H., Wang, G., Evans, 
A.R., Safe, S., Wu, C., Zhou, B., 2012. A novel regulator of macrophage activation: 
	   155	  
miR-223 in obesity-associated adipose tissue inflammation. Circulation 125, 2892–
903. doi:10.1161/CIRCULATIONAHA.111.087817 
Zukor, K. a, Kent, D.T., Odelberg, S.J., 2011. Meningeal cells and glia establish a 
permissive environment for axon regeneration after spinal cord injury in newts. 
Neural Dev. 6, 1. doi:10.1186/1749-8104-6-1 
Zukor, K. a., Kent, D.T., Odelberg, S.J., 2010. Fluorescent whole-mount method for 
visualizing three-dimensional relationships in intact and regenerating adult newt 
spinal cords. Dev. Dyn. 239, 3048–3057. doi:10.1002/dvdy.22441 
 
 
 
 
 
 
 
 
 
Appendix 
Table 3.1. Raw data from the microarray performed by LC Sciences (Houston, TX), 
comparing the signal intensities of LE135 or DMSO treated regenerates. Custom chips 
containing all known miRNAs from miRBase version 16.0 for Danio rerio, Xenopus 
laevis and Xenopus tropicalis were used. 
      Group 1 Group 2   
      DMSO & EtOH LE135 
Log2 
(G2/G1) 
No. Reporter Name p-value Mean Mean   
3 dre-let-7c 6.61E-03 633 505 -0.33 
Following transcripts are statistically significant but have low signals (signal < 
500) 
168 dre-miR-26a 3.65E-07 92 190 1.05 
249 xla-miR-1306 1.03E-06 155 244 0.66 
245 dre-miR-92b 7.69E-06 121 70 -0.78 
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161 dre-miR-223 1.16E-05 191 118 -0.70 
41 dre-miR-133a 1.10E-04 102 154 0.59 
62 dre-miR-145 1.79E-04 108 63 -0.77 
217 dre-miR-462 2.54E-04 79 41 -0.96 
26 dre-miR-125a 2.63E-04 81 145 0.84 
124 dre-miR-205 2.73E-04 67 104 0.62 
43 dre-miR-133b 6.56E-04 94 137 0.54 
11 dre-miR-1 1.08E-03 167 241 0.53 
66 dre-miR-150 3.29E-03 68 43 -0.66 
169 dre-miR-26b 3.75E-03 26 52 1.01 
99 dre-miR-193a 5.06E-03 47 26 -0.89 
166 dre-miR-24 5.65E-03 61 88 0.52 
227 dre-miR-727* 7.09E-03 56 36 -0.64 
100 dre-miR-193b 9.03E-03 70 98 0.48 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2. A list of the miRNAs that were significantly different between DEAB and 
DMSO treatment groups in a microarray performed by LC Sciences (Houston, TX). 
Custom chips containing all known miRNAs from miRBase version 18.0 for Danio rerio, 
Xenopus laevis, Xenopus tropicalis, Homo sapien and Mus musculus were used. Red 
represents P<0.0001, yellow P<0.001 and blue P<0.01. 
Reporter Name p-value 
hsa-miR-1236-3p 5.19E-05 
mmu-miR-6393 6.80E-05 
hsa-miR-3177-3p 9.68E-05 
hsa-miR-6864-3p 1.18E-04 
mmu-miR-485-3p 1.25E-04 
mmu-miR-705 1.68E-04 
mmu-miR-6987-3p 1.68E-04 
xla-miR-1b 1.93E-04 
hsa-miR-3665 2.00E-04 
mmu-miR-466o-3p 2.05E-04 
hsa-miR-4764-3p 2.17E-04 
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mmu-miR-7058-3p 2.50E-04 
mmu-miR-467b-3p 2.53E-04 
hsa-miR-1224-5p 2.91E-04 
mmu-miR-6984-3p 3.29E-04 
hsa-miR-4465 3.52E-04 
hsa-miR-6777-5p 3.78E-04 
mmu-miR-1940 4.28E-04 
mmu-miR-7082-5p 4.47E-04 
mmu-miR-6382 4.70E-04 
mmu-miR-7088-3p 5.27E-04 
hsa-miR-6728-3p 5.28E-04 
mmu-miR-7041-3p 5.36E-04 
mmu-miR-6974-3p 5.40E-04 
hsa-miR-6732-3p 5.48E-04 
hsa-miR-1281 5.48E-04 
mmu-miR-5126 5.68E-04 
mmu-miR-8103 5.95E-04 
mmu-miR-8114 6.00E-04 
hsa-miR-3610 6.60E-04 
hsa-miR-6809-3p 7.21E-04 
mmu-miR-3572-3p 7.42E-04 
mmu-miR-669p-3p 7.48E-04 
mmu-miR-7116-5p 7.62E-04 
hsa-miR-4419b 7.65E-04 
hsa-miR-7110-3p 8.01E-04 
mmu-miR-6917-3p 8.29E-04 
mmu-miR-7219-3p 8.38E-04 
hsa-miR-5699-5p 8.69E-04 
hsa-miR-1825 8.72E-04 
mmu-miR-7088-5p 8.82E-04 
mmu-miR-709 9.29E-04 
mmu-miR-5107-5p 9.89E-04 
xtr-miR-202-3p 1.05E-03 
dre-miR-1 1.06E-03 
hsa-miR-6779-3p 1.06E-03 
mmu-miR-7027-3p 1.09E-03 
dre-miR-30c 1.12E-03 
dre-let-7e 1.15E-03 
mmu-miR-7070-3p 1.16E-03 
mmu-miR-6939-5p 1.17E-03 
hsa-miR-466 1.19E-03 
mmu-miR-3970 1.23E-03 
hsa-miR-4687-3p 1.26E-03 
hsa-miR-6881-3p 1.35E-03 
hsa-miR-4701-5p 1.37E-03 
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mmu-miR-7036-3p 1.42E-03 
mmu-miR-297a-3p 1.43E-03 
mmu-miR-376b-3p 1.44E-03 
dre-let-7d 1.45E-03 
hsa-miR-6509-3p 1.50E-03 
hsa-miR-6873-3p 1.55E-03 
mmu-miR-6942-3p 1.59E-03 
mmu-miR-341-5p 1.62E-03 
mmu-miR-5110 1.73E-03 
mmu-miR-7001-3p 1.74E-03 
hsa-miR-6780a-5p 1.79E-03 
hsa-miR-4516 1.80E-03 
mmu-miR-1966-3p 1.81E-03 
hsa-miR-7641 1.85E-03 
mmu-miR-877-3p 1.86E-03 
mmu-miR-6368 1.87E-03 
mmu-miR-678 1.98E-03 
hsa-miR-1973 2.01E-03 
mmu-miR-6973b-3p 2.03E-03 
dre-miR-125c 2.19E-03 
mmu-miR-6961-3p 2.19E-03 
hsa-miR-6750-3p 2.20E-03 
mmu-miR-3071-5p 2.24E-03 
hsa-miR-4298 2.26E-03 
dre-miR-130b 2.32E-03 
mmu-miR-382-3p 2.34E-03 
mmu-miR-6946-3p 2.35E-03 
hsa-miR-6823-3p 2.39E-03 
mmu-miR-3547-5p 2.43E-03 
hsa-miR-6734-3p 2.55E-03 
hsa-miR-1227-5p 2.56E-03 
hsa-miR-5096 2.57E-03 
hsa-miR-449b-3p 2.64E-03 
mmu-miR-6915-3p 2.67E-03 
hsa-miR-6849-3p 2.68E-03 
mmu-miR-6960-3p 2.82E-03 
mmu-miR-5107-3p 2.83E-03 
mmu-miR-6944-3p 2.88E-03 
mmu-miR-7028-5p 2.88E-03 
hsa-miR-485-3p 2.92E-03 
mmu-miR-466g 2.92E-03 
hsa-miR-6878-3p 2.96E-03 
hsa-miR-6809-5p 3.01E-03 
mmu-miR-467c-3p 3.13E-03 
hsa-miR-6756-5p 3.17E-03 
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mmu-miR-7658-3p 3.24E-03 
hsa-miR-6775-5p 3.25E-03 
xtr-miR-30c 3.26E-03 
hsa-miR-3141 3.30E-03 
hsa-miR-483-3p 3.36E-03 
mmu-miR-3968 3.60E-03 
mmu-miR-6978-3p 3.65E-03 
xtr-miR-10b 3.69E-03 
hsa-miR-4499 3.87E-03 
hsa-miR-4667-5p 3.90E-03 
mmu-miR-7211-5p 3.93E-03 
hsa-miR-6754-3p 3.99E-03 
dre-miR-223 4.04E-03 
dre-miR-204 4.16E-03 
mmu-miR-1892 4.27E-03 
mmu-miR-8104 4.29E-03 
hsa-miR-6767-5p 4.39E-03 
hsa-miR-6769a-5p 4.55E-03 
mmu-miR-466m-3p 4.57E-03 
hsa-miR-4281 4.81E-03 
hsa-miR-6778-5p 4.84E-03 
hsa-miR-6830-3p 4.90E-03 
hsa-miR-4443 4.97E-03 
hsa-miR-7856-5p 5.08E-03 
mmu-miR-1895 5.27E-03 
mmu-miR-7056-3p 5.28E-03 
dre-miR-26a 5.29E-03 
hsa-miR-6891-5p 5.36E-03 
dre-miR-214 5.47E-03 
hsa-miR-3682-3p 5.53E-03 
hsa-miR-1224-3p 5.77E-03 
hsa-miR-6816-3p 5.78E-03 
mmu-miR-467a-3p 5.81E-03 
mmu-miR-7017-3p 5.90E-03 
mmu-miR-667-3p 6.03E-03 
hsa-miR-6751-3p 6.25E-03 
mmu-miR-196a-1-3p 6.30E-03 
hsa-miR-4319 6.44E-03 
mmu-miR-1903 6.45E-03 
mmu-miR-149-3p 6.45E-03 
hsa-miR-6832-3p 6.60E-03 
hsa-miR-3197 6.61E-03 
mmu-miR-3569-5p 6.74E-03 
hsa-miR-196b-3p 6.74E-03 
mmu-miR-6967-5p 6.81E-03 
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mmu-miR-669d-3p 6.89E-03 
mmu-miR-5112 6.90E-03 
mmu-miR-483-5p 6.91E-03 
xtr-miR-26 7.02E-03 
hsa-miR-6736-3p 7.03E-03 
hsa-miR-6865-5p 7.04E-03 
xtr-let-7i 7.05E-03 
hsa-miR-23c 7.23E-03 
hsa-miR-6831-3p 7.32E-03 
mmu-miR-6914-3p 7.75E-03 
mmu-let-7j 7.82E-03 
dre-miR-10a-5p 7.88E-03 
mmu-miR-7224-3p 7.94E-03 
hsa-miR-6861-3p 7.97E-03 
xtr-miR-98 7.99E-03 
hsa-miR-1260b 8.35E-03 
mmu-miR-669d-2-3p 8.45E-03 
dre-miR-125a 8.57E-03 
hsa-miR-7106-5p 8.76E-03 
hsa-miR-630 8.97E-03 
mmu-miR-467d-3p 9.42E-03 
hsa-miR-4290 9.44E-03 
hsa-miR-6508-5p 9.61E-03 
mmu-miR-466q 9.66E-03 
hsa-miR-4690-5p 9.84E-03 
 
